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The genome of Campylobacter jejuni NCTC 11168 contains a small three gene operon encoding 
a series of seemingly un-related proteins not typically found in bacteria.  Immediately 
upstream of this operon are two genes encoding a small DNA-binding protein and a membrane 
bound cytoplasmic protein, proposed to act as a sensor-regulator system.  The DNA-binding 
protein tightly represses the expression of the structural operon under normal growth 
conditions and its removal results in a strong (>100-fold) up-regulation of the operon.  The 
operon contains 3 structural genes which encode for proteins not typically found in microbial 
genomes, cj0423 encodes a small membrane protein, cj0424 encodes a periplasmic lipid 
binding MORN domain protein (Membrane Occupation and Recognition Nexus) and cj0425 
encodes for a periplasmic cystatin like protein (cysteine protease inhibitor). 
 
Bioinformatic analysis revealed that the structural genes within this cluster are highly variable 
between Campylobacter jejuni and Campylobacter coli strains yet the regulatory mechanisms 
appear highly conserved.  The only structural gene which appears conserved between 
Campylobacter strains is cj0423, which shows architectural similarity to phage derived holin 
proteins. 
 
Initially the project focused on the hypothesis that the genes were responsible for defending 
against cationic antimicrobial peptides (CAMPs).  This however proved to be incorrect and a 
series of mutant and complementation constructs were produced in a newly genome 
sequenced laboratory variant of C. jejuni (designated NCTC 11168-DJK for this study).  To assay 
for the roles of the genes, a series of LacZ reporter constructs were produced to screen for 
potential inducers of the operon.  The Biolog© phenotype microarray system was also adapted 
for use as a high throughput screening system using the LacZ reporter.   
 
During the course of this work the cystatin like protein Cj0425 was shown to not inhibit the 
activity of the archetypal cysteine protease papain.  Both bioinformatic analysis and in-vitro 
pulldown assays were unable to locate a native binding partner for the protein, implying its 
role may be targeted to foreign proteins or perhaps unrelated to protease inhibition. 
 
A series of novel assays were developed to examine the possibility that the operon may be 
involved in defending against foreign derived periplasmic-acting toxins such as those secreted 
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1 Chapter 1 Introduction 
 
1.1 Campylobacter jejuni 
 
1.1.1 Campylobacter jejuni: discovery 
Campylobacter species and other closely related genera are Gram-negative, motile, spiral 
shaped, ε-proteobacteria which are often found as colonisers of the mammalian and avian 
gastrointestinal tracts (Blaser, 1997).  Initially discovered as a cause of abortive infection in 
cattle, Campylobacter was originally named Vibrio fetus based on its morphological similarity 
to another Vibrio species (Smith, 1918).  Another species which showed similar pathogenic 
characteristics but different antigenic properties, also isolated from diseased cattle, was 
named Vibrio jejuni in 1931 (Jones et al., 1931).  The authors also noted the difficulty of 
culturing V. jejuni in the laboratory and that it could not utilise common carbohydrates as a 
growth medium.  The first reported human case of Campylobacter infection was after a huge 
outbreak of gastroenteritis at a prison in Illinois involving some 3,500 people.  The source was 
traced to a contaminated milk supply and a spiral shaped bacterium was isolated from many of 
the patients (Levy, 1946).  While the author initially suspected a virus they noted the possibility 
that V. jejuni may have been the causative agent after finding the organism in fecal samples. 
 
Some of the early work on the characterization of Campylobacter was carried out by Elizabeth 
King who began to note that Vibrio fetus and Vibrio jejuni were commonly occurring in human 
disease cases as well as farm animal outbreaks (King, 1957, King, 1962).  King also importantly 
noted that these species had an optimum growth temperature of 42°C.  The organisms were 
subsequently re-named as Campylobacter after it became apparent that they differed in 
certain fundamental aspects and sera reactivity from other Vibrio species (Sebald and Veron, 
1963).  It took a further 10 years before it was noticed that this seemingly opportunistic 









Early attempts to isolate Campylobacter from stool samples had proved ineffective due to the 
presence of large numbers of contaminating coliforms, so the bacterium became associated 
with in-frequent but life threatening systemic blood infections.  A Campylobacter-selective 
media was developed containing vancomycin, trimethoprim and the antimicrobial peptide 
polymyxin-B, which could effectively isolate Campylobacter species from stool samples 
(Skirrow, 1977).  Following this improvement in detection methodology, Campylobacter 
outbreaks started to become heavily associated with undercooked chicken meat and 
Campylobacter was frequently isolated from processed chicken at the point of sale.  Seasonal 
variations of Campylobacter infections also became apparent with increases in the number of 
cases during the summer months (Skirrow, 1982).  Campylobacter has since been shown to be 
the most common cause of human gastroenteritis in the developed world, outnumbering 
other gastric pathogens like Shigella, Escherichia coli and norovirus.  The number of reported 
infections is thought to be an underrepresentation of the true scale of the disease due to the 
often mild symptoms and the similarity between campylobacteriosis and viral food poisoning 
(Allos and Blaser, 1995).  Taxonomic studies based on 16s rRNA and whole genome sequencing 
have categorised a number of different bacterial families into the Campylobacterales order, 
including the Campylobacteraceae, Helicobacteraceae, Wolinella, Sulfurospirillium, Thiovulum 
Figure 1: Campylobacter jejuni NCTC 11168 cell morphologies.  (A) NCTC 11168-O the original clinical isolate of 
the wild type strain.  (B) NCTC 11168-GS, a variant of the 11168-O strain used for producing the original 11168 
genome sequence.  The cells were negatively stained with 2% (w/v) phosphotungstic acid, the bars are 1 µM.  




and Arcobacter specie (Okoli et al., 2007).  The majority of these are microaerophilic to varying 
degrees.  These organisms fall into the epsilon subdivision of the proteobacteria. 
 
1.1.2 The epsilonproteobacteria 
The ε-proteobacteria are better known as colonisers of deep sea thermal vents than chickens, 
yet Campylobacter and Helicobacter species are closer relatives of deep sea vent bacteria, 
which can thrive at 50-60°C than to E. coli or Salmonella (Campbell et al., 2006).  The ε-
proteobacteria are estimated to have been the second sub-group of proteobacteria to diverge 
from the original proteobacteria group (after the δ-proteobacteria) (Gilbreath et al., 2011).  
They are metabolically versatile organisms which play an important role in the Sulphur and 
Nitrogen cycles around deep sea vents (Nakagawa and Takai, 2008).  As such many ε-
proteobacteria can utilise hydrogen or reduced sulphur compounds as electron donors and 
nitrate or elemental sulphur as electron acceptors (Takai et al., 2003).  Strangely some deep 
sea vent ε-proteobacteria appear to share some virulence factors with their terra bound 
cousins, including hemolysin, the invasion antigen CiaB and the N-linked glycosylation gene 
cluster, suggesting that these virulence factors may have originated as survival genes and were 
adapted as virulence factors by C. jejuni and H. pylori (Nakagawa et al., 2007). 
 
As well as Campylobacter species the other pathogenic members of the Campylobacterales are 
Helicobacter species.  Helicobacter pylori (previously known as Campylobacter pylori) is 
famously associated with duodenal ulcers, causing relapsing infections of the gastric mucosal 
layer (Marshall et al., 1988).  Helicobacter species are estimated to infect nearly half the adult 
human population (Peleteiro et al., 2014), though infection rates vary significantly between 
countries.  Helicobacter species possess multiple virulence factors which can severely damage 
the epithelial layer, including CagA (Cytotoxin associated gene) and VacA (Vacuolating 
cytotoxin).  These toxins are both highly immunogenic with CagA being exported via the Type 
IV secretion system (along with some peptidoglycan fragments) into the host cell where it 
interacts with host signaling molecules and VacA, which forms membrane channels in the host 
cell and can induce apoptosis (Kusters et al., 2006).  Helicobacter can also use molecular 
hydrogen as a respiratory substrate (Olson and Maier, 2002), a process which may have 
evolved in deep sea thermal vents.  Another non-pathogenic ε-proteobacteria ‘Wolinella 
succinogens’ shares approximately one third of its genes with Campylobacter and another 
third with Helicobacter (Baar et al., 2003).  Unlike these strains Wolinella is able to grow 
microaerobically and anaerobically using hydrogen or formate as electron donors and a range 




non-pathogenic ε-proteobacteria W.  succinogens contains a Nickel-dependent hydrogenase 
common to anaerobic bacteria. 
 
1.1.3 Features of the Campylobacter genome sequence 
The first Campylobacter jejuni genome sequence became available in 2000, the NCTC11168 
pathogenic human isolated strain was fully sequenced by (Parkhill et al., 2000).  The single 
1,641,481 base pair chromosome contains 1,654 predicted ORFs with at least 20 probably 
representing pseudogenes.  The genome of C. jejuni is comparatively dense with 94.3% of the 
genome taken up with coding sequences and is relatively AT rich (69.4%).  The genome 
contains 48 distinct poly-G/C tracts which can lead to phase variable switching of genes 
(Bayliss et al., 2012) (Fouts et al., 2005), these tracts were often found in genes relating to the 
synthesis or modification of cell surface structures (Parkhill et al., 2000).  The 11168 genome 
predicts only 3 sigma factors, the housekeeping RpoD (σ70), and the motility sigma factors FliA 
(σ28) and RpoN (σ54) (Jagannathan et al., 2001).  The C. jejuni NCTC 11168 genome sequence 
was re-annotated in 2007 by (Gundogdu et al., 2007), the number of complete ORFs was 
reduced to 1643 and the products from 18.2% of the coding sequence were revised to include 



























The genomes of three other commonly used strains of C. jejuni were sequenced in 2005 (C. 
jejuni RM 1221), 2006 (C. jejuni 81-176) and 2007 (C. jejuni 81116) by (Fouts et al., 2005) 
(Hofreuter et al., 2006) (Pearson et al., 2007) respectively.  C. jejuni RM1221 contains 1,884 
predicted ORFs and a similar CG content and genome length to the 11168 reference strain.  
The RM1221 strain contains more predicted pseudogenes than 11168 (47 compared to 20) and 
also contains two non-specific DNA/RNA endonucleases which are thought to inhibit the 
natural transformation efficiency of RM1221 (Gaasbeek et al., 2010).  The C. jejuni 81-176 
strain is known for its heightened virulence compared to other strains of C. jejuni, the strain 
Figure 2: Circular representation of the original C. jejuni NCTC 11168 genome sequence.  Features of the 
1,641,481 bp nucleotide sequence are represented by coloured circles with the putative origin of replication 
marked.  From the outside to the inside, the dark green represents ORFs transcribed in a clockwise orientation, 
the lighter green represents ORFs transcribed in the anticlockwise orientation.  The black lines represent 
hypervariable sequences and the pink lines represent genes involved in in surface polysaccharide, flagellar or 
lipooligosaccharide production, these clusters are also marked.  The inner yellow and orange histogram shows 
the similarity of each gene to its Helicobacter pylori orthologue, the height of the bar and the colour intensity are 




contains two plasmids pTet, which contain a tetracycline resistance gene (Batchelor et al., 
2004). And pVir which contains components of a Type IV secretion system and has recently 
been shown to contain a toxin-antitoxin system, where a proteic toxin CjpT is inhibited at the 
RNA level by a small non-coding RNA cjpA (Shen et al., 2016).  C. jejuni 81116 contains 1,626 
predicted ORFs and a similar AT content to 11168.  The 81116 genome contains fewer poly-G 
tracts than 11168 (17 compared to 30 respectively) and has been shown to be both amenable 
to genetic manipulation while maintaining genome fidelity (Manning et al., 2001).  The C. jejuni 
promoter regions differ from other bacteria as instead of a -10 and -35 box region the C. jejuni 
promoters appear to contain only an extended -10 box (Petersen et al., 2003).   
 
1.2 Epidemiology and chicken colonisation of Campylobacter jejuni 
Campylobacter jejuni is one of the most common causes of food borne illness in the developed 
world.  Its prevalence is largely due to the difficulty in eradicating C. jejuni from poultry 
products and its low infectious does (>500 cells) (Robinson, 1981).  Campylobacter infection 
often leads to bloody diarrhea for a few days and will typically clear up in less than a week 
without treatment.  The most common source of infection is via contaminated poultry meat, 
or meat contaminated with poultry derived Campylobacter such as cross contamination during 
food preparation.  Other sources include contaminated groundwater, cow or pig meat and 
some unpasteurized milk products as well as domestic pets (Dasti et al., 2010).  Poultry birds 
are the most common hosts for Campylobacter probably because of their 42°C body 
temperature which is the optimum growth temperature for C. jejuni and C. coli.   Typically, 
Campylobacter will colonise chickens between 2-3 weeks old with >90% being colonized by 7 
weeks.  Colonisation will spread rapidly throughout broiler chicken flocks, becoming almost 
impossible to eradicate once established in a flock (Evans and Sayers, 2000).  This near ubiquity 
of Campylobacter colonisation in chicken production facilities is passed on to the retail market 
where 60-80% of raw chicken products are contaminated with Campylobacter at the point of 
sale (Müllner et al., 2010).  
 
Campylobacter species take hold in the gastrointestinal tract of chickens and other poultry 
birds, typically in the caecum and colon.  When poultry birds are processed the contents of the 
caecum and colon can be washed over the skin of the bird where Campylobacter will become 
entrapped in the feather follicles and remain viable at 4°C for over 72 hours (Chantarapanont 
et al., 2004).  The rate of reported Campylobacter infections is thought to be considerably 
lower than the true rate of infection, the infection rate in the Unites States is estimated to be 
close to 1 in every 100 every year (Allos and Blaser, 1995).  Because Campylobacter infection 




norovirus infection it is probably mistaken for these when in fact Campylobacter infection is 
more common. 
 
1.3 Iron homeostasis mechanisms of Campylobacter jejuni 
Iron storage and acquisition is essential for microbial survival as iron plays crucial roles in 
electron transport, gene regulation, the oxidative stress response and metabolic processes.  
Like most metals, the uptake and storage of iron must be carefully regulated due to the 
potentially damaging effects of free radical formation (Gilbreath et al., 2011).  Campylobacter 
jejuni 11168 encodes homologues of the ferric uptake regulator (Fur) and also contain a 
separate peroxide stress regulator (PerR) which is a functional analog of a different peroxide 
stress regulator (OxyR) found in other bacteria (Van Vliet et al., 1999).  Unusually the 
expression of the peroxide stress response in C. jejuni is responsive to iron levels rather than 
reactive oxygen species.  Iron can be transported across the outer membrane by porins and 
dedicated iron specific siderophore uptake mechanisms.  C. jejuni cannot produce iron 
chelating siderophores such as enterobactin but is able to scavenge iron from siderophores 
probably produced by other bacteria.  C. jejuni possesses a dedicated ferrous enterobactin 
transporter CfrA which transports iron-bound enterobactin across the inner membrane 
(Naikare et al., 2013).  This transport requires the proton motive force, which is provided by 
TonB3 which transfers the energy needed for active transport from the inner membrane to the 
outer membrane (Gresock et al., 2011).  The 11168 genome also encodes a FeoB, homologue 
which is responsible for Fe2+ transport across the inner membrane, and is necessary for 
colonisation and intracellular survival (Naikare et al., 2006).  Free iron in the presence of 
oxygen can lead to reactive oxygen species such as hydroxyl radicals (OH•), peroxides (ROOH) 
and superoxide (O2-) (Storz and Imlayt, 1999), which can cause damage to multiple targets 
within a cell.  C. jejuni possesses a ferritin-like protein (Campylobacter ferritin Cft) which is the 
main iron storage protein and binds to iron at a 1.5:1 ratio (iron phosphate : ferritin) thereby 
removing it from circulation (Wai et al., 1995). 
 
1.4 Campylobacter jejuni oxygen tolerance 
Campylobacter jejuni is a microaerophilic organism which thrives in an oxygen concentration 
of between 3-10 % and a carbon dioxide concentration of between 5-10 % (Bolton and Coates, 
1983).  Both atmospheric oxygen and completely anaerobic conditions inhibit growth, though 
C. jejuni does possess mechanisms to cope with oxidative stress.  In order to successfully 
transfer between hosts Campylobacter will likely have to persist in atmospheric oxygen and 
may have to survive sudden oxidative shock when internalised by phagocytes (Wooldridge and 




oxygen, in particular those containing reactive iron-sulphur clusters.  Resisting this damage 
requires both resistance and repair mechanisms.  C. jejuni is known for preferential catabolism 
of L-serine as a primary carbon source, the L-Serine dehydratase SdaA enzyme which 
catabolises L-serine to pyruvate contains an iron-sulphur cluster and is sensitive to 
atmospheric oxygen (Velayudhan et al., 2004).  The pyruvate and 2-oxoglutarate:acceptor 
oxidoreductase enzymes (Por and Oor) from the TCA cycle also contain iron Sulphur clusters 
and homologues from of these enzymes from H. pylori have been shown to be damaged by 
atmospheric oxygen (Hughes et al., 1995).  Por and Oor are thought to be protected from 
oxygen damage by the presence of oxygen binding hemerythrins (Kendall et al., 2014).  The C. 
jejuni 11168 genome also encodes two methionine sulphoxide reductases msrA and msrB 
which contribute to oxidative stress resistance by repairing methionine residues damaged by 
oxygen (Atack and Kelly, 2008).  It is not known how C. jejuni is able to mediate the response 
to oxidative stress as no direct oxygen sensing mechanism has been found so far.  The recently 
discovered ‘Regulator of Response to Peroxide’ (RrpA/B) proteins may act as part of a novel 
oxidative stress response mechanism; both proteins act as DNA-binding regulators.  
Mutagenesis of RrpB leads to increased sensitivity to oxidative stress and reduced expression 
of the catalase gene katA, the iron responsive peroxide response regulator perR and the heat 
shock regulator hspR (Gundogdu et al., 2011, Gundogdu et al., 2015).  While high levels of 
oxygen can cause considerable damage to C. jejuni, the 11168 genome also encodes an oxygen 
dependent I-type ribonucleotide reductase (RNR) for the production of ribonucleotides (most 
bacteria contain a class II-type which functions in aerobic and anaerobic environments), the 
lack of an oxygen independent RNR contributes to the need for low levels of oxygen for growth 
(Sellars et al., 2002). 
 
1.5 Capnophilic growth of Campylobacter 
Campylobacter jejuni requires a higher than atmospheric concentration of carbon dioxide for 
optimal growth (5-10 %) (Bolton and Coates, 1983), the molecular reasons for this unusually 
high requirement are unclear but it may be due to relatively inefficient enzymes for which CO2 
is a substrate.  Campylobacter jejuni 11168 encodes an acetyl-CoA carboxylase, essential for 
fatty acid biosynthesis.  This protein has a homologue in Helicobacter pylori which shows a low 
affinity for CO2 which is considered a reason for the high CO2 requirement of H. pylori (Burns et 
al., 1995).  The C. jejuni 11168 genome also encodes 2 carbonic anhydrase enzymes which 
produce bicarbonate from gaseous CO2 (Smith and Ferry, 2000).  One of these enzymes Cj0237 
(CanB) is required for growth in low atmospheric CO2 concentrations and is only active above 
pH8 and with a relatively low affinity for CO2 suggesting inefficient conversion of CO2 to 




1.6 Pathogenicity and virulence of Campylobacter jejuni 
1.6.1 Campylobacter jejuni motility 
The best understood virulence factor of C. jejuni is probably the flagellar motility apparatus.  
Knockout deletions of motility genes lead to strains deficient in chicken colonisation and with a 
reduced ability to cause infection in animal models (Wassenaar et al., 1993, Golden and 
Acheson, 2002).  Campylobacter expresses a bipolar unsheathed flagellar composed of FlaA 
and FlaB oligomers which are close homologues of each other (91.9% sequence identity).  flaA 
is regulated by the classical motility sigma factor σ28, while flaB is regulated by σ54.  Deletion of 
flaA results in the production of a truncated flagellar composed of FlaB, while deletion of FlaB 
produces only a slight reduction in motility (Guerry et al., 1991).  Motility is controlled by the 
two component FlgS/R sensor regulator system (Wösten et al., 2004), where the production of 
the major flagellin filament by σ28 is induced only after the assembly of the Type III secretion 
motility apparatus (also known as the flagellin export apparatus) (Joslin and Hendrixson, 2009).  
This may be because motility is energetically costly and motility mutants in C. jejuni are able to 
grow 3X faster that fully motile strains (Wösten et al., 2004).  Flagellar-mediated motility is 
thought to allow C. jejuni to reach certain niches within the host such as passing through the 




Figure 3: The motility apparatus of Campylobacter jejuni and Helicobacter pylori compared to Salmonella spp 
and E. coli.  The protein components of the flagellar apparatus are colour coded to represent alternate 
transcriptional hierarchies, where the archetypal flagellar apparatus of E. coli and Salmonella are transcribed in 
two stages (red then blue).  In C. jejuni the type III secretion system components shown in black are expressed 
first which then activates the expression of those in red and then blue.  The components shown in grey are 
transcribed separately to the traditional flagellar hierarchy.  Image adapted from (Gilbreath et al., 2011) where 




1.6.2 Campylobacter jejuni chemotaxis 
Chemotaxis is the movement towards or away from specific environmental attractants or 
repellants.  The C. jejuni 11168 genome predicts 10 methyl-accepting chemotaxis proteins 
(MCPs) which are involved in sensing extracellular attractants or repellants (Marchant et al., 
2002).  A 1988 study screening potential chemoattractants and repellants showed that C. jejuni 
demonstrates classical chemotaxis towards L-fucose, L-serine, L-aspartate, L-glutamate, L-
cysteine, pyruvate, fumarate, succinate, citrate, malate and ketoglutarate, showing a strong 
preference for amino acids and metabolic intermediates over carbohydrates.  C. jejuni also 
showed chemotactic motility towards mucins which are secreted by epithelial cells.  Some 
types of bile acids were shown to act as chemo-repellants to C. jejuni such as cholic acid, 
deoxycholic acid and taurocholic acid (Hugdahl et al., 1988).  C. jejuni is also able to respond to 
localised energy levels and will migrate in response to the redox state of the electron transport 
chain/proton motive force, this energy-taxis system is mediated by the Campylobacter energy 
taxis proteins CetA and CetB (Elliott and DiRita, 2008). 
 
1.6.3 Adhesion and Invasion 
C. jejuni is able to invade intestinal epithelial cells using microtubules rather than the more 
common actin-cytoskeletal rearrangement internalisation method used by Salmonella, Shigella 
or Yersinia strains (Oelschlaeger et al., 1993) (Dramsi and Cossart, 1998).  The C. jejuni genome 
does not encode for fimbrae or pili, instead attachment to host cells is mediated by adhesins 
exposed on the cell surface, including the flagellum (Grant et al., 1993).  C. jejuni produces 
multiple adhesion and invasion protein including the fibrinonectin binding protein CadF 
(Konkel et al., 1997), the autotransporter protein CapA (Ashgar et al., 2007) and the outer 
membrane lipoprotein JlpA (Jin et al., 2001).  Intracellular Campylobacter is often isolated from 
patient biopsies and the ability of C. jejuni to invade cells has been demonstrated in multiple 
cell lines (Grant et al., 1993, Dasti et al., 2010).  Once internalised within host cells C. jejuni is 
able to resist destruction in the lysosomes by creating its own membrane bound compartment 
within the host cell termed the Campylobacter-containing vacuole or CCV where it undergoes 
physiological changes in oxygen sensitivity and can persist and divide (Watson and Galán, 
2008).  When cultured with animal cell cultures C. jejuni produces and exports a series of 
invasion antigens termed Campylobacter invasion antigens (Cia) (Rivera-Amill et al., 2001), 
these are likely secreted by the motility apparatus system due to the lack of any other type III 
secretion system (Konkel et al., 2004).  This indicates that the motility apparatus is involved in 
both motility and virulence factor secretion which may suggest why the flaA flagellin gene is 
under the control of a different sigma factor to the rest of the motility apparatus, to allow for 




1.6.4 Toxin production 
The symptoms of Campylobacter infection suggest that toxins play a role in disease 
progression, the transition from watery to bloody diarrhea suggest that C. jejuni is able to 
actively damage the epithelial lining of the intestines.  A variety of different toxins have been 
associated with Campylobacter infection but the best studied are the cytoleathal distending 
toxins cdtABC (Dasti et al., 2010).  The CdtABC holotoxin is incorporated into the eukaryotic 
cell by an unknown uptake mechanism where CdtA and CdtC remain at the target cell 
membrane, these two proteins contain lectin like regions which are structurally similar to the 
toxin ricin (these domains recognise oligosaccharides) (Heywood et al., 2005) (Young et al., 
2007).  The exact mechanism for uptake of the Cdt toxins and how they cause cell death are 
still not fully understood, but it has been demonstrated that toxicity requires all 3 Cdt proteins, 
the CtdB toxin is thought to be the active component of this system which is exported into the 
host cell and causes double strand breaks in the host DNA from within the nucleus, eventually 
leading to pre-programmed cell death (Lara-Tejero and Galán, 2001).  The 11168 genome 
sequence also predicts two haemolysins (cj0183 and cj0588), knockout mutations showed that 
Cj0588 is required for invasion but does not show hemolytic activity in-vitro and surprisingly 
removal of cj0183 does not abolish hemolytic activity (Sałamaszyńska-Guz and Klimuszko, 
2008).  The study concludes that haemolysis may be mediated by other un-annotated 
hemolytic proteins.  C. jejuni also contains a putative phospholipase toxin pldA, a deletion 
mutant of this gene shows impaired colonisation of chickens (Ziprin et al., 2014). 
 
1.6.5 Protein glycosylation 
Glycosylation is a common post translational modification system where sugar moieties are 
covalently bound to proteins.  N-linked glycosylation links a glycan to the amide nitrogen of an 
asparagine residue and O-linked glycosylation links a glycan to the hydroxyl group of serine or 
threonine residues.  Campylobacter contains a complex glycosylation pathway which uses both 
N- and O-linked glycans to modify a range of target proteins.  The N-linked glycosylation 
system in Campylobacter is considered the archetypal N-linked glycosylation system, the pgl 
gene cluster is responsible for synthesis of glycans and the attachment of acetylglucosamine-
containing heptasaccharide to the asparagine residues of some proteins (Szymanski et al., 
1999, Young et al., 2002).  The glycan is attached to the conserved residue D/E-X-N-Z-S/T, 
where N is the glycosylated asparagine and the X and Z are any amino acid (with the exception 
of proline) (Kowarik et al., 2006).  The O-linked glycosylation system is used to heavily modify 
the flagellar FlaA protein, with up to 19 separate glycans per monomer (McNally et al., 2006).  
The pse gene cluster is responsible for producing pseudaminic acid derivatives which are then 




causes a loss of motility implying that glycosylation is essential for motility, and therefore 
successful colonisation and adherence (McNally et al., 2006, Nothaft and Szymanski, 2010).  
The biological role of glycosylation is still not clear, mutations within pgl genes show decreased 
colonisation of chickens and a reduction in adherence and invasion of human cells, but why is 
not fully understood (Karlyshev et al., 2004). 
 
1.7 Gram negative peptidoglycan  
Peptidoglycan (also known as murein) is a crucial component of both Gram-positive and Gram-
negative bacteria.  The peptidoglycan structure is composed of a glycan based backbone 
composed of repeating residues of N-acetylglucosamine (GlcNAc) and N-acetylmuramic acid 
(MurNAc).  Attached to the GlcNAc residues are short peptide side chains containing both 
proteinogenic and non-proteinogenic (L and D) amino acids, these peptides are crosslinked 
forming a rigid net like polymer which is located in the periplasm of Gram-negative bacteria 
and forms the outer layer of the Gram-positive cell envelope (Vollmer et al., 2004).  The 
peptidoglycan layer is typically anchored to the outer membrane by approximately 105 
individual lipoproteins (known as Braun’s lipoprotein or major outer membrane lipoprotein), 
which is covalently bound at both ends to the peptidoglycan layer and the outer membrane 
(Braun, 1975).  Synthesis of peptidoglycan begins with the peptide side chains being attached 
individually to the MurNAc residue using the MurABCDEF pathway (Pinho et al., 2013).  The 
GlcNAc residue is then attached and the whole PG monomer is flipped across the inner 
membrane and attached to the existing peptidoglycan layer by transpeptidase and 
transglycosylase enzymes.  Transpeptidases are also known as penicillin-binding proteins 
(PBPs) and are common targets for antibiotics (Spratt and Cromie, 1988).  The peptidoglycan 
wall can be repaired and replaced by the action of lytic-transglycosylases, endopeptidases and 
amidases (Goodell, 1985).  Some of the cleaved peptidoglycan fragments are exported outside 
the cell but many are recycled, in E. coli the AmpG (GlcNAc-anhMurNAc) permease transports 
single peptidoglycan unit from the periplasm to the cytoplasm and the AmpD (anhMurNAc-L-
Ala) amidase separate the peptide stem from the glycan dimer (Jacobs et al., 1994).  It is 
estimated that E. coli is able to recycle up to 50% of the cleaved peptide stem which can then 
be re-used without the need to reproduce the peptide (Goodell, 1985).   
 
1.8 Campylobacter peptidoglycan  
The formation of the Campylobacter jejuni cell wall is not particularly well studied, but it 
appears that the peptidoglycan layer of C. jejuni is highly similar in structure to other Gram-
negative bacteria.  The C. jejuni peptidoglycan N-acetylmuramic acid residue can be acetylated 




esterase Ape1.  Strangely, the loss of PatB produces no colonisaion defect (though the authors 
note that the acetylation of MurNAc was not abolished suggesting the presence of a PatB 
analog), while the loss of Ape1 leads to an accumulation of acetylated peptidoglycan residues 
and reduced chicken colonisation (Ha et al., 2016).  Modifications of the C. jejuni cell wall have 
been shown to cause the typical helical shape of Campylobacter.  The actions of two LD-
endopeptidases in C. jejuni termed Pgp1 and Pgp2 (peptidoglycan peptidases 1 and 2) cleave 
specific sites in the peptide stem of the peptidoglycan layer.  Removal of these genes results in 
a non-helical cell, the localisation and expression of these genes is thought to be important as 
expression of both genes in the periplasm of E. coli does not cause the cells to become spiral 
(Frirdich et al., 2012, Frirdich et al., 2014).  Strangely, the 11168 genome does not appear to 
encode a homologue of Braun’s lipoprotein, the relatively high abundance and small size (8 
kDa) of Braun’s lipoprotein in the Gram-negative periplasm is usually visible on SDS-PAGE gels 
and is notably absent from C. jejuni (Logan and Trust, 1982).  C. jejuni does encode a potential 
substitute protein termed Omp18 (outer membrane protein 18) which may act as an 
alternative to Braun’s lipoprotein, but has not been well studied (Burnens et al., 1995, Konkel 
et al., 1996).  The peptidoglycan recycling system of E. coli appears to have no homologues in 
the C. jejuni 11168 genome, the AmpG permease is not found and neither are any of the 
enzymes involved in degrading and re-forming the peptidoglycan unit after transport into the 
cytoplasm.  Whether C. jejuni is able to recycle peptidoglycan is unknown (Parkhill et al., 2000).  
 
1.9 Cationic antimicrobial peptides  
Cationic antimicrobial peptides (CAMPs) are an ancient component of the eukaryotic immune 
system; these simple oligopeptide structures are highly conserved between eukaryotes and 
are produced to defend against a broad spectrum of potential pathogens including bacteria, 
fungi, viruses and in some cases tumors.  While they do not offer the same flexibility as the 
adaptive immune system, they play a crucial role within the innate immune system (Hancock 
and Sahl, 2006).  Antimicrobial molecules containing primarily amino acids are produced by all 
3 domains of life (Parisien et al., 2008).  When synthesised by microbes, AMPs can be 
produced either ribosomally or via multi-enzyme pathways, which allows for the inclusion of 
non-proteinogenic amino acids and the formation of cyclic structures (Wiesner and Vilcinskas, 
2010).  Examples of these include the polymyxins, bacitracins, gramicidins, nisin and the 
lantibiotics, some of which are used as antimicrobials in the food industry (Guinane et al., 
2005).  Antimicrobial peptides produced by bacteria are typically referred to as bacteriocins 
while those produced by higher eukaryotes are referred to as antimicrobial peptides; these 
tend to be ribosomally produced and are classed into three major families based on secondary 




defensins characterised by conserved cysteine residues forming β-sheet ladders.  (3) Linear 
peptides, which tend to show a strong, bias for certain amino acids such as tryptophan, 
proline, arginine or histidine (Boman, 2003, Gruenheid and Le Moual, 2012).  All three families 
of antimicrobial peptides are largely characterised by their net positive charge and 
amphipathic properties and are thus named cationic antimicrobial peptides (CAMPs).  The 
peptide sequences of many CAMPs are not highly conserved between eukaryotes yet the 
structures and positively charged residues are, implying that the mechanism of action and 
microbial target is highly conserved between bacteria (Matsuzaki, 1999).  Almost any type of 
mammalian cell can produce CAMPs though they are most often associated with areas 
particularly at risk of infection such as the skin, intestinal lining, eyes and mouth (Gruenheid 









Figure 4: The three main classes of ribosomally produced CAMPs.  (A) the defensins, characterised by their 
folded structure and disulfide bonds.  (B)  the linear cathelicidins and (C) the shorter linear peptides.  All three 
groups share a net positive charge and are ribosomally synthesised.  Positive residues are shown in blue and 
negative residues are shown in red.  All structure taken from the protein data bank 




1.9.1 The model CAMP polymyxin-B 
CAMPs produced by higher eukaryotes typically fall into one of three classes, as discussed in 
the previous section.  CAMPs may also be produced by bacteria and are typically produced 
using non ribosomal peptide synthesis.  The CAMP polymyxin-B was originally found in the 
organism Paenibacillus polymyxa (originally known as Bacillus polymyxa), it is a cyclic peptide 
antimicrobial which contains a mixture of L-amino acids, D-amino acids and other non-
proteinogenic amino acids (Paulus and Gray, 1964).  There is some evidence to suggest that 
the non-ribosomal synthesis of polymyxin-B may be a defence mechanism against other 
bacteria that produce protein synthesis inhibiting antibiotics, as polymyxin-B production is 
roughly doubled in P. polymyxa when treated with chloramphenicol (Paulus and Gray, 1964).  
Polymyxin-B is produced by the pmxABCDE gene locus from P. polymyxa, and is more active 
against Gram-negative bacteria (Kim et al., 2015).  Polymyxin-B has been shown to bind to the 
lipid-A major outer membrane lipid from Gram-negative bacteria (Yin et al., 2003).  The 
binding appears to increase the surface charge of the outer membrane lipopolysaccharide 
(LPS) and induces LPS aggregation which can reduce the severity of infection (Domingues et al., 
2012).  It is not known exactly how polymyxin-B causes cell death and there are competing 
models for the exact mechanism as the concentrations of polymyxin-B required to cause 
membrane permeabilisation are often higher than the reported inhibitory concentrations 
(Hancock, 1997).  It is thought that at low concentrations polymyxin-B may induce exchange of 
lipids between the cytoplasmic and outer membranes, compromising the integrity of the outer 
membrane and causing cell death or inhibition of growth (Clausell et al., 2003). 
 
1.9.2 Cathelicidins and ß-defensins 
The cathelicidin classes of CAMPs are generally simple α-helical peptides with multiple 
positively charged residues.  The class includes the human CAMP LL37, and the chicken CAMPs 
Folwlicidn-1 and Fowlicidin-2 (Mukhopadhyaya et al., 2010).  The human cathelicidin LL37 has 
been shown to not only lyse bacterial cells but also to act as a localised modulator of the 
immune response by potentially acting as a chemotaxin for mast cells (Niyonsaba et al., 2002).  
LL37 has also been implicated in promoting epithelial repair at wound sites (Heilborn et al., 
2003).   
 
The β-defensins are characterized by their folded structure often containing 6 or more cysteine 
residues forming up to 3 disulfide bridges (Pasupuleti et al., 2012).  There are 3 different 
classes of defensins (α, β and θ) where α and β are synthesised as a single pro-peptide chain 
and are stored in Paneth cells or as mature peptides in neutrophils.  θ defensins are not found 




peptides into a cyclic peptide (Tang et al., 1999).  Artificial θ defensins have been shown to be 
effective in-vitro inhibitors of the herpes simplex virus adhesion and entry into host cells (Yasin 
et al., 2004).  Antimicrobial peptides can also act as stimulators of the immune system in 
response to infection (Arnett et al., 2011).  It has recently been shown that the human 
defensin (HD1) is significantly more potent against bacteria when the disulfide bonds are 
broken whereas another defensin (HD3) shows a slight reduction in potency when in its 
reduced form (Schroeder et al., 2011), suggesting that the disulfide bonds are not required for 
activity in all defensins but may help to stabilize the peptide during storage or transport.  A 
third human defensin (HD5) has been shown to bind around a single zinc ion when in its 
reduced form and is protected from proteolytic degradation in this state.  Since HD5 is 
primarily localized to the intestines, this metal bound state may protect the defensin from 
accidental digestion in the gut (Zhang et al., 2013). 
 
1.10 Mechanisms of antimicrobial peptide activity 
The primary target for antimicrobial peptides appears to be the membrane bilayer found in all 
bacteria.  The outer leaflet of the eukaryotic cell membrane is composed of zwitterionic 
phospholipids and usually carries a net neutral charge, both leaflets of the gram negative 
external membrane show a net negative charge due to a larger proportion of acidic 
phospholipids (Matsuzaki, 1999).  Thus cationic AMPs are preferentially attracted to the 
negatively charged bacterial membranes.  Since many CAMPs are also amphipathic, the 
hydrophobic region is likely preferentially inserted into the cell membrane.  This action is also 
thought to be a reason for the anti-tumor effect seen in some CAMPs as many types of tumor 
cells contain unusually high numbers of negatively charged gangliosides lowering the net 
charge of the cell membranes (Lee et al., 2008).  While there is no clear agreement on the 
exact mechanism of cell killing, there are 3 primary models of how CAMPs can interact with 


























Figure 5: The three models for CAMP interactions with lipid membranes.  Initially CAMPs are thought to attach 
to the lipid bilayer surface and cluster together to form pores.  (A) the barrel-stave model hypothesizes that the 
hydrophobic residues of the CAMPs align with the hydrophobic acyl chains in the lipid bilayer forming a straight 
pore through the bilayer.  (B) the toroidal model is similar to the barrel-stave model except that the hydrophilic 
heads of the bilayer associate along the edge of the pore bending the bilayer around the hole.  (C) the carpet 
model is thought to require a threshold concentration of CAMPs on the membrane surface before small micelles 
or peptide-lipid aggregates are formed away from the cell.  The CAMPs are represented as linear when bound to 
the surface, hydrophilic and lipophilic parts of the CAMPs are represented by grey and black respectively.  Image 




1.10.1 The barrel-stave model 
The barrel stave model was considered the archetypal model for peptide-induced pore 
formation (Wiesner and Vilcinskas, 2010).  This model depicts spontaneous pore formation by 
insertion of the peptide through the entire lipid bilayer, which requires the peptide to be of 
equal or greater length to the bilayer.  Since it would be energetically unfavorable for a single 
peptide to transverse the hydrophobic and hydrophilic regions of the lipid membrane, this 
model is hypothesized to be dependent on a local ‘threshold’ concentration of surface bound 
CAMPs before the pore is formed (Pasupuleti et al., 2012).  Only a few AMPs have been shown 
to act in this way, including the mammalian C9 protein from the complement pathway of the 
adaptive immune system (Rosado et al., 2008). 
 
1.10.2 The toroidal model 
The toroidal (worm-hole) model is similar to the barrel-stave model and is the preferred model 
for the action of the majority of CAMPs including the cathelicidins and defensins (Wiesner and 
Vilcinskas, 2010, van Dijk et al., 2008).  The toroidal model is ‘hypothetically’ dependent on the 
hydrophilic head of the lipids aiding in pore formation by bending with the peptide which is 
likely preceded by localised membrane thinning due to the insertion of peptides into the outer 
leaflet of the lipid membrane (Chen et al., 2003). 
 
1.10.3 The carpet model 
The carpet model is a more general model for the action of CAMPs exhibiting a detergent like 
effect, where localised surface aggregation of CAMPs leads to the removal of micelle like 
‘bundles’ of phospholipids (Chang et al., 2008).  This method of pore formation has been 
shown to be more easily repairable than the other models as the peptides are removed from 
the cell surface along with the micelles (Chang et al., 2008). 
 
Much of the work characterising which model a particular CAMP exerts upon the lipid 
membrane has been carried out using artificial membranes as models and so what effect 
differences in membrane composition and trans-membrane proteins may have between 
species has not been well studied (van Dijk et al., 2008).  There also does not yet appear to be 
a strong consensus about whether different families of CAMPs preferentially form one of the 
three models of pore formation.   
 
Some CAMPs are able to transverse the microbial membrane and affect intracellular 
components, for example Buforin-II and Magainin-II are both amphipathic α-helical CAMPs 




lysis (Ludtke et al., 1996).  Buforin-II however was shown to cause cell death without causing 
cell lysis but by strongly binding to DNA and RNA (Park et al., 1998).  Another example is the 
silk moth CAMP Attacin, which was shown to prevent outer membrane protein synthesis at the 
pre-translational level in E. coli (Carlsson et al., 1991). 
 
1.11 Sensing and defending against CAMPs 
While the majority of CAMPs target a fundamental and not easily altered component of the 
microbial cell membrane, there are five main ways in which Gram-negative bacteria can 
defend against host CAMPs, (1) degradation of host CAMPs, both Pseudomonas aeruginosa 
and Proteus mirabilis have been shown to produce outer membrane proteins which can 
degrade the human α-helical cathelicidin LL37 (Schmidtchen et al., 2002).  (2) modification of 
the cell membrane, Salmonella typhimurium possess a lipid modification protein (pagP) which 
attaches acyl groups to lipid-A, this is hypothesised to alter the fluiditiy of the outer membrane 
making it harder for CAMPs to form pores (Guo et al., 1998).  P. aeruginosa possess a system 
for modifying components of the outer membrane prior to being flipped into the outer leaflet, 
by attaching aminoarabinose moieties to the negatively charged phosphate groups on lipid-A, 
the net membrane charge becomes more neutral which is thought to attract fewer CAMPs 
(Moskowitz et al., 2004).  (3) Shielding of the outer membrane, strains of Klebsiella 
pneumoniae with mutations in capsule polysaccharide synthesis pathways have been shown to 
be more sensitive to CAMPs (Campos et al., 2004).  Another study showed that secretion of 
only anionic capsular polysaccharide increased resistance to CAMPs (Llobet et al., 2008), (4) 
Pumping CAMPs either into the cell for degradation or out of the cell.  A well-studied example 
from Salmonella typhimurium is the sensitivity to antimicrobial peptide (sapABCDF) operon 
containing an ABC transporter, which was, required for CAMP resistance (Parra-Lopez et al., 
1993).  Another example is the N. gonorrhoeae RND efflux transporter mtrCDE that was shown 
to be required for resistance to LL37 (Shafer et al., 1998).  (5) Down-regulation of host CAMP 
expression, this is a mechanism some Gram-negative pathogens use to resist killing by host 
derived peptides, Salmonella typhimurium has been shown to lower the expression of the 
mouse defensin Cryptdin in paneth cells, using a process involving a type III secretion system 
and the phoP regulon (Salzman et al., 2003, Gruenheid and Le Moual, 2012). 
 
One of the best-studied mechanisms of defence against CAMPs in Gram-negative bacteria is 
the PhoP/PhoQ two component sensor regulator system in S. typhimurium.  This was first 
shown to provide resistance to CAMPs by up-regulating the pagP gene, which alters the 
structure of lipid A, reducing the ability of CAMPs to bind to the lipid bilayer (Guo et al., 1998).  




CAMPs on the cell surface via displacement of divalent metal cations (Bader et al., 2005).  
While CAMPs were able to induce this system it was also shown that a drop in pH and a 
decrease in divalent metal cation concentration could act as inducers.  Further investigation 
showed that a large number of genes are under the control of the PhoP/Q system, including 
some for survival following internalization within a host cell, leading to speculation that this 
system is a global host survival regulator rather than a dedicated CAMP resistance system 
(Groisman and Mouslim, 2006).  Homologues of parts of the PhoP/Q system have been found 
in several Gram-negative pathogens including Yersinia pestis and Shigella flexneri (Otto, 2009).  
More recently CAMP activation of the PhoP/Q system was shown to induce not only Lipid-A 
modification in Klebsiella pneumoniae, but also to induce virulence factors.  The authors also 
showed that exposure to sub-inhibitory concentrations of the model CAMP polymyxin-B 
increased short-term resistance to higher concentrations of both polymyxin-B and other 
CAMPs (Llobet et al., 2011). 
 
1.12 CAMP resistance in Campylobacter jejuni 
One of the early Campylobacter selective medias contained the CAMP polymyxin-B as a 
selective agent, showing that Campylobacter possesses an intrinsic resistance to this particular 
CAMP (Skirrow, 1977).  Much of the work on the effect of CAMPs upon Campylobacter species 
has focused on the roles of the unique LOS (lipooligosaccharide) layer.  Disruption of the 
lipooligosaccharide layer by deletion of the heptosyltransferase gene waaF in C. jejuni shows 
an increase in susceptibility to polymyxin-B, but interestingly disruption of the capsular 
polysaccharide (CPS) layer by deletion of a putative CPS transporter showed no increased 
sensitivity (Jeon et al., 2009).  Other studies on aspects of the Campylobacter LOS layer have 
shown similar increases in polymyxin-B sensitivity, such as modification of lipid-A (Van Mourik 
et al., 2010) and truncation of the LOS core (Naito et al., 2010).  Mutagenesis of the 
phosphoethanolamine (pEtN) transferase (cj0256) causes a large increase in sensitivity to 
polymyxin-B, this deletion also causes a near complete loss of flagellar production (Cullen and 
Trent, 2010).  Further work looking for specific resistance mechanisms in C. jejuni 81-176 using 
high throughput transposon mutagenesis and polymyxin-B sensitivity screening has highlighted 
genes involved in synthesis of cell surface carbohydrates, modulation of membrane potential, 
and further genes involved in membrane and LOS synthesis (Lin et al., 2009).  There does not 






1.13 The type VI secretion system 
The type VI secretion system (T6SS) is a Gram-negative specific, secretory apparatus for the 
export of proteins through the membranes of neighboring cells.  The T6SS was discovered in 
Vibrio cholerae as being required for virulence and further genetic analysis of the T6SS gene 
cluster revealed homologies between the T6SS export apparatus and bacteriophage tail spike 
apparatus (Pukatzki et al., 2006, Pukatzki et al., 2007).  The T6SS was shown to export 
virulence factors in both V. cholerae and P. aeruginosa (Mougous et al., 2006), yet non-
pathogenic bacteria were also shown to possess homologues of the T6SS export apparatus (Ho 
et al., 2014).  It was also discovered that P. aeruginosa is able to export toxic effector proteins 
directly into the periplasm of other Gram-negative cells via the T6SS (Russell et al., 2011).  P. 
aeruginosa was shown to export two peptidoglycan amidase toxins into other bacteria, the 
toxins are exported directly from the attacking cell cytoplasm to the prey cell periplasm and so 
never interact with the cell’s own peptidoglycan layer.  To prevent attack from closely related 
species, P. aeruginosa produces and exports antitoxins into their own periplasms to quench 
attacks from close relatives.  The crystal structure of the P. aeruginosa T6SS amidase toxin and 
antitoxin has been solved multiple times and has been shown to contain a cysteine-histidine 
catalytic site and a papain like fold (Chou et al., 2012, Ding et al., 2012).  Some of the best 
studied antibacterial T6SS systems are in V. cholerae, Pseudomonas, Burkholderia and S. 
marcescens (Schell et al., 2007, Murdoch et al., 2011), it is estimated that 25% of all Gram-
negative bacteria may possess related systems (Ho et al., 2014). 
 
Some strains of C. jejuni do possess a type VI secretion system but it is seemingly related to 
host cell invasion and pathogenesis rather than interbacterial competition.  The C. jejuni strain 
ACCT 43431 was shown to be defective in chicken colonisation and shows reduced adhesion 








1.13.1 The type VI secretion system toxin-antitoxin system 
Since the discovery of the T6SS a wide range of toxin-antitoxin pairs have been characterised in 
Gram-negative bacteria.  A recent study in V. cholera has shown that while the T6SS is 
widespread and exports both host-targeted and anti-bacterial effectors, there are often 
different types of anti-bacterial targeting effector toxins, usually found with an antitoxin gene 
immediately downstream (Unterweger et al., 2014).  From V. cholera species alone there are 3 
classes of toxin-antitoxin systems, multiple types of peptidoglycan amidase and muramidase 
enzymes, a class of membrane acting lipases (which presumably act from within the periplasm) 
and a class membrane-spanning pore forming toxins, each with their respective antitoxins.  
The antitoxins for the enzymatic effectors are typically active site blocking inhibitors.  While 
the antitoxins for pore-forming toxins are smaller membrane spanning proteins, which 
Figure 6: Model for the assembly and function of the antibacterial type VI secretion system (T6SS).  (A) the 
formation of the baseplate complex consisting of TssEJKLM.  (B) the recruitment and assembly of the effector 
proteins VgrG/PAAR to the baseplate complex, it is unknown if they are localised to the cytoplasm, periplasm or 
inner membrane at this point.  (C) the Hcp effector delivery tube polymerises from the baseplate complex with 
the VipA/B contractile sheath polymerizing around the growing Hcp tube.  (D) conformational changes in VipA/B 
propels the Hcp tube outside the cell and through the outer membrane of a neighbouring cell.  The VgrG/PAAR 
proteins act as both ‘wahead’ proteins to pierce the membrane as well as toxic effector proteins.  Other effector 
proteins are delivered from the Hcp tube.  (E) ClpV remodels the contractile sheath using ATP and disassembles 
the tube components.  The recycled components can be immediately re-used or degraded.  (F) the baseplate 
complex can also be re-used or recycled depending on the activation state of the T6SS.  Image adapted from (Ho 




presumably act as inhibitors of pore formation (Russell et al., 2014).  The S. marcescens DB10 
genome encodes 6 putative toxic effectors, all of which have been shown to be active against 
E. coli (Fritsch et al., 2013).  Two of these toxins (Ssp1 and Ssp2) have been characterised as 
peptidoglycan amidase toxins (English et al., 2012) while the others remain unknown, though 
Ssp3, Ssp5 and Ssp6 have been shown to be active against unknown cytoplasmic targets 
(Fritsch et al., 2013). 
 
A study of a P. aeruginosa amidase toxin showed that the inhibiting antitoxin, which is 
expressed in the periplasm, does not share any structural homology to a more general class of 
cysteine containing protease inhibitors called cystatins.  They hypothesize that having a non-
specific peptidoglycan amidase inhibitor in the periplasm would hinder cell wall turnover, 
leading to the evolution of a highly specific inhibitor for the toxin (Key et al., 2012).  The T6SS is 
a diverse and under-characterised way for bacteria to interact with each other in both 
environmental and infection niches.  The toxin-antitoxin system ensures that closely related 
species do not inhibit each other during times of stress.  To the best of the authors knowledge 
no defense mechanisms has yet been discovered for bacteria to actively inhibit foreign T6SS 






















1.14 A cluster of genes in Campylobacter jejuni NCTC11168 which may protect against 
Cationic Antimicrobial Peptides (CAMPs) 
 
1.14.1 Previous work on the gene cluster 
The antimicrobial peptide polymyxin-B is a commonly used model peptide for studying CAMP 
resistance mechanisms in bacteria.  While Campylobacter species are known to be more 
resistant to polymyxin-B than other Gram-negative bacteria (Skirrow, 1977), no specific or 
active defense mechanism has been found.  Previous work in this lab has suggested that a 5 
gene cluster in C. jejuni NCTC11168 (cj0421c-cj0425) may be involved in active resistance to 
CAMPs.  These genes were provisionally named as the Rid system (Resistance to Innate 
Defenses).   
 
One of the genes in this cluster is a DNA-binding protein (Cj0422c), which was initially 
discovered as part of another project looking at differences in gene regulation in response to 
lowering atmospheric oxygen in chemostat cultures.  This work showed a small up-regulation 
(4.5 fold) of cj0422c by microarray at 1.88% oxygen compared to the standard 10% oxygen (E.J. 
Guccione, R.K. Poole and D.J. Kelly, unpublished data).  Because it is still unknown how C. jejuni 
is able to ‘sense’ and respond to oxygen levels this putative DNA-binding protein was thought 
of as a candidate regulator for oxygen stress response genes.  Due to the predicted DNA 
binding domain of Cj0422c a mutant was produced and RNA extracted for microarray analysis.  
The microarray transcriptome of this mutant showed multiple changes in gene expression 
compared to wild type C. jejuni, including both up and down regulation of genes, suggesting 
that Cj0422c is able to act as both a repressor and activator of transcription.  The microarray 
results (performed and analysed by Dr Ed Guccione) are shown in (Figure 7).  The genes 
showing the greatest change in expression do not appear to have any obvious role in oxygen 
stress response, instead the largest differences in expression are in the genes immediately 













Figure 7: Microarray analysis of the cj0422c mutant compared to wild type.  RNA was extracted from cultures 





This microarray analysis of the cj0422c mutant revealed that while it may not be involved in 
the oxygen stress response it does appear to regulate a number of genes throughout the C. 
jejuni NCTC11168 genome with no clear link between them.  The largest changes in expression 
are in cj0423 and cj0424 (34 and 18-fold increases respectively), implying that the two are 
transcriptionally linked in an operon (a further gene cj0425 is found immediately downstream 
in the same orientation but this does not appear on the microarray).  The roles of these genes 
are unknown, analysis of the protein sequence has shown that Cj0423 contains 2 
transmembrane domains and Cj0424 contains 7 MORN (Membrane Occupation and 
Recognition Nexus) motif repeats and an N-terminal membrane lipid anchor sequence.  Cj0425 
contains a periplasmic export sequence and two separate CXXT motifs, potentially implying a 
role in redox reactions in the periplasm.  None of these 3 proteins show any strong homologies 
to proteins outside of Campylobacter species so their roles are unknown.  Other genes which 
are significantly up-regulated in the cj0422c mutant are cj0864 which encodes a DsbA like 
periplasmic protein (9.8 fold) and cj0653c which encodes as cytoplasmic aminopeptidase (5.2 
fold).  Several genes are also down-regulated including cj0204c, a predicted peptide 
transporter (-4.4 fold) and cj0263 a ZupT like zinc transporter (-3.8 fold). 
 
Cj0424 is the only protein from the cj0423-cj0425 operon which contains a characterised 
motif, the membrane occupation and recognition nexus or MORN motif.  MORN proteins are 
split into 2 families, MORN 1 and 2, with MORN 1 motifs being found mostly in eukaryotes and 
MORN 2 motifs in prokaryotes, though there are exceptions (PFAM database 
(http://pfam.xfam.org), MORN 1-PF02493, MORN 2-PF07661).  MORN 2 proteins are 
characterised by a 22-residue variable amino acid motif that is typically repeated multiple 
times within a single protein (Takeshima et al., 2000). 
 
MORN motifs were originally found in junctophillin proteins which mediate the junctional 
complex between the cytoplasmic membrane and endoplasmic/sarcoplasmic reticulum in 
higher eukaryotes (Takeshima et al., 2000).  MORN motifs are often replicated within a single 
protein, sometimes up to 17 individual motifs per protein, that are often clustered at the C or 
N terminal ends of a protein (Habicht et al., 2015).  The exact role of MORN domains is not 
fully understood but they were initially hypothesised to bind to the phospholipid membrane as 
a way of localising other protein domains to the lipid membrane (Shimada et al., 2004).  It has 
since been shown that some MORN domains are required for cell division in Toxoplasma 




domain proteins including Helicobacter bilis (>100 MORN domains), Fusobacterium 
periodonticum (234), Tetrahymena thermophile (129).  The presence of large numbers of 
MORN domains appears to strongly correlate with organisms which actively invade host cells 
(McGuire et al., 2014, Habicht et al., 2015).  A study on four MORN domain proteins from 
Tetrahymena thermophile has shown that all four proteins localise to distinctly different 
locations within the cell though the mechanism for this localisation is unknown (Habicht et al., 
2015).  There are currently no reported studies on individual MORN proteins in bacteria and 
the structure-function relationships in MORN motifs are also not known.  
 
The microbial MORN 2 motif is variable between species but will typically contain multiple 
tyrosine and glycine residues, with a central YYxNGKL motif.  The C. jejuni genome encodes a 
single MORN 2 motif protein Cj0424, which contains 7 repeated (xeGxxkxYYeNGKLxxexxYkN) 
motifs, where uppercase letters represent heavily conserved amino acid residues and 


















1.14.2 The Rid operon 
 
Gene Description Domain Architecture 
cj0421c 
ridS 
37 kDa protein, contains 6 
transmembrane helices with globular 
C-terminal cytoplasmic domain.  Some 
weak homology to GGDEF domain 




8.4 kDa protein containing a helix-turn-
helix domain.  It binds to an 18bp 
recognition sequence in the cj0423 
promoter region repressing expression. 
 
Promoter 168 bp region between cj0422c-cj0423.  
18 bp palindromic repeat sequence 
found upstream of cj0423 which 




8.6 kDa inner membrane protein 
containing 2 transmembrane helices.    
cj0424 
ridL 
24 kDa periplasmic protein.  Contains 7 
MORN motifs and forms an antiparallel 





15.6 kDa periplasmic protein.  Contains 






Table 1: A brief description of the 5 genes within the primary Rid operon, the diagrams show the 
predicted domain architecture of the proteins using data obtained from 




1.14.3 Early characterisation of the rid system 
Since there is no immediately obvious role that links all the genes that are regulated by 
Cj0422c, initial work focused on the roles of some of the individual proteins.  It was shown that 
Cj0422c does bind to a very specific 18bp palindromic repeat sequence immediately upstream 
of cj0423 and binding would likely block transcription.  Purified recombinant Cj0422c was 
shown to tightly bind the 18 bp sequence (Kd <1 PM) and less so to an 18 bp sequence altered 
by site directed mutagenesis (Kd a5 PM), the protein was also shown to bind upstream of 
cj0864, cj0204 and cj0263 however the binding was notably weaker at these promoters, 
shown by electrophoretic mobility shift assays (Hitchcock, 2011). 
 
The Cj0424 MORN domain protein was purified and crystallised by Dr Andrew Hitchcock in 
collaboration with Dr John Rafferty, the crystal structure was solved to 2.1 Å, which to our 
knowledge is the first reported structure of a MORN domain protein (unpublished data).  The 
crystal structure showed that Cj0424 contains 15 folded antiparallel ß-sheet strands arranged 
in a ‘ladder like’ formation, with the MORN domains located along one edge of the protein, 
(see Figure 8).  The structure also shows a small protruding loop designated the ED loop 
composed of negatively charged residues (Glutamic acid and Aspartic acid).   
 
Figure 8: The crystal structure of Cj0424 (RidL).  The 2.1 Å structure of Cj0424 (residues 21-205), (A) shows the 
protein structure represented by ribbons showing the 15 antiparallel ß-sheet strands, the protruding ‘ED’ loop is 
highlighted.  (B) shows the structure in the same orientation showing the surface electrostatic potential (blue 
shows negatively charged residues and red shows positively charged residues).  (C) shows the structure in the 
same orientation with the MORN domains filled with the surface charge and the rest of the protein represented by 




The Cj0425 periplasmic protein contains 2 CXXT motifs which may be involved in redox 
reactions within the periplasm, however the protein has no close homologues outside the 
Campylobacter genus and previous studies have not revealed anything about the role of 
Cj0425 in Campylobacter.  A cj0425 mutant showed a small but statistically significant increase 
in biofilm formation when grown in high oxygen conditions compared to wild type C. jejuni, 
the cj0425 mutant also showed a slight increase in sensitivity to peroxide and sulphide 
(Hitchcock, 2011). 
 
1.14.4 How the Rid system may be involved in CAMP defence 
The data obtained from the microarray on the cj0422c mutant showed large changes in gene 
expression in the cj0423-cj0425 operon and smaller, yet significant changes elsewhere in the 
genome of C. jejuni NCTC11168, including both up and down-regulation of genes.  This implies 
that the role of these genes collectively may be specific to a particular niche condition or stress 
and the data showing that Cj0422c acts as a strong repressor implies that some type of 
condition or stress may act as an inducer or ‘on switch’ for the Rid system, and that the 
cj0422c mutant in effect mimics this condition.  Further data from previous students has 
shown that none of the mutant strains appear to show any growth defects when grown under 
normal conditions, implying that these genes are not essential for normal growth.  While the 
roles of the genes in the primary operon cj0423-cj0425 are not known, the microarray reveals 
that the cytoplasmic aminopeptidase cj0653c is up-regulated and the peptide transporter 
cj0204 is down regulated.  This lead to the hypothesis that the whole Rid system may be 
involved in resistance to Cationic Antimicrobial Peptides (CAMPs).  This hypothesis was initially 
tested by assaying the sensitivity of the rid mutant strains to polymyxin-B a model CAMP.  Wild 
type C. jejuni is able to effectively resist 200 µg ml-1 polymyxin-B for 2 hours in microtiter 
assays whereas the cj0422c mutant showed a complete loss of viability at only 20 µg ml-1 
polymyxin-B over the same time period, the cj0424 mutant also showed increased sensitivity 
to polymyxin-B.  This hypersensitivity strongly suggested that the Rid system acts as a defence 
mechanism against polymyxin-B and probably other CAMPs since they share a similar 
mechanism of action.  Further work in assaying the sensitivities of Rid mutants to polymyxin-B 
and other CAMPs as well as characterising how the primary Rid proteins (Cj0423-Cj0425) act to 
defend against CAMPs was undertaken by another PhD student Halah Al-Haideri.  This work 
showed that the mutants in the other Rid genes showed large increases in sensitivity to 
polymyxin-B as well as other CAMPs from both humans and chickens.  Further work in this 
area showed that heterologous expression of Cj0424 in the periplasm of E. coli afforded extra 




polymyxin-B suggesting its role may be to bind and inhibit CAMPs in the periplasm.  This data 
suggested that the whole Rid system is involved in defence against CAMPs and may be the 
reason why Campylobacter species are intrinsically so resistant to polymyxin-B.  Further work 
on the roles of the individual proteins within the Rid operon was continued alongside work to 










Figure 9: The hypothetical model of how the Rid system would work to defend against CAMPs.  The model is 
based on the difference in gene expression observed in the cj0422c (ridR) mutant strain.  This assumes that the 
‘on’ state for the Rid system is mimicked by the cj0422c mutant.  The model is based on most of the genes 
which show strong up or down-regulation being part of a system to defend against CAMPs.  The individual roles 







Gene Annotation Predicted Role In CAMP Defence 
Cj0421c X Hypothetical protein 
Potentially acts as a ‘sensor’ for CAMPs or 
other stimuli 
Cj0422c X DNA binding H-T-H 
Master regulator, acts to repress whole 
system during normal conditions 
Cj0423 34.33 Hypothetical membrane protein 
Contains positively charged residues, possibly 
acting to repel positively charged CAMPs 
Cj0424 18.31 
Outer membrane lipid anchor 
MORN protein  
Outer membrane bound protein, possibly acts 
to ‘soak up’ CAMPs by binding 
Cj0425 X Periplasmic protein  
Contains 2 CXXT motifs so may be involved in 
redox reactions, role unknown 
Cj0864 9.83 Putative periplasmic Dsb protein 
Forms part of the Dsb operon so may act to 
re-fold some families of CAMPs which become 
more active when unfolded 
Cj0653c 5.22 
Putative M23 family cytoplasmic 
aminopeptidase 
May act to degrade CAMPs that reach the cell 
cytoplasm 
Cj0263 -3.77 Zinc transporter 
Likely transports multiple 2+ metal cations, 
role unknown 
Cj0204 -4.43 Putative oligopeptide transporter 
May gratuitously transports CAMPs so is 
down-regulated to prevent accidental 











Table 2: A table detailing how the hypothetical CAMP resistance model would work using the genes altered 
from the cj0422c mutant microarray data.  The genes listed show the largest difference in expression in the 
cj0422c mutant microarray data or are in an operon with those that are.  The model is based on the genes being 
up or down-regulated by Cj0422c in response to some king of external stimuli which is currently unknown but 




1.15 Project Aims: 
 
x To determine the sensitivity phenotypes of the two regulator mutants cj0421c and 
cj0422c against a wide range of CAMPs and other antimicrobials. 
x Bioinformatically analyse the rid genes to look for homologues in other Campylobacter 
strains and to produce knockout mutants of the rid homologues in C. jejuni 81116. 
x To confirm the microarray data by qRT-PCR and to examine the role of Cj0421c as a 
potential regulator by qRT-PCR. 
x To produce a lacZ reporter construct and to screen for potential inducers of the rid 
system by CAMPs or other conditions. 
x To overexpress and purify Cj0421c and Cj0422c to look for binding to CAMPs or 
protein-protein interactions with each other. 
x To attempt crystalisation of both Cj0421c and Cj0422c. 



















2 Chapter 2 Materials and Methods 
 
2.1 Materials used in this study 
All chemicals used were obtained from BDH, Bibco, Oxoid, Sigma-Aldrich, Acros, Duchefa, 
Melford, VWR, Apollo Scientific or Thermo-Fisher scientific.  Antimicrobial peptides were 
synthesized by Peptide Synthetics.  Gasses were supplied by BOC.  Molecular biology reagents 
were supplied by New England Biolabs, Promega, Roche, Ambion, Bioline, Fermentas or 
Invitrogen. 
 
2.2 Organisms used in this study 
All strains used in this study are listed in Tables 3-5, C. jejuni was stored at -80°C in Brain Heart 
Infusion (BHI) broth containing 20% [v/v] glycerol as cryoprotectant. E. coli, S. marcescens and 
P. aeruginosa strains were preserved at -80°C in Luria-Bertani (LB) broth containing 25% [v/v] 
glycerol as cryoprotectant. 
 
2.3 Campylobacter growth Media 
C. jejuni was routinely grown on Columbia blood agar base containing 5% lysed horse blood 
with 10 μg ml-1 amphotericin-B and vancomycin.  C. jejuni was also grown on Mueller-Hinton 
(MH) agar and CCDA agar for colony counts.  Liquid cultures of C. jejuni were grown in (BHI) or 
MH broth. Both were made as per manufacturer’s instructions and autoclaved for 20 min at 
121°C.  Amphotericin B and vancomycin were added as standard to 10 μg ml-1.  Mueller-Hinton 
broth was supplemented with 20 mM L-serine prior to autoclaving and is referred to as MHS 
broth. 
 
2.4 E. coli, S. marcescens and P. aeruginosa growth Media 
Escherichia coli was grown routinely at 37 °C on LB Agar (Oxoid) which was made according to 
the manufacturer’s instructions and sterilised by autoclaving.  Liquid cultures of E. coli were 
grown in LB broth. 
 
2.5 Antibiotics 
Antibiotics were prepared in distilled water and filter sterilised through 0.2 μm filters except 
for chloramphenicol which was dissolved in ethanol.  Amphotericin B was dissolved in water 
using a few drops of concentrated NaOH (10 M).  Antibiotics were used at the following 




kanamycin 50 μg ml-1, chloramphenicol 20 μg ml-1 (40 μg ml-1 for E. coli), carbenicillin / 
ampicillin 50 μg ml-1 and cefoperazone 32 μg ml-1. 
 
2.6 Growth of C. jejuni  
C. jejuni strains were routinely grown at 37°C in microaerobic conditions (5% [v/v] O2, 10% 
[v/v] CO2 and 85% [v/v] N2) in a MACS-VA500 Incubator (Don Whitley Scientific Ltd, UK).  
Typically, cells were plated on blood agar and grown for 1-2 days, cell material was then 
scraped off and used to inoculate 50-250 ml MH broth media.  Cultures were routinely 
supplemented with 10 μg ml-1 amphotericin-B and vancomycin, selective antibiotics such as 
kanamycin or chloramphenicol were not used for sensitive assays.  Liquid cultures were 
typically incubated overnight and shaken at 200 rpm. 
 
2.6.1 Growth of C. jejuni in MCLMAN minimal media 
The MCLMAN minimal media was based on work by (Alazzam et al., 2011), the media 
composition was modified for this study.  The final concentration of the individual components 
is described here: 
x CaCl2.2H2O  1.8 mM  
x Fe(NO3)3.9H2O  25 μM (dissolved in equimolar ascorbate solution) 
x MgCl2.6H2O  1.75 mM   
x KCl   5.4 mM   
x NaCl   0.1 M   
x NaHCO3  44 mM   
x NaH2PO4  0.9 mM 
x Niacinamide  33 μM 
x L-Serine  20 mM 
x L-Cysteine  0.2 mM 
x L-Methionine  0.2 mM 
x L-Leucine  0.8 mM 
x L-Aspartic acid  10 mM 
 
The following changes in how the media was produced were also made:  
x The Fe(NO3)3.9H2O was dissolved to a 1000X stock solution in equimolar ascorbate to 
prevent oxidation. 
x The salts (MgCl2.6H2O, KCl, NaCl, NaHCO3, NaH2PO4) were mixed to at 3X stock solution 
and adjusted to pH 7.2 with concentrated HCl, the CaCl2.2H2O was added after 
adjustment to prevent precipitation. 
 
All components were mixed together and made up to 75 ml with SDW, the compounds were 







2.6.2 Growth of E. coli, S. marcescens and P. aeruginosa 
All strains were routinely cultured aerobically at 37°C on LB agar or broth.  Liquid cultures were 
shaken at 250 rpm.  S. marcescens was cultured in liquid MHs broth. 
 
2.7 Campylobacter strains used in this study 
Table 3 
Campylobacter jejuni Description Source / Reference 
Wild type NCTC11168 (DJK) Laboratory wild type strain, original human clinical isolate Parkhill et al., 2000 
Wild type NCTC11168-H Hypermotile human clinical isolate Karlyshev et al., 2002 
Wild type 81116 Genetically stable strain Pearson et al., 2007 
Wild type 81-176 Highly virulent strain with pVir and pTet plasmids Hofreuter et al., 2006 
∆c8j_0398 C. jejuni 81116 c8j_0398 deletion :: Kan This Study 
∆c8j_0399 C. jejuni 81116 c8j_0399 deletion :: Kan This Study 
∆c8j_0400 C. jejuni 81116 c8J_0400 deletion :: Kan This Study 
∆c8j_0398-c8j_0400 (3X) C. jejuni 81116 triple gene deletion :: Kan This Study 
∆cj0421c C. jejuni 11168-DJK cj0421c deletion :: Kan This Study 
∆cj0421c / metK+ C. jejuni 11168-DJK ∆cj0421c metK complementation :: Kan / Cat This Study 
∆cj0421c / metK C+ C. jejuni 11168-DJK ∆cj0421c C-terminal metK complementation :: Kan / Cat This Study 
∆cj0422c C. jejuni 11168-DJK cj0422c deletion :: Cat This Study 
∆cj0422c / Nat + C. jejuni 11168-DJK ∆cj0422c Natural promoter complementation :: Kan / Cat This Study 
∆cj0421c-cj0422c (2X) C. jejuni 11168-DJK double gene deletion :: Kan This Study 
∆cj0423 C. jejuni 11168-DJK cj0423 deletion :: Kan This Study 
∆cj0424 C. jejuni 11168-DJK cj0424 deletion :: Kan This Study 
∆cj0425 C. jejuni 11168-DJK cj0425 deletion :: Kan This Study 
∆cj0423-cj0425 (3X) C. jejuni 11168-DJK triple gene deletion :: Kan This Study 
∆cj0421c-cj0425 (5X) C. jejuni 11168-DJK quintuple gene deletion :: Kan This Study 
cj0423 fdxA+ C. jejuni 11168-DJK cj0423 fdxA complementation :: Kan / Cat This Study 
cj0425-His fdxA+ C. jejuni 11168-DJK His-tagged cj0425 fdxA complementation :: Kan / Cat This Study 
lacZ-F-pK46 C. jejuni 11168-DJK cj0423 promoter lacZ reporter strain :: Kan This Study 
lacZ-F-pC46 C. jejuni 11168-DJK cj0423 promoter lacZ reporter strain :: Cat This Study 
lacZ-R-pC46 C. jejuni 11168-DJK cj0422 promoter lacZ reporter strain :: Kan This Study 









2.8 E. coli strains used in this study 
Table 4 
Escherichia coli Genotype Source 
DH5α™ 
F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 recA1 
endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1 
gyrA96 relA1 
Invitrogen 
BL21 (DE3) F– ompT hsdSB(rB–, mB–) gal dcm (DE3) Invitrogen 
 
2.9 Other strains used in this study 
Table 5 
Strain Genotype Source 
Serratia marcescens DB10 Wild type insect pathogen Dr Sarah Coulthurst (University of Dundee) 
Serratia marcescens ∆tssE Silent deletion of the tssE gene Dr Sarah Coulthurst (University of Dundee) 
Pseudomonas aeruginosa PA01 Wild type wound isolate 
Professor Colin Manoil 
transposon library (University 
of Washington) 
 
2.10 DNA manipulation 
 
2.10.1 Isolation and purification of DNA 
Genomic DNA was isolated using the GenElute genomic extraction kit, plasmid DNA was 
extracted using the GenElute miniprep and midiprep kits.  DNA was extracted from agarose 
gels using the GenElute gel extraction kit and purified using the GenElute PCR purification kit.  
All kits were purchased from Sigma and the manufacturers instruction were followed. 
 
2.10.2 DNA manipulation techniques 
Unless otherwise stated all standard DNA manipulation techniques used were based on those 
described in (Sambrook et al., 1989). 
 
2.10.3 Polymerase chain reaction 
Standard PCR reactions were carried out in a final volume of 50 μl, two types of polymerase 
were used, Phusion (Thermo) for high fidelity cloning and MyTaq (Bioline) for screening.  Each 
reaction was made up with the following components. 
2X Polymerase solution  25 μl (Phusion)  10 μl (MyTaq) 
100 μM Primer solutions 2 μl   1 μl 
Template DNA   1 μl   1 μl 




Conditions were occasionally modified according to requirements.  The PCR reactions were 
performed in a 48 well (Techgene) thermal-cycler using the settings described in (Table 6).  All 
primers were purchased from (Sigma). 
 
Table 6 
Stage Temperature Duration Cycles Description 
1 98°C 
95°C 
5 mins (Phusion) 





10 seconds (Phusion) 




20 seconds (Phusion) 




1 minute kb-1 (Phusion) 
1 minute kb-1 (Taq) 
Extension 
3 72°C 5 minutes 1 Final Extension 
4 4°C Hold 1 Final Hold 
 
 
2.10.4 PCR primers used in this study 
Table 7 























































C. jejuni 11168 complementation primers (5’ – 3’) 
Cj0421c-pC-MetK+ F GTTCATTTTAAATGAAAGGACTTTTTCATGTTTTTATTAGATTTTTTAAT 
Cj0421c-pC-MetK+ R CTTTTGCTAAAGATAAATTAAAACGTCTCATTAGTCTAAGAGTCTTGCTC 
Cj0421c-C-pC-MetK+ F GTTCATTTTAAATGAAAGGACTTTTTCATGGACACCTTAACAAAGCTACC 
Cj0421c-C-pC-MetK+ R CTTTTGCTAAAGATAAATTAAAACGTCTCATTAGTCTAAGAGTCTTGCTC 
Cj0422c-pK F TGCTAAAGATAAATTAAAACGTCTCACATGAAATAAAAATTTTATAAAAA 
Cj0422c-pK R ATATTATCTTATCAGTATTGTCAATACATGTTATTTAAATTTAGCAATTT 
Cj0423-pC-Fdx F TTTAAATCTTAATATTAAAAAGGAGAAAACATGGAAGGTGCAAGTGGCGG 
Cj0423-pC-Fdx R TGCTAAAGATAAATTAAAACGTCTCACATGCTATTTCTCATTTTTTTCTT 
Cj0425_His-pC-Fdx F TTTAAATCTTAATATTAAAAAGGAGAAAACATGTTTAAAAAAGTAATTTT 
Cj0425_His-pC-Fdx R AAATTAAAACGTCTCACATGTTAGTGGTGGTGGTGGTGGTGCTCGAGTTGGAAATCTCCA 
C. jejuni 11168 lacZ reporter primers (5’ – 3’) 
LacZ A1 TGCTAAAGATAAATTAAAACGTCTCACATGAAAAATTTAGCCTTTAAAAA  
LacZ B1 TAATCATGGTCATAGCTGTTTCCTGTGTGAAAATAAAAATTTTATAAAAA 
LacZ C1 TTTTTATAAAATTTTTATTTTCACACAGGAAACAGCTATGACCATGATTA 
LacZ D1 ATCAGTATTGTCAATACATGTTATTTTTGACACCAGACCAACTGGTAATG 
LacZ A2 TGCTAAAGATAAATTAAAACGTCTCACATGAAATAAAAATTTTATAAAAA 
LacZ B2 TAATCATGGTCATAGCTGTTTCCTGTGTGAAAAAATTTAGCCTTTAAAAA 
LacZ C2 TTTTTAAAGGCTAAATTTTTTCACACAGGAAACAGCTATGACCATGATTA 
LacZ D2 TATCCACTTTTCAATCCATGTTATTTTTGACACCAGACCAACTGGTAATG 




Cj0421c-pET28-F (NdeI) GGGAATTCCATATGGACACCTTAACAAAGCTACCCAATG 
Cj0421c-pET28-R (XhoI) ATTCCACTCGAGTTAGTCTAAGAGTCTTGCTCTTAGAC 
Cj0422c-pET21-F (NheI) AGGTAAGCGCTAGCATGACAAAAAAGAGCAAGC 
Cj0422c-pET21-R (XhoI) AGTGATTCCTCGAGTTTAAATTTAGCAATTTCATCT 
Cj0422c-pET28-F (NheI) AGGTAAGCGCTAGCACAAAAAAGAGCAAGCGTGATATGGC 
Cj0422c-pET28-R (XhoI) ATTCCACTCGAGTTATTTAAATTTAGCAATTTCATCTT 
Cj0425-pET22-F (NcoI) TTAATACCATGGATAACTCATTAGACAAATGT 
Cj0425-pET22-R (XhoI) AATATTCTCGAGTTGGAAATCTCCATTG 



















Isothermal assembly construct primers (5’ – 3’) 
KO Kanamycin cassette-F ATTCTCCTTGGTTCTCATGTTTGACAGCTTAT 
KO Kanamycin cassette-R GCACACCTTGGCTAGGTACTAAAACAATTC 
KO Chloramphenicol cassette-F ATTCTCCTTGGGAATTCCTGCAGCCC 
KO Chloramphenicol cassette-R GCACACCTTGGACTAGTGGATCCCGG 
ISA p46 Kan internal-F AAGACACTCCATTTAAAGATCCGCGCGAGC 
ISA p46 Kan internal-R GCTCGCGCGGATCTTTAAATGGAGTGTCTT 
ISA p46 Cat internal-F AAAAGTTATACCCAACTCTTTTATATGGAG 
ISA p46 Cat internal-R CTCCATATAAAAGAGTTGGGTATAACTTTT 
ISA pK46-F CATGTATTGACAATACTGATAAGATAATATATAATTAAATACTGTAGAAA 
ISA pK46-R CATGTGAGACGTTTTAATTTATCTTTAGCAAAAGTAGAAGCATTAGGCGT 
ISA pC46-F CATGGATTGAAAAGTGGATAGATTTATGATATAGTGGATAGATTTATGAT 
ISA pC46-R CATGTGAGACGTTTTAATTTATCTTTAGCAAAAGTAGAAGCATTAGGCGT 
ISA p46 MetK-F TGAGACGTTTTAATTTATCTTTAGCAAAAG 
ISA p46 MetK-R CATGAAAAAGTCCTTTCATTTAAAATGAAC 
ISA p46 FdxA-F GTTTTCTCCTTTTTAATATTAAGATTTAAA 







2.10.5 Agarose gel electrophoresis 
0.8 – 2% agarose gels in TAE buffer (40 mM Tris-acetate pH 8.0, 1 mM EDTA) with added 
ethidium bromide (0.1 μg ml-1) were used to separate and visualise DNA fragments using the 
10 Kb hyperladder-1 (Bioline) as a size marker.  6X loading buffer (Bioline) was added to all 
DNA samples before loading and the samples were separated by electrophoresis using a 
constant voltage of 100V for varying lengths of time (typically 1 hour).  
For extraction of DNA from agarose gels after electrophoresis, the desired bands of DNA were 
excised with a scalpel and the DNA extracted using the Sigma-Aldrich GenElute gel extraction 
kit according to the manufacturer’s instructions. 
 
2.10.6 Restriction enzyme digestion of DNA 
Restriction digestions of PCR products and plasmids were carried out using NEB or Fermentas 
enzymes according to the manufacturer’s instructions based on the concentration of DNA 
being digested, a typical reaction lasted for 3-4 hours at 37°C using 20-100 units of enzyme.  
The samples were then separated by agarose gel electrophoresis for analysis or purification 
using the (Sigma) gel extraction kit. 
 
2.10.7 Ligation of DNA 
The concentration of digested plasmid and PCR products was analysed on a Genova Nano 
Spectrophotometer (Jenway) and the volumes required for an approximate 3:1 ration of insert 
: vector was calculated.  Appropriate volumes were mixed with 1 μl of T4 DNA ligase (Thermo) 
and 2 μl of the associated 10X buffer and made up to 20 μl total reaction volume.  Reactions 
were incubated at room temperature for 2-3 hours. 
 
2.10.8 Short fragment sequencing of DNA 
DNA samples were sequenced using a drop-off sequencing service (GATC-Biotech).  Read 
lengths were typically 0.8-1.2 Kb in length.  
 
2.11 Isothermal Assembly Cloning  
Isothermal assembly (ISA) cloning was used to generate mutant and complementation 
plasmids for transformation into C. jejuni.  The method is based on (Gibson et al., 2009).  This 
method allows for multiple overlapping DNA fragments to be incorporated into a vector in a 
single step without the need for multiple restriction digestion steps.  An ISA mastermix was 
prepared by mixing 40 µl 5 x ISA buffer (25 % polyethylene glycol [PEG-8000], 500 mM Tris-HCl 




µl T5 exonuclease (Cambio), 2.5 µl Phusion polymerase (NEB) and 20 µl Taq ligase (NEB) (made 
up to 150 µl with dH2O). The mastermix was divided into 15 µl aliquots and stored at -20oC. 
 
For C. jejuni knockout mutants the ISA reaction was performed using 4 fragments, HincII 
digested pGEM3Zf(-) vector, the resistance cassette and two flanking regions.  The pGEM3Zf(-) 
vector was linearised with HincII, the kanamycin or chloramphenicol resistance marker was 
amplified from pJMK30 or pAV35 respectively.  Approximately 400 bp of the flanking regions of 
the gene of interest were amplified (typically removing most of the ORF).  The left flanking 
region for the gene of interest was amplified using primers named F1F and F1R, the right 
flanking region was amplified by F2F and F2R.  All PCR amplifications were performed with 
Phusion.  The F1F and F2R primers contain 30 bp adapters for the pGEM3Sf(-) vector cut with 
HincII and the F1R and F2F primers contain 30 bp adapters for either the kanamycin or 
chloramphenicol resistance markers. 
 
For C. jejuni complementation and lacZ reporter construction the ISA reaction was performed 
using 3 fragments, the large fragment of a p46 vector, the small fragment of the same p46 
vector and the gene of interest.  The two vector fragments were amplified by Phusion PCR 
directly from the plasmid, the two fragments shared a 30 bp overlapping region within either 
the kanamycin or chloramphenicol resistance marker.  The gene of interest for 
complementation or the lacZ gene for the reporter system were amplified by Phusion PCR. 
 
All the PCR products and fragments were purified using the PCR purification kit (Sigma).  The 
ISA mastermix was gently thawed on ice and the DNA fragments were added, typically a 3:1 
ratio of each fragment to the vector was used for cloning.  The reaction was made up to 20 µl 
total with SDW.  ISA reactions were typically incubated at 50oC for 4 hours and chilled for 













2.12 Preparation of chemically competent E. coli 
Competent E. coli cells for plasmid transformation were produced using methods described by 
(Hanahan, 1983).  E. coli was grown in LB broth at 37°C until the OD600nm reached 0.6.  Cells 
were then incubated on ice for 15 min before centrifugation (6000 x g, 20 min, 4 °C. The 
supernatant was discarded and the cells re-suspended in 50 ml solution RF1 (100 mM KCl, 
50mM MnCl2.4H2O, 30 mM CH3COOK, 10 mM CaCl2.2H2O, 15% [w/v] glycerol), adjusted to pH 
5.8 with 0.2 M acetic acid.  Following incubation on ice for 15 min cells were harvested by 
centrifugation (as above) and re-suspended in 8 ml solution RF2 (10 mM MOPS, 10 mM KCl, 75 
mM CaCl2.2H2O, 15% [w/v] glycerol) adjusted to pH 6.8 with NaOH.  Cells were then incubated 
for a further 15 min at 4°C before being aliquoted and stored at -80°C. 
 
Figure 10: Isothermal assembly (ISA) cloning.  (a) pGEM3Zf(-) was digested with HincII.  The flanking 
regions F1 and F2 and the resistance marker (AbR) were amplified by Phusion PCR.  The region highlighted 
in red are the overlapping adapter regions.  (b)  The vector and fragments were mixed with the ISA reaction 
buffer and incubated for 4 hours at 50 oC.  (c)  The T5 exonuclease removes nucleotides from the 5’ end of 
each DNA fragment, the T5 enzyme is heat liable and will become inactive during the course of the 
reaction.  (d).  The homologous adapter regions anneal and the single strand nicks are filled in by Phusion 
polymerase.  The final construct contains the flanking regions of the gene of interest with a resistance 
marker between them allowing for the gene of interest to be replaced with the resistance marker.  Figure 






2.12.1 Transformation of competent E. coli 
200 µl of competent cells were thawed on ice and 10-20 ng plasmid DNA added. The cells were 
incubated for 2 minutes on ice then heat shocked at 42 °C for 1 min, then placed on ice for 5 
minutes.  1 ml of SOC broth was added to the cells and placed in a 37°C water bath for 1 hr. 
Cells were then harvested by centrifugation (5,000 x g 5 min), resuspended in 200 µl plain LB 
broth and plated out onto selective LB agar and left at 37 °C overnight. 
 
2.13 Plasmids used in this study 
Table 8 




Standard cloning vector used for making 
mutagenesis constructs. 
MCS in frame with lac operon to allow 
blue/white colour selection 
Amp Promega 
pJMK30 
Cloning vector containing the aphAIII gene 
encoding kanamycin resistance 
Amp Kan 
Van Vliet et al., 
1998 
pAV35 
Cloning vector containing the chloramphenicol 
acetyl transferase (cat) inserted at BamHI site 
Amp Cat 
Van Vliet et al., 
1998 
p(K/C)46 (Metk / 
FdxA) 
Group of vectors for complementation of C. 
jejuni mutants by insertion at the cj0046 
pseudogene locus  
Kan or Cat 
Gaskin et al., 
2007 
pET21a(+) 
Used for over-expression of proteins with C-




Used for over-expression of proteins with N-
terminal pelB signal sequence and C-terminal 




Used for over-expression of proteins with N-
terminal His-tag and thrombin cut site under 
control of IPTG inducible T7 promoter 
Kan Novagen 
pGEM-c8j_0397 pGEM3Zf(-) containing the flanking regions of 
c8j_0397 around a Kan cassette 
Amp Kan This study 
pGEM-c8j_0398 pGEM3Zf(-) containing the flanking regions of 
c8j_0398 around a Kan cassette 
Amp Kan This study 
pGEM-c8j_0399 pGEM3Zf(-) containing the flanking regions of 
c8j_0399 around a Kan cassette 




pGEM-c8j_0400 pGEM3Zf(-) containing the flanking regions of 
c8j_0400 around a Kan cassette 
Amp Kan This study 
pGEM-c8j_0398-
400 
pGEM3Zf(-) containing the flanking regions of 
c8j_0398-400 around a Kan cassette 
Amp Kan This study 
pGEM-cj0421c pGEM3Zf(-) containing the flanking regions of 
cj0421c around a Kan cassette 
Amp Kan This study 
pGEM-cj0422c pGEM3Zf(-) containing the flanking regions of 
cj0422c around a Cat cassette 
Amp Cat This study 
pGEM-cj0421c-
422c 
pGEM3Zf(-) containing the flanking regions of 
cj0421c-422c around a Kan cassette 
Amp Kan This study 
pGEM-cj0423 pGEM3Zf(-) containing the flanking regions of 
cj0423 around a Kan cassette 
Amp Kan Halah Al-
Haideri 
pGEM-cj0424 pGEM3Zf(-) containing the flanking regions of 
cj0424 around a Kan cassette 
Amp Kan Halah Al-
Haideri 
pGEM-cj0425 pGEM3Zf(-) containing the flanking regions of 
cj0425 around a Kan cassette 
Amp Kan Halah Al-
Haideri 
pGEM-cj0423-425 pGEM3Zf(-) containing the flanking regions of 
cj0423-425 around a Kan cassette 
Amp Kan This study 
pGEM-cj0421c-
425 
pGEM3Zf(-) containing the flanking regions of 
cj0421c-425 around a Kan cassette 
Amp Kan This study 
pCMetK46-
Cj0421c 
pCMetK46 with the cj0421c ORF under the metK 
promoter 
Cat This study 
pCMetK46-
Cj0421c-C 
pCMetK46 with the cytoplasmic domain of 
cj0421c under the metK promoter 
Cat This study 
pK46-Cj0422c pK46 with the cj0422c ORF under the natural 
promoter 
Kan This study 
pCFdxA46-Cj0423 pCFdxA46 with the cj0423 ORF under the fdxA 
promoter 
Cat This study 
pCFdxA46-
Cj0425His 
pCFdxA46 with the cj0425 ORF under the fdxA 
promoter with a C-terminal 6His tag 
Cat This study 
pK46-LacZ-F pK46 with the lacZ gene under the cj0423 
promoter 
Kan This study 
pC46-LacZ-F pC46 with the lacZ gene under the cj0423 
promoter 
Cat This study 
pC46-LacZ-R pC46 with the lacZ gene under the cj0422c 
promoter 
Cat This study 
pET28-Cj0421c pET28a(+) with the cytoplasmic domain of 
cj0421c, with a N-terminal His tag 
Kan This study 




cj0421c, with a C-terminal His tag 
pET28-Cj0422c pET28a(+) with the cj0422c ORF, with a N-
terminal His tag 
Kan This study 
pET22-Cj0425 pET22b(+) with the cj0425 ORF, with the native 
signal sequence replaced with the pelB signal 





2.14 Preparation of chemically competent C. jejuni 
C. jejuni was grown on blood agar overnight, scrapped off and re-suspended in 1 ml BHI broth.  
The cells were centrifuged (15,000 x g, 5 minutes, 4°C) and re-suspended in 1ml chilled  wash 
buffer (9% sucrose w/v, 15% glycerol v/v in SDW).  This was repeated two more times and the 
cells re-suspended in 300 µl chilled wash buffer.  The cells were then separated into 150 µl 
aliquots and stored at -80°C. 
 
2.14.1 Transformation of competent C. jejuni 
150 µl of competent C. jejuni was thawed on ice and mixed with 200-500 ng plasmid DNA, the 
mixture was incubated on ice for 15 minutes and transferred to a pre-chilled electroporation 
cuvette (VWR).  The cells were electroporated with a pulse of 25 F, 2.5 kV and 200 Ω, giving 
time constants for 4 – 5 ms in a Gene pulsar chamber (Biorad).  150 µl of BHI broth was added 
and the cells were plated onto 2 non selective blood agar plates and grown for 24 hours.  The 
cell material was harvested and plated onto 4 selective blood agar plates and grown for 2-5 
days until individual colonies formed.  The colonies were re-plated onto selective blood agar 
and screened by PCR.  The procedure was scaled up as necessary. 
 
2.15 Whole cell RNA extraction and purification 
Typically, C. jejuni was grown in triplicate in MHS broth culture to a mid-log phase OD600nm 
(0.5-0.6) under standard conditions unless otherwise stated.  RNA was extracted directly from 
the cultures using the ‘SV total RNA isolation system’ (Promega) as recommended by the 
supplier.  The only modification was the use of a 1 mg ml-1 lysozyme solution instead of the 
recommended 0.3 mg ml-1.  Purified RNA samples were DNAse treated using the ‘Turbo-DNA 
Free’ kit (Ambion) to remove any contaminating DNA according to the manufacturer’s 
instructions.  The RNA concentration and purity were determined by using a ‘Genova nano 
micro-volume spectrophotometer’ (Jenway).  The treated RNA samples were matched to 10 ng 




contaminating DNA by performing a PCR reaction without any reverse transcriptase.  All water 
used for RT-PCR is DEPC treated nuclease free water (Thermo). 
 
2.15.1 Real time quantitative reverse transcriptase PCR 
qRT-PCR gene specific primers (Table 7), were designed to amplify a 100-300 bp fragment 
within the gene of interest, with the C. jejuni gyrA gene being used as a reference.  RT-PCR 
primers were checked for specificity prior to use by performing a standard PCR reaction.  The 
primers were diluted to 25 µM in nuclease free water prior to use.  Each qRT-PCR reaction was 
carried out in a 20 μl volume in a MicroAmp® 96-well optical reaction plate (ABI prism).  
Reactions were performed using the Sensifast SYBR Lo-ROX one step kit (Bioline, UK).  Each 
reaction contained 10 μl Sensifast SYBR 2x buffer, 0.2 μl of each primer, 0.2 μl reverse 
transcriptase, 0.4 μl RNAse inhibitor, 2 μl of matched RNA or DNA template and 7 μl nuclease 
free water.  Each reaction using RNA was repeated in triplicate; reactions using genomic DNA 
for the standard curve were replicated in duplicate.  Some reactions were performed using the 
Sensifast SYBR Hi-ROX one step kit.  All other components remained the same.  PCR 
amplification was carried out in a Stratagene MX3005p thermal cycler (Agilent) at 45qC for 10 
min; 95qC for 2 min followed by 40 cycles of 95qC for 20 s; 55qC for 30s and 72qC for 20s.  Data 
was collected with the associated MxPRO QPCR software (Agilent).  A standard curve for each 
gene was generated using a series of C. jejuni genomic DNA dilutions.  The relative expression 
levels of the target genes were calculated following the standard curve protocol described in 
the User Bulletin #2 (ABI Prism 7700 Sequence Detection System, Subject: Relative 
Quantification of Gene Expression) provided by Applied Biosystems.  Gene expression was 
calculated as relative to gyrA expression.  No-template controls were included for each primer 
set being used. 
 
2.16 Preparation of C. jejuni cell free extracts 
1 litre of C. jejuni was grown overnight in 4X 250 ml MHS broth cultures under standard 
conditions.  Cells were harvested by centrifugation (8,000 x g, 5 minutes) and re-suspended in 
100 ml 10 mM Tris-HCl pH 7.4, 500 mM NaCl.  The cells were lysed using a French press (SIM 
Aminco).  The resulting cell free extract was stored at 4qC prior to use or at -20qC for long term 
storage. 
 
2.17 C. jejuni growth curves 
C. jejuni strains were grown overnight on blood agar plates with selective antibiotics.  Cell 




saline water.  Pre-equilibrated MHS broth (without selective antibiotics) was distributed into 6-
well plates (Greiner) and the media inoculated to a starting OD600nm of 0.05.  OD600nm 
readings were taken at 0, 2, 4, 6, 8 and 24 hours to generate a growth curve. 
 
2.18 Antimicrobial disc diffusion assay 
100 ml cultures of C. jejuni were grown to and OD600nm of 1.0.  Individual 50 ml aliquots of MH 
agar were cooled to 40qC in a water bath and 10 ml of the cell culture was added to each.  The 
agar-cell culture mixture was poured into individual petri dishes and allowed to set.  Using 
sterilized forceps, the antibiotic discs (Mast Diagnostics, disc number M14) were placed onto 
the agar and gently pressed down to ensure complete contact.  The plates were incubated 
under standard conditions for 24 hours and the zones of inhibition measured in millimeters. 
 
2.19 Antimicrobial sensitivity microtiter assay 
C. jejuni starter cultures were cultured overnight in standard conditions.  The cells were diluted 
to an OD600nm of 0.6 in fresh MHS broth (without selective antibiotics) and briefly incubated.  
Sterile 200 μl, 96 well microtitre plates (Greiner) were prepared for the assays by adding 100 μl 
of MHS broth into the wells in row A and mixing 160 μl of MHS broth with 20 μl of the 
appropriate antimicrobial dilution into the wells in row B.  180 μl of MHS broth was added to 
all remaining wells in rows C-H and the plates equilibrated for 30 minutes under standard 
conditions.  Typically, the plates contain 12 wells per row and these are divided into 4 sets of 3 
replicates.  The 4 sets were used for the different antimicrobial concentrations with the first 
set being used as the negative control which contained only SDW.  To start the assay 100 μl of 
the diluted C. jejuni culture was added to the 100 μl MHS broth in the wells in row A.  20 μl of 
these cultures were diluted 1:10 into the wells in row B containing the antimicrobial 
compound.  The dilutions were performed using a 12-channel pipette.  The plates were 
incubated for typically 2 or 4 hours, depending on the antimicrobial, under standard 
conditions.  Following the incubation the cultures were serially diluted down the 96 well plate 
using a multichannel pipette at 1:10 dilutions (20 μl : 200 μl).  10 μl was transferred from each 
well to CCDA agar plates, using an 8-channel pipette, to perform colony counts.  The plates 
were incubated for 2 days and the colonies counted.  The CFU ml-1 was calculated in Microsoft 
excel and the data expressed in Graphpad prism.  
 
2.20 LacZ expression (Miller) assays 
To measure the expression of the lacZ protein from broth cultures of C. jejuni reporter strains 




Eppendorf tube containing 780 μl of Z-buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 
mM MgSO4, pH7), 2.7 μl ß-mercaptoethanol, 20 μl chloroform and 10 μl 0.1% [w/v] SDS.  The 
mixture was briefly shaken and incubated at room temperature for 5 minutes.  The reaction 
was started by adding 200 μl ONPG solution (ortho-Nitrophenyl-ß-galactoside, 4 mg ml-1) and 
the tubes incubated at 30qC for 1 hour (this was altered depending on the speed of the 
reaction).  The reaction was stopped by adding 500 μl of 1 M Na2CO3 solution.  The tubes were 
centrifuged (10,000 x g for 10 minutes) to pellet cell debris and 1 ml of the mixture was 
transferred to a cuvette for the OD420nm reading.  The relative expression of the LacZ protein 
is expressed in Miller units (Simons et al., 1983) where the expression is calculated as relative 
to the cell density.  The equation used is as follows: 
 
M = 1000 X Abs420nm / (T X V X Abs600nm) 
 
M – Relative expression (Miller units) 
T – Time (minutes) 
V – Volume (milliliters) 
Abs420nm – Absorption at 420nm  
Abs600nm – Absorption at 600nm 
 
2.20.1 96 well Biolog phenotype microarray Miller assay 
For high throughput screening of the LacZ reporter construct using the phenotype microarray 
system, the Miller assay was adapted for use in a 96 well plate format.  Broth cultures of C. 
jejuni were grown under standard conditions to an OD600nm of 0.6.  75 ml of the MCLMAN 
minimal media (Section 2.6.1) was prepared and equilibrated under standard conditions.  Cells 
from the MHS broth culture were harvested by centrifugation (5,000 x g, 5 minutes, 37qC) and 
used to inoculate the MCLMAN culture to a starting OD600nm of 0.5.  The cultures were 
incubated for 1 hour and the OD600nm measured to ensure the culture was growing.  100 μl of 
the culture was transferred to the 96 well phenotype microarray plates and the plates were 
incubated for 4 hours under standard conditions with gentle shaking. 
 
During the incubation the 96 well Miller assay was prepared, the volumes and concentrations 
used for the Miller assay in a 96 well format are exactly half those described in (Section 2.20).  
The final step involving Na2CO3 uses 200 μl of 1.25 M instead of 250 μl of 1 M.  The Z-buffer, ß-
mercaptoethanol, chloroform and SDS solutions were mixed together in 1 ml volume 96 well 
plates (Greiner) with each well corresponding to the same well from the Biolog phenotype 




were measured and 50 μl of the culture from each of the 96 wells was added to the 
corresponding wells in the 1 ml 96 well plates.  The reaction was started by adding 100 μl 
ONPG solution and the plates incubated for 2 hours at 30qC.  200 μl of 1.25 M Na2CO3 was 
added to each well to stop the reaction and the plates were centrifuged at 3,000 x g for 10 
minutes to pellet the cell debris.  200 μl of the solution from each well was transferred to a 
fresh 200 μl flat bottomed 96 well plate and the OD420nm measured.  The absorptions at 600 
and 420nm were measured on a FLOUstar omega 96-well plate reader (BMG Labtech).  The 
relative expression in Miller units for each well was calculated as described in (Section 2.20). 
 
2.21 Type VI secretion competition assays with S. marcescens 
C. jejuni strains were grown on blood agar plates overnight and S. marcescens strains were 
grown on LB agar plates overnight under standard conditions.  6 ml cultures of MHS broth 
were prepared in 6-well plates (Greiner) and equilibrated.  Both the C. jejuni and S. marcescens 
strains were harvested from the agar plates and used to inoculate the 6 ml cultures to a 
starting OD600nm of 0.5, the cultures were briefly incubated with gentle shaking.  The C. jejuni 
and S. marcescens cultures were mixed together in duplicate in 1 ml Eppendorf tubes at a 50:1 
ratio respectively (20 μl added to 980 μl).  25 μl of these mixtures were spotted onto MH agar 
plates in duplicate and allowed to dry, the plates were inverted and incubated under standard 
C. jejuni growth conditions for exactly 24 hours.  For each individual spot a single Eppendorf 
tube was prepared with pre-equilibrated PBS buffer (Sigma).  The spot was scraped off the MH 
plates and transferred to the PBS using a sterile plastic loop.  The cell suspensions were serially 
diluted down a 200 μl 96 well plate using 1:10 dilutions in 180 μl volumes of pre warmed PBS 
and 10 μl samples were transferred to mCCDA agar pates (containing Amphotericin-B and 
Cefoperazone at 10 and 32 μg ml-1 respectively final concentration.  The plates were incubated 
under standard C. jejuni conditions (except at 42qC) for 2 days and the colonies counted.  The 
procedure was repeated using LB agar plates under aerobic conditions at 37qC for counting S. 
marcescens colonies.  The CFU ml-1 for both C. jejuni and S. marcescens was calculated from 
the serially diluted colonies using Microsoft excel and the data presented in Graphpad prism. 
 
2.22 C. jejuni membrane rigidity assays 
The method for measuring the rigidity of the C. jejuni membrane is adapted from work by (Wu 
et al., 2015).  The method uses a hydrophobic fluorescent dye 1, 6-diphenyl-1, 3, 5-hexatriene 
(DPH) that inserts into the membrane.  C. jejuni strains were cultured in MHS broth under 
standard conditions and the assay was performed on both mid log phase cells and overnight 




the cells were washed twice with pre-warmed PBS (Sigma) and diluted in PBS to an OD600nm of 
0.2 in 40 ml.  DPH (7.5 mM stock solution in DMF) was added to the cells to a final 
concentration of 7.5 μM.  The cells were incubated with gentle shaking for 30 minutes at 37qC.  
The cells were re-harvested by centrifugation and washed twice with PBS to wash away any 
non-incorporated DPH.  The cells were re-suspended in PBS to an OD600nm of 0.2. 
 
The fluorescence readings were measured using a Cary Eclipse fluorimeter (Varian Ltd, UK) 
using a 3 ml quartz cuvette and a manual accessory polarizer (Varian).  The excitation 
wavelength was 358 nm with a 10 nm slit, the emission wavelength was 428 nm with a 10 nm 
slit.  The machine voltage was set to high.  The fluorescence values were measured at V-V, V-H, 
H-H and H-V, where V is vertical and H is horizontal polarization of the excitation and emission 
respectively.  The cuvette was maintained at 37qC at all times during the assay.  Measurements 
were taken for 30 seconds for each polarization set and the average of the middle 20 seconds 
was used as the fluorescence value.  The polarization value for the membrane-bound DPH was 
calculated using the following equation: 
 
P = (Ivv – GIvh) / (Ivv + GIvh)       
 
Where  
P – Polarization value (must be <0.5) 
G – Correction factor (Ihv/Ihh) 
I – Fluorescence intensity 
h – Horizontal polarization 
v – Vertical polarization 
 
2.23 Outer membrane permeability nitrocefin assay 
Nitrocefin is a chromogenic cephalosporin that can be hydrolysed by periplasmic beta-
lactamase.  The rate of hydrolysis can be used as an indicator of membrane permeability after 
osmotic shock treatment.  20 ml C. jejuni cultures were grown overnight and matched to an 
OD600nm of 0.5 under standard conditions and harvested by centrifugation (10,000 x g, 5 
minutes).  The cell pellets were re-suspended in osmotic shock buffer (10 mM Tris-HCl, pH 8, 
8% [w/v] sucrose and 0.4% [w/v] EDTA) and incubated with gentle shaking for 5 minutes at 
room temperature.  The pellets were re-harvested by centrifugation and re-suspended in 800 
μl chilled 20 mM sodium phosphate buffer pH 7.5.  The cells were incubated at 4qC with gentle 
shaking for 5 minutes and the soluble periplasmic extracts separated by centrifugation (15,000 




quartz cuvette containing 5 μg of nitrocefin (Sigma) in 900 μl 20 mM sodium phosphate pH 7.5, 
was checked for to ensure there was no background rate and 100 μl of the periplasmic extract 
added to start the reaction.  The change in Abs495nm was measured over 2 minutes using a 
Shimadzu UV-2401PC recording spectrophotometer, the rate of reaction calculated in 
Microsoft excel. 
 
2.24 Outer membrane permeability lysozyme assay 
Lysozyme is a glycoside hydrolase which degrades microbial peptidoglycan, Gram-negative 
bacteria are typically resistant to lysozyme due to the outer membrane.  If the outer 
membrane is compromised Gram-negative bacteria become more sensitive to lysozyme.  The 
rate of cell lysis due to lysozyme can be measured by the decrease in the Abs OD600nm of a cell 
suspension.  Overnight cultures of C. jejuni grown under standard conditions were matched to 
an OD600nm of 0.5 in 20 mM sodium phosphate buffer pH 7.5 with 5 mM sodium azide.  
Lysozyme (Sigma) was prepared in fresh aliquots of 1 mg ml-1 in 20 mM sodium phosphate 
buffer.  Lysozyme was added to a final concentration of 50 μg ml-1 in a 1 ml cuvette in with 870 
μl of cell suspension.  The background rate of OD600nm was measured for 20 seconds and a 
stressor compound such as sodium deoxyholate or buffer as a negative control was added and 
the decrease in OD600nm measured over 2 minutes using a Shimadzu UV-2401PC recording 
spectrophotometer, the rate of reaction calculated in Microsoft excel. 
 
2.25 Protein manipulations 
2.25.1 Protein concentration determination 
Soluble (cell-free) protein concentration was determined using a Bio-Rad Protein Assay Kit 
according to the manufacturer’s instructions.  For approximate determination of soluble 
protein concentration, the method was adapted as follows: 1-5 μl of protein solution was 
added to a 1 ml cuvette containing 0.8 ml of SDW and 0.2 ml Bio-Rad Dye Reagent 
Concentrate.  The cuvette was mixed by inversion and absorbance measured at 595 nm. The 
approximate protein concentration (mg ml-1) was calculated using the following formula: 
(OD595 x 15)/volume of protein (µl).  For more accurate determination of soluble protein from 
whole cell free extracts, the Bio-Rad reagent was used in a 96-well plate format and compared 
to a standard BSA curve. 
 
For accurate determination of pure protein concentration by spectroscopy, the protein was 




UV-2401PC recording spectrophotometer.  The concentration of pure protein was calculated 
using the following equation: 
M = Abs280nm – Abs320nm / ε  
Where: 
M – Molar concentration 
Ε – Extinction coefficient  
The extinction coefficient for each protein was calculated from the complete amino acid 
sequence using the ExPasy ProtParam service (http://web.expasy.org/protparam/).   
 
2.25.2 SDS poly acrylamide gel electrophoresis 
SDS-PAGE was performed using the Mini-Protean Tetra system (Bio-Rad), 12% resolving gels 
were prepared (30% [w/v] acrylamide with 0.8% [w/v] bis-acrylamide was diluted in 1 M Tris-
HCl pH 8.8, 10% [w/v] SDS and dH2O to create a 375 mM Tris-HCl pH 8.8, 0.1 % [w/v] SDS, 
12.5% acrylamide mixture).  Addition of 0.1% [w/v] ammonium persulphate (APS) and 0.01% 
N,N,N’,N’-Tetramethylethylenediamine (TEMED) initiated polymerisation.  The components 
were mixed by gentle swirling and pipetted into assembled gel casts.  100% Ethanol was added 
to the top of the mixture to ensure an even spread, this was removed by filter paper and 
gentle rinsing prior to the addition of the stacking gel.  5% stacking gels were prepared (30% 
[w/v] acrylamide with 0.8% [w/v] bis-acrylamide was diluted in 1 M Tris-HCl pH 6.8, 10% [w/v] 
SDS and dH2O to create a 125 mM Tris-HCl pH 6.8, 0.1% [w/v] SDS. 6% acrylamide mixture).  
Polymerisation was initiated as described above and the mixture poured on top of the 
resolving gel with a loading comb which was removed upon polymerization.  Protein samples 
were boiled for 5 minutes in equal volumes of sample buffer (60 mM Tris-HCl pH 6.8, 2% [w/v] 
SDS, 0.05% [w/v] bromophenol blue, 5% [v/v] E-mercaptoethanol, 10 % [w/v] glycerol.  
Samples were loaded into the gel with the prestained EZ-Run protein ladder (Fisher).  The gel 
was loaded into a gel tank containing 1X running buffer (25 mM Tris, 250 mM glycine, 0.1% 
[w/v] SDS).  The samples were separated by electrophoresis at 180V until the tracking dye had 
reached the bottom of the gel. Gels were stained with coomassie brillaint blue (50 % [(/v) 
methanol, 10 % [v/v] glacial acetic acid, 0.1 % [w/v] coomassie brilliant blue (Sigma-Aldrich)) 
and de-stained (50 % [v/v] methanol, 10 % [v/v] glacial acetic acid) until individual bands were 
visible.  
 
2.25.2.1 Silver staining  
SDS-PAGE gels were silver stained for increased sensitivity, silver staining was performed using 





2.25.2.2 SDS-PAGE tricine gels 
SDS-PAGE Tricine gels were prepared in the same way as described in (Section 2.25.2) with the 
following exceptions.  The acrylamide concentration was made up to 16% for the resolving gel 
and 6% for the stacking gel using the same gel buffer at pH 8.45.  For the electrophoresis 
separate anode (0.1 M Tris-HCl pH 8.9) and cathode (0.1 M Tris-HCL, 0.1 M Tricine, 0.1 % [w/v] 
SDS, pH8.25) buffers were used.  All other steps were the same as for standard SDS-PAGE gels. 
 
2.25.3 Preparation of C. jejuni cell free extracts for western blotting 
Overnight cultures of C. jejuni cells were harvested by centrifugation at 8,000 x g for 10 
minutes at 4°C and re-suspended in 10 mM Tris-HCl pH 8.  The cells were sonicated for 4 x 15 
second pulses at a frequency of 16 amplitude microns using a Soniprep 150 ultrasonic 
disintegrator (SANYO).  The cell debris was removed by centrifugation at 15,000 x g for 30 
minutes at 4°C.  The remaining supernatant was stored at -20°C. 
 
2.25.4 Western blotting for detection of Cj0424 from C. jejuni cell free extracts 
Cell free extracts were separated by SDS-PAGE, the transfer of proteins was carried out using a 
Mini Trans-Blot Electrophoretic Cell (Bio-Rad) according to manufacturer’s instructions.  The 
protein samples were transferred to a nitrocellulose membrane (Hybond-C Extra, Amersham 
Biosciences) at a constant voltage of 100 V for 90 min at 4 ºC in ice cold transfer buffer (25 mM 
Tris, 190 mM glycine, 20 % [v/v] methanol).  All immuno-detection steps were carried out at 
room temperature with constant agitation.  TBS-T20 buffer (25 mM Tris-HCl pH 7.4, 137 mM 
NaCl, 2.7 mM KCl, 0.1 % Tween 20) was used as both a base for blocking agent (5 % dried 
skimmed-milk powder, incubated overnight) and for washing (15 minutes and 2 x 5 minutes).  
Polyclonal antibodies for the Cj0424 protein was raised from rats and provided by Halah Al-
Haideri.  This was diluted 1:20,000 and applied to the membrane for 1 hour.  The membrane 
was then washed 3 times with TBS-T20.  The secondary antibody (peroxidase linked goat anti-
rat IgG (Sigma) was diluted (1:2000) in TBS-T and applied to the membrane for 1 hr.  After 
washing in TBS-T 4 times, antibody binding was visualised by means of enhanced chemi-
luminescence (ECL Kit, GE Healthcare), according to manufacturer’s instructions. 
 
2.26 Protein purification procedures 
Three individual proteins were purified during the course of this work, the exact 






2.26.1 Overexpression of recombinant protein in E. coli BL21 (DE3) 
All protein overexpressions were performed using the T7 promoter in the pET vector system in 
E. coli BL21 (DE3) as the expression strain.  Cultures were grown in LB broth with selective 
antibiotics to an OD600nm of 0.6 and induced with isopropyl-β-D-thiogalactopyranoside (IPTG).  
The concentration of IPTG used and the incubation times and temperatures are detailed in the 
results chapters for each individual protein.  Cells were harvested by centrifugation (8,000 x g, 
5 minutes, 4qC) and stored at -80qC before use. 
 
2.26.2 Overexpression of selenomethionine incorporated protein 
For production of selenomethionine incorporated protein the E. coli BL21 (DE3) 
overexpression strain was grown in 1 L volumes of M9 minimal media containing 6.78 g 
Na2HPO4, 3 g KH2PO4, 0.5 g NaCl, 1 g NH4Cl and 5 ml glycerol, the total volume was made up to 
950 ml with SDW.  The media was autoclaved and allowed to cool prior to the addition of the 
following components from 0.2 μm filter sterilised stock solutions to final concentrations of: 50 
mg l-1 carbenicllin, 0.1 mM CaCl2, 2 mM MgSO4, 2 mg l-1 thiamine hydrochloride, 40 mg/l L-
selenomethionine and 100 mg l-1 of each of L-lysine, L-threonine, L-phenylalanine, L-isoleucine, 
L-valine and L-leucine.  The culture was grown under standard conditions till the cells reached 
an OD600nm of 0.6 and IPTG was added.  As with standard protein overexpression the exact 
IPTG concentrations, length and temperature of the induction is explained in the results 
chapters.  The cells were harvested in the same way for standard protein expression. 
 
2.26.3 Preparation of E. coli cell free extracts 
The cell pellets from protein overexpression samples were thawed gently on ice and re-
suspended in buffer solution, typically 20 mM sodium phosphate buffer with 500 mM NaCl 
was used (the individual buffers used are described for each protein in the results chapters).  5 
mg DNAse I (Sigma) was added to the cell suspension to remove DNA and the soluble protein 
extracted using a French press (SIM Aminco) according to the manufacturer’s instructions.  The 
extracts were centrifuged (40,000 x g, 30 mintes, 4qC) and the soluble fraction was filtered 
through a 0.45 μm filter prior to protein purification. 
 
2.26.4 Nickel affinity chromatography 
The cell extracts were fractionated on a HisTrapTM HP 5 ml column (GE Healthcare) connected 
to an Akta Prime purification system (GE healthcare) by affinity chromatography. The proteins 




eluted from the resin by a linear gradient from 20-500mM imidazole in the same buffer.  
Fractions containing eluted protein were pooled and kept on ice. 
 
2.26.5 Ion exchange chromatography 
Pooled elutions from His trap purification containing the protein of interest were de-salted 
using PD10 de-salting columns (GE healthcare) according to the manufacturers instructions.  
The fractions containing protein were pooled and loaded onto a HiTrapTM Phenyl HP column 
(GE healthcare) and eluted with a gradient of 0-1 M NaCl in the same buffer over 10 column 
volumes. 
 
2.26.6 Hydrophobic interaction chromatography 
Pooled elutions from His trap purification containing the protein of interest were mixed with 
(NH4)2SO4 to a final concentration of 1.5 M.  The protein solution was loaded onto a HiTrapTM 
HIC column (GE healthcare) and eluted with a gradient of 1-0 M (NH4)2SO4 in the same buffer 
over 10 column volumes. 
 
2.26.7 Gel filtration chromatography 
The pooled protein was concentrated to less than 5 ml using vivaspin concentration columns 
(GE healthcare) with a molecular weight cutoff (MWCO) of less than half the protein of 
interest.  The protein was loaded onto a HiLoad Superdex 200 gel filtration column (GE 
healthcare) according to the manufacturer’s instructions.  The protein was eluted into 
whichever buffer was desired for final purification. 
 
All elutions were checked for purity by SDS-PAGE analysis and the final protein concentration 
determined by spectroscopic analysis. 
 
2.26.8 Protein dialysis 
Pooled protein fractions were dialysed to remove imidazole and other contaminants using 
benzoylated dialysis tubing with a MWCO less than half the protein of interest (Sigma).  
Typically, dialysis was performed for 1 hour, the buffer was replaced and the sample was 
dialysed overnight, the buffer replaced again with sterilised buffer and the protein dialysed for 







2.27 Recombinant Cj0425 pull down assays 
2.5 L of C. jejuni cells were cultured under standard conditions overnight.  The cells were 
harvested by centrifugation (8,000 x g, 5 minutes, 4qC) and the soluble protein extracted as 
described in (2.26.3).  The proteins were extracted into loading buffer (20 mM sodium 
phosphate buffer at pH 7.4 with 100 mM NaCl).  C. jejuni soluble cell free extracts were loaded 
onto a HisTrap column and the column was washed with 5 column volumes (CVs) loading 
buffer and the pooled fractions collected.  The column was then washed with 5 CVs of binding 
buffer (loading buffer with 20 mM Imidazole) and the fractions collected.  The column was 
then washed with 5 CVs of elution buffer (loading buffer with 300 mM imidazole) and the 
fractions collected.  The column was re-equilibrated with loading buffer and purified Cj0425 
was loaded onto the column.  The column was then washed with 5 CVs of loading, binding and 
elution buffer and the fractions pooled together.  Samples from all the wash steps were 
analysed by SDS-PAGE.  
 
2.28 Thermal shift analysis of Cj0421c 
All thermal shift (thermofluor) screens were performed using an Mx3005P qRT-PCR machine 
(Stratagene) and the data collected with the associated mxpro software (Stratagene).  Each 50 
µl well contained 50 µM purified Cj0421c in 20 mM sodium phosphate buffer with 500 mM 
NaCl pH7.4 and 5 µl of the 10X SYPRO orange dye (Invitrogen), the potential ligand of interest 
was added to whichever concentration was required and the difference made up with buffer.  
The SYPRO dye was stored in darkness and was added last.  The assays were performed in a 
MicroAmp® 96-well optical reaction plate (ABI prism) over a temperature gradient of 25-95qC, 
with the fluorescence measured at each degree increase.  The fluorescence was measured 
using the same settings for the measurement of SYBR green for qRT-PCR reactions.  The 
thermofluor reaction is described in (Niesen et al., 2007).  The data was analysed in Microsoft 
excel using publicly available analysis packages available at 
(ftp://ftp.sgc.ox.ac.uk/pub/biophysics).  The graphs were generated in Graphpad prism. 
 
2.29 DTNB thiol assay 
To measure the concentration of free thiol groups the compound 5,5’-Dithiobis(2-nitrobenzoic 
acid (DTNB) also known as Ellman’s reagent was used to determine the number of free thiol 
groups in a protein solution, thereby acting as an indicator of disulfide bond formation in 
purified proteins.  A 10 mM stock solution of DTNB (dissolved in DMSO) was diluted to 100 µM 
in whichever buffer the protein of interest is stored in.  50 µl of the sample was added to 950 




temperature.  A standard curve was generated using acetyl-cysteine (Sigma) to calculate the 
exact thiol molar concentration lysozyme was used as a control protein. 
 
2.30 Papain assay 
Papain activity was assayed by measuring the rate of liberation of methylcoumarin from Nα-
Benzoyl-L-arginine-7-amido-4-methylcoumarin (BAEE-Coumarin) (Sigma).  Purified papain 
(Sigma) was dissolved in activation buffer (20 mM sodium phosphate, 5 mM EDTA, 100 mM 
NaCl, pH 6.2) containing 5 mM L-cysteine and 67 μM ß-mercaptoethanol.  The reaction was 
performed in a 3 ml quartz cuvette and the final concentration of papain was calculated to be 
1 unit per 3 ml, where 1 unit should hydrolyse 1 μmol BAEE per minute at 25qC pH 6.2.  The 
reaction was performed at 37qC due to the higher temperature requirement of C. jejuni.  The 
papain solution was pre-warmed to 37qC and transferred to the reaction cuvette and a final 
concentration of 50 μM BAEE-Coumarin (dissolved in 1:1 methanol:DMSO) was added to start 
the reaction.  Once a repeatable reaction could be achieved inhibitor compounds were added 
to the reaction to assay for papain inhibition. 
 
The fluorescence data was collected on a Cary Eclipse fluorimeter (Varian Ltd, UK) with a λex of 
345 nm with a 5 nm slit width and a λem of 442 nm with a 10 nm slit width, the machine voltage 
was set to low.  A standard curve of 7-amido-4-methylcoumarin (Sigma) fluorescence was 
generated to calculate the rate of hydrolysis.  Data was collected over a 2 minutes and the rate 
of reaction calculated using Microsoft excel.  
 
2.31 Cathepsin-B assay 
Human cathepsin-B activity was assayed by measuring the rate of liberation of 
methylcoumarin from Z-Arg-Arg-7-amido-4-methyl-coumarin (ZAA-Coumarin) (Sigma).  
Cathepsin-B (Sigma) was dissolved in a 0.1% [w/v] chilled Brij35 solution in SDW.  Assay buffer 
(100 mM sodium potassium phosphate, 2 mM EDTA, pH 6) was prepared containing 5 mM L-
cysteine and 67 μM ß-mercaptoethanol.  The reaction was performed in a 3 ml quartz cuvette 
and the final concentration of cathepsin-B was calculated to be 0.2 units per 3 ml, where 1 unit 
should hydrolyse 1 nmol BAEE per minute at 25qC pH 6.  The reaction was performed at 37qC 
due to the higher temperature requirement of C. jejuni.  The cathepsin-B solution was added 
to the pre-warmed reaction buffer and transferred to the reaction cuvette and a final 
concentration of 50 μM ZAA-Coumarin (dissolved in DMSO) was added to start the reaction.  
Once a repeatable reaction could be achieved inhibitor compounds were added to the reaction 





The fluorescence data was collected on a Cary Eclipse fluorimeter (Varian Ltd, UK) with a λex of 
348 nm with a 5 nm slit width and a λem of 440 nm with a 10 nm slit width, the machine voltage 
was set to low.  A standard curve of 7-amido-4-methylcoumarin (Sigma) fluorescence was 
generated to calculate the rate of hydrolysis.  Data was collected over 30 minutes and the data 
presented in Graphpad prism.  
 
2.32 Protein crosslinking 
Purified protein-protein crosslinking was performed using dithiobis(succinimidyl propionate 
(DSP) (Thermo-Fisher).  The proteins of interest were mixed at different ratios in their 
respective buffers, to a 50 µl final volume (no Tris buffer was used for the reaction as Tris 
reacts with DSP) and DSP added to a final concentration of 0.5 or 2 mM and incubated for 30 
minutes at 25°C.  The reaction was stopped by adding 5 µl of 1M Tris-HCl, pH 7.4 to each 
reaction.  The samples were analysed on SDS-PAGE gels without boiling or reducing with ß-
mercaptoethanol to keep the crosslinked proteins intact. 
 
2.33 Crystalisation screening 
Purified protein was screened for crystalisation using 5-10 mg ml-1 of pure protein solution in 
individual buffer solutions.  Microdrops of 200 nl protein and 200 nl precipitant were set up in 
sitting drop vapour diffusion trials using a Matrix Hydra II Plus One crystalisation robot in 
collaboration with Dr John Rafferty.  Proteins were screened using the PACT, JCSG+, 
Ammonium Sulphate, Proplex, MPD and classic crystal screens (Qiagen). 
 
2.33.1 Crystalisation optimisation 
Once individual crystalisation conditions were determined hanging drop trials were performed 
where 3 µl of purified protein (5-10 mg ml-1) and 3 µl of crystalisation buffer were suspended 
from siliconized cover slips in sealed wells and allowed to vapor diffuse until crystals formed.  
Typically, during a crystalisation optimization trial the concentration of the precipitant and the 
pH values of the buffer were slightly altered in each individual well to allow for a greater range 
of conditions to be screened. 
 
2.33.2 Crystal cryoprotectant and X-ray diffraction 
Crystals were looped from the hanging drop trials and stored in cryoprotectant (typically the 




stored in liquid nitrogen.  X-ray diffraction analysis was performed by Dr John Rafferty at the 





































3 Chapter 3 – The role of the rid system in Campylobacter sub strains and the role of 
Cj0422c in CAMP defence. 
 
3.1 Introduction 
Previous work had identified a novel gene cluster in Campylobacter jejuni 11168 which was 
thought to provide resistance to Cationic Antimicrobial Peptides (CAMPs).  This 5 gene cluster 
spans the cj0421c-cj0425 region within the C. jejuni 11168 genome and is organised into two 
operons separated by a divergent promoter region.  One operon contains the hypothetical 
regulator genes (cj0421c and cj0422c) and the other contains the structural genes (cj0423, 
cj0424 and cj0425).  Data from a previous PhD student had shown that when these genes are 
deleted the strains show large increases in sensitivity to CAMPs compared to wild type.  For 
this reason, the genes have been renamed as the Resistance to Innate Defences or rid operon 
for this study; a table of the genes and their names is shown in (Table 1).  This table and the 
model depicted in (Figure 9) shows what was known about the rid system at the start of this 
project. 
 
So far all of the work on this project had been completed using our laboratory standard variant 
of Campylobacter jejuni NCTC11168-GS (Parkhill et al., 2000).  Some previous work has 
established that the rid genes found in this strain (which we are using as our archetypal rid 
system) are also found in other Campylobacter strains.  Using the NCBI BLAST tool 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) to search for rid genes in other bacteria showed that 
most C. jejuni strains contain the rid regulator genes (cj0421c and cj0422c) but only about half 
contain the structural genes (cj0423, cj0424 and cj0425).  It was decided to utilise the recent 
advances in whole genome sequencing (WGS) to examine a large number of sequenced 
Campylobacter genomes for the presence of rid genes, this was done in collaboration with Dr 
Sam Sheppard who provided summary data on a sample of 182 C. jejuni and C. coli genomes 
isolated from multiple animal and human sources.  The data revealed that the rid regulator 
genes (cj0421c and cj0422c) are found in around 90% of C. jejuni strains whereas the 3 
structural genes (cj0423, cj0424 and cj0425) are found in about 40%.  Following this it was 
decided to produce mutant strains in the rid genes of a different laboratory strain, C. jejuni 
81116.  This strain is known to possess the rid regulator genes cj0421c and cj0422c but does 
not possess the 3 structural genes cj0423-cj0425.  Instead the strain appears to have 3 
different genes located in an operon immediately upstream of the regulatory genes.  Since the 
regulatory genes from C. jejuni NCTC11168, cj0421c-cj0422c share near perfect homology at 




respectively) it seems that the regulation of the operon is conserved between the species yet 
strangely the genes being regulated are not. 
 
The aim of this chapter was first to bioinformatically analyse how conserved the rid genes are 
between different Campylobacter sub strains.  I also produced knockout mutations for the 3 
rid genes in C. jejuni 81116 to determine how sensitive the mutants are to CAMPs.  A further 
aim was to complete some previous work on the cj0422c mutant by using a genetic 
complementation strain (produced by a previous PhD student) in CAMP sensitivity assays to 
check that the wild type phenotype is restored.  I used a variety of different CAMPs to check 
for sensitivity including the human cathelicidin LL37, the chicken cathelicidin Fowlicidin-2 and 




















3.2 Chapter 3 Results 
 
3.2.1 Bioinformatic analysis of the rid operon in Campylobacter jejuni sub strains 
 
3.2.2 Prevalence of the rid operon in Campylobacter strains isolated from animal 
sources 
The lab of Dr Sam Sheppard utilises large scale whole genome sequencing to analyse the 
genomes of hundreds of Campylobacter strains, conveniently one of the project areas involves 
using multiple genomes isolated from different animal sources to look for gene prevalence in 
Campylobacter strains from these sources, with an aim to determine which genes may be 
specially adapted to that particular animal niche (Sheppard et al., 2010).  Data from 182 
Campylobacter genomes was analysed for the presence of the 5 rid genes, the genomes were 
taken from 6 animal sources (human, chicken, duck, wild bird, pig and cattle).  The data was 
expressed for each gene shows the number isolates containing the gene of interest as a 
percentage of the total (Figure 11).  The data shows that the 5 genes within the operon are 



















Figure 11: Whole genome analysis of multiple Campylobacter strains for the prevalence of the rid operon.  (A) 
The distribution of the 5 Rid genes (arranged by colour) expressed as a percentage of the total number of 
isolates from a particular animal source.  This graph highlights that the regulator genes (red and blue) are found 
together in the majority of strains analysed, whereas the other genes (green, purple, light blue) are also found 
grouped together but in less than half of all strains analysed.  (B) A table showing the total genome sample size 
from each animal source.  (C) The total percentage distribution of each of the 5 Rid genes throughout the 182 
Campylobacter genomes analysed.  This data indicates that though around 90% of Campylobacter strains 
possess the regulator genes cj0421c and cj0422c, only around 40% of strains contain the structural genes.  Data 




3.2.3 Bioinformatic analysis reveals different sub types of rid system 
The majority of Campylobacter species analysed in (Figure 11) (around 90%) appear to contain 
the two regulator genes cj0421c and cj0422c, yet only around 40% contain the 3 structural 
genes cj0423-cj0425.  This implies that while the rid system as a whole is widespread in 
Campylobacter, the structural genes within the operon may be variable.  Following on from 
this it was decided to align the rid regions from a group of fully annotated Campylobacter 
genomes to determine how variable he rid system is. 
From the 10 genomes analysed by regional alignments of the rid gene cluster in (Figure 12) it 
appears that the rid system can be sub-categorised into 3 distinct groups A, B and C.  A is 
strains 1-3, B is strains 4-6, C is strains 7-9 and X is C. jejuni 81-176 which does not appear to 
possess a rid system.  Since the majority of work in this study is being done on Campylobacter 
jejuni NCTC11168, this strain is considered the archetypal rid system.  
Figure 12: Multi alignment of the rid gene cluster from Campylobacter sub strains.  The 10 annotated 
genomes of Campylobacter from the XBase database were aligned using the region alignment tool 
(http://rid.xbase.ac.uk/ accessed on July 2013).  The order of the genomes are as follows (all are C. jejuni 
unless otherwise stated) (1) NCTC11168, (2) IA3902, (3) ICDCCJ07001, (4) C. jejuni. subsp doylei 269.97, (5) 
RM1221, (6) S3, (7) 81117, (8) M1, (9) C. coli RM2228, (10) 81-176.  The blue lines separate the different 
regions of the gene cluster, highlighting that while all strains have cj0421c (some are probably pseudogenes), 














Figure 13: A representative diagram of the 4 primary varieties of Rid system.  The figure highlights the high 
variability between the Rid structural genes of (A) NCTC11168 and those found in other Campylobacter 
isolates, including (B) C. jejuni RM1221, (C) C. jejuni 81116 and (X) C. jejuni 81-176.  None of the genes from 
any of these groups show any close similarity to any other genes of known function in the NCBI database 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and are all designated genes with unknown function.  The arrows 
represent transcriptional start sites (TSS) for the operons, these are based on data from a whole cell RNA 
sequencing study on Campylobacter species which happened to include these 4 strains (Dugar et al., 2013).  
The orange arrows show primary TSS, which are conserved between strains, the blue arrows show internal 
TSS.  The genes highlighted in green, while not similar at the nucleotide level are structurally similar and likely 






3.2.5 Sequence alignments of the rid transmembrane proteins 
The genes highlighted in green from (Figure 13) are structurally similar small membrane 
proteins which appear to be the only family of proteins conserved between the different sub-
groups of the rid system.  The alignment shown in (Figure 14) suggests that the membrane 
proteins from C. jejuni 81116 and RM1221 share a common evolutionary origin.  While Cj0423 
from C. jejuni 11168 appears to have originated separately yet likely shares a common function 
due to the similar domain architecture. 
  
Figure 14: Protein sequence alignment of a conserved family of proteins from the rid system.   The regional 
alignment shown in (Figure 12) reveals that while the Rid structural genes vary between different 
Campylobacter sub strains some share a degree of structural similarity.  (A) Protein sequence alignment of the 
triple transmembrane proteins which are conserved between different Rid systems.  Cj0423 was excluded 
from this alignment as it does not show strong homology at the sequence level to any of the other proteins, 
possibly implying a different ancestral origin.  (B) Domain architecture of Cj0423, with the transmembrane 
regions represented in blue.  (C) Domain architecture of CJE0472, C8j_0398 and C8j_0400.  The protein 
sequence alignment was generated from (http://rid.ebi.ac.uk/Tools/msa/clustalo/) and represented in 
(http://espript.ibcp.fr/ESPript/ESPript/), the protein domain architecture images were generated by 






The conservation of the small transmembrane proteins between rid systems implies that this 
family of proteins is essential for the role of the rid system between strains.  BLAST analysis of 
the Cj0423 protein sequence shows some homology to the T4 immunity protein from T4 
bacteriophage.  T4 immunity proteins exclude foreign DNA from entering the cytoplasmic 
membrane thereby preventing superinfection by multiple phage (Lu and Henning, 1989).  
However, this homology is not found in the membrane proteins from C. jejuni 81116 or 
RM1221.  Since the rid membrane proteins are so small and most of the proteins length is 
occupied with transmembrane domains, searching for proteins with similar domain 
architecture rather than sequence homology may give a better indication of the proteins role.  
Searches revealed that a family of proteins known as holins (also derived from bacteriophage) 
share similar domain architecture to the transmembrane rid proteins.  Holins are small ‘hole-
forming’ transmembrane proteins which are used by phage to lyse the cytoplasmic membrane 
to allow phage endolysins to escape the cell and degrade peptidoglycan.  Holins may also be 
used to mediate pre-programmed cell death (Reddy and Saier, 2013).  Structurally holins are 
small membrane proteins which vary in the number of transmembrane domains they possess 




The similarities between the domain architecture of holins and the transmembrane rid 
proteins Cj0423, C8j_0398, C8j_0400 and CJE0472 imply a similar function.  The possible role 
of the transmembrane domain proteins and holins is discussed in (Section 3.3.2). 
 
 
Figure 15: Bacterial holin superfamilies.  Transmembrane topologies of members of holin superfamilies, 
dashed lines show transmembrane regions present in some but not all holin families.  Figure adapted from 





The variability of the rid structural genes between Campylobacter strains indicates that 
individual rid systems may have evolved to defend against different niche stresses.  Since data 
from a previous student had shown that rid mutant strains show sensitivity to CAMPs, it may 
be that the variable rid systems have evolved to counter specific sub types of CAMP.  The 
varieties of CAMP families are discussed in the introduction (Section 1.9).   
 
3.2.6 Generation of knockout mutants in C. jejuni 81116 by Isothermal Assembly 
Cloning (ISA)  
The rid system of C. jejuni NCTC11168 has been shown to be involved in resistance to Cationic 
Antimicrobial Peptides (CAMPs); this phenotype is based on previous work showing knockout 
mutations of the rid genes being more sensitive to CAMPs than wild type NCTC11168.  Since it 
has been shown that the rid system is highly variable between Campylobacter strains it was 
decided to knockout some of the rid genes from another Campylobacter strain, C. jejuni 81116.  
The rid operon for this strain is showed as (C) in (Figure 13).  Since the cj0422c mutant from 
NCTC11168 shows the greatest sensitivity to CAMPs it was decided to mutate the homologue 
of this as well as the 3 rid structural genes in 81116.  These mutants would then be tested for 
sensitivity to CAMPs. 
 
Knockout constructs were produced using pGEM-3Zf(-) plasmids which were assembled using 
Isothermal Assembly (ISA) cloning (Section 2.11).  These were then transformed into C. jejuni 
81116 to remove most of the genes of interest while not disrupting flanking genes.  The 
mutations in the structural genes were produced relatively easily, however despite multiple 
attempts, using both chloramphenicol and kanamycin resistance cassettes a mutant in 
c8j_0397 (the cj0422c homologue) was unable to be produced.  Since this was attempted 
numerous times it may be that this gene is unable to be deleted or is potentially an essential 











Figure 16: Generation of a Campylobacter mutation vector by Isothermal Assembly Cloning (ISA).  (A) 
Flanking regions for the gene of interest (c8j_0397) were amplified by high fidelity phusion PCR (shown 
by blue arrows).  (B)  The flanking PCR products shown include the start and end of the gene of interest 
but remove the majority of the internal coding region.  (C) The resistance marker (in this case 
Chloramphenicol Acetyl Transferase catR) is inserted into the pGEM-3Zf(-) vector by ISA cloning.  (D) the 











Figure 17: Plasmid maps of the C. jejuni 81116 knockout vectors.  All plasmids shown were produced by ISA 
cloning in the same way as (Figure 16), all constructs shown used the kanamycin resistance cassette (kanR).  
The maps show the knockout constructs for c8j_0398 (A), c8j_0399 (B), c8j_0400 (C) and a 3 gene deletion 
c8j_0398-c8j_0400 (D).  The 3 gene deletion utilised the flanking regions F1 from (A) and F2 from (C).  All 






Figure 18: Mutagenesis of Rid genes in C. jejuni 81116.  The ISA vectors shown in (Figure 17) were 
transformed into C. jejuni 81116 to remove the genes of interest.  (A) shows the gene arrangements of WT 
81116 and the 4 mutant strains following removal of the gene and insertions of the kanamycin resistance 
cassette.  The mutants were confirmed by PCR analysis.  The numbers correspond to the PCR products 
expected using the knockout screening primers.  The PCR confirmation bands are shown in (B).  The lane 
numbers correspond to the numbers shown above the arrows, the band sizes also correspond to the arrow 
lengths.  The expected PCR product sizes in bp are 1-2616, 2-1046, 3-1879, 4-1815, 5-1243, 6-2378, 7-742, 8-
1046, 9-742.  The PCR primers were designed to be outside the flanking primers used to produce the 
construct, this was to show that the construct was correctly inserted in the correct orientation and that the 






3.2.7 Sensitivity of wild type C. jejuni strains and 81116 mutants to the CAMP 
polymyxin-B 
The new mutations in C. jejuni 81116 were tested for sensitivity to CAMPs using methods 
described in (Section 2.19).  Briefly, overnight broth cultures of cells were checked to ensure 
they had all grown to a similar OD600nm (typically around 1.1-1.3) and were diluted to a 
starting OD of 0.6.  These cells were transferred to a 96-well plate and were mixed with 
appropriate volumes of CAMPs (or SDW as a negative control) to a final volume of 200 µl.  The 
cells were then incubated for 2 hours under normal growth conditions.  Typically, there were 3 
concentrations of CAMPs used and a negative control per assay, each individual concentration 
was repeated in triplicate.  The cells were then serially diluted down the 96-well plate (1:10) 
and 10 µl from each dilution was spotted onto Mueller-Hinton agar.  The plates were 
incubated for 2 days and the colonies counted. 
 
In this experiment 3 wild type strains of C. jejuni were also tested for sensitivity to the model 
CAMP polymyxin-B.  The 3 strains (NCTC11168, 81116 and 81-176) are useful as both 
NCTC11168 and 81116 contain rid systems yet they contain different sets of structural genes.  
C. jejuni 81-176 however does not contain a rid system, it does contain a pseudogene which 
shows strong homology to cj0421c but no other genes (Figure 12-13).  The data shown in 
(Figure 19) suggests that the wild type C. jejuni 81-176 strain appears slightly more resistant to 
polymyxin-B compared to 11168 and 81116.  And that none of the mutant strains produced in 
C. jejuni 81116 show the same level of sensitivity as the Rid mutants from 11168 (comparing 
this data to data from Halah Al-Haideri on the NCTC 11168 mutant strains) one of the strains 













Figure 19: Sensitivity of 3 wild type C. jejuni strains and the C. jejuni 81116 mutants to polymyxin-B. Microtitre 
sensitivity assays were performed using methods described in (Section 2.19) with the strains incubated for 2 
hours.  (A) 3 wild type strains of C. jejuni were tested for innate polymyxin-B sensitivity.  (B) The 3 mutant 
strains produced in C. jejuni 81116 were also tested for polymyxin-B sensitivity.  The asterisks represent a P-
value < 0.05 comparing the wild type and c8j_0400 mutant strain.  All error bars show the standard deviations 






3.2.8 Sensitivity of the cj0422c mutant to a range of CAMPs 
Since the rid mutants in C. jejuni 81116 did not show much sensitivity to the model CAMP 
polymyxin-B it was decided to suspend this line of enquiry and to focus on the archetypal rid 
system in C. jejuni NCTC11168.  Since polymyxin-B is a model CAMP and is produced by Bacillus 
polymyxa using non-ribosomal peptide synthesis (Paulus and Gray, 1964) it is not necessarily 
an accurate model for short chain CAMPs produced by higher organisms.  To study whether 
the rid system is involved in resistance to human and chicken CAMPs a selection of synthetic 
CAMPs was acquired including the human cathelicidin LL37, and the chicken cathelicidins 
Fowlicidin-1 and Fowlicidin-2.  The cj0422c mutant and a newly produced complementation 
strain (both provided by Halah Al-Haideri) were used to test for sensitivity to these CAMPs.  As 
a control the strains were also tested for sensitivity to the anionic detergent sodium dodecyl 
sulphate (SDS).  SDS was used as it is active against the cell membrane in a non-specific 
manner, so if the rid system is protecting against pore forming CAMPs, then there should be 
no difference in sensitivity to SDS.  The data shown in (Figures 20-21) revealed that the cj0422c 
mutant does show increased sensitivity to polymyxin-B, LL37 and Fowlicidin-2 as expected, 
while no increase in sensitivity was observed against the SDS control, however the 
complementation strain of cj0422c did not show any restoration of wild type resistance. 
 
Figure 20: Sensitivity of the cj0422c mutant and complementation strains to the model CAMP polymyxin-B.  
Microtitre sensitivity assays were performed using methods described in (Section 2.19) with the strains 
incubated for 2 hours.  The error bars show the standard deviation from at least 3 biological replicates for each 







Figure 21: Sensitivity of the cj0422c mutant and complementation strains to LL37, Fowlicidin-2 and SDS.  
Microtitre sensitivity assays were performed using methods described in (Section 2.19) with the strains 
incubated for 4 hours (2 hours for SDS).  (A) shows that like polymyxin-B (Figure 20) the cj0422c mutant is 
much more sensitive to fowlicidin-2, and slightly more sensitive to LL37 as shown in (B).  (C) shows that 
the cj0422c mutant is no more sensitive to SDS compared to wild type.  Asterisks represent a T-test P 






The data presented shows that while the cj0422c mutant is highly sensitive to CAMPs 
(particularly polymyxin-B and fowlicidin-2) this phenotype is not reversed, when the cj0422c 
complementation strain is tested.  The complementation strain used was produced using the 
C. jejuni metK promoter which is constitutively expressed at a moderate level in C. jejuni (Van 
Vliet et al., 2001).  It may be that this promoter is unable to completely mimic the wild type 
promoter.  It was decided to re-produce the complementation strain using the natural 
promoter.  The construction of this complementation strain is discussed further in the next 
chapter. 
 
3.2.9 The rid operon is not up-regulated by polymyxin-B 
Since transcriptomic microarray data from the cj0422c mutant shows that the rid structural 
genes are highly up-regulated in the mutant strain, (Figure 7), it seems peculiar that this strain 
should be highly sensitive to polymyxin-B since the model for CAMP resistance assumes that 
the up-regulation of the rid genes is what promotes resistance.  To test that it is up-regulation 
of the rid structural genes that promotes resistance, both western blot analysis and qRT-PCR 
were used to look for up-regulation of the rid structural proteins and genes respectively in 
response to polymyxin-B.  As part of the previous work on this project a polyclonal rat 
antibody for Cj0424 was produced.  Cultures of wild type C. jejuni 11168 were grown for 24 
hours in the presence of 200 ng ml-1 and 2 µg ml-1 polymyxin-B with samples taken at 8 and 24 
hours.  These concentrations were chosen as they are the approximate minimum inhibitory 
concentrations of the cj0422c mutant and wild type C. jejuni respectively, over 24-hour growth 
curve (data not shown).  The samples were matched by whole cell protein concentration using 
the Bio-Rad assay (Section 2.25.1) and separated on a 12% SDS-PAGE gel.  A western blot was 
performed using the anti-Cj0424 antibody in conjunction with a goat anti-rat HRP conjugated 
antibody (Section 2.25.4).  To test for induction of the rid operon over a short time period, 
qRT-PCR was used to determine expression of cj0423 in response to a higher concentration of 
polymyxin-B (25 µg ml-1) over a 15-minute time period.  The expression of cj0423 was 
measured at both T=0 and T=15 minutes.  The data shown in (Figure 22) shows no observable 













Figure 22: Western blot analysis of the expression of Cj0424 in wild type C. jejuni NCTC11168 in the presence 
of polymyxin-B.  (A) shows whole cell protein extracts from wild type cells after matching by BioRad assay 
(Section 2.25.1) and separated by 12% SDS-PAGE (Section 2.25.2).  Lanes 1 and 2 show WT C. jejuni grown under 
normal conditions with no polymyxin-B and samples taken at 8 and 24 hours respectively.  Lanes 3 and 4 show 
WT C. jejuni grown in the presence of 2 µg ml-1 polymyxin-B with samples taken at 8 and 24 hours respectively.  
Lanes 5 and 6 show WT C. jejuni grown in the presence of 200 ng ml-1 polymyxin-B with samples taken at 8 and 
24 hours respectively.  Lane 7 shows purified recombinant Cj0424 used as a control (provided by Halah Al-
Haideri).  Figure (B) shows the same SDS-PAGE gel following western blotting with anti-Cj0424 rat antibody and 






3.2.11 Quantitative reverse transcriptase PCR (qRT-PCR) analysis suggests cj0423 is not 
up-regulated in response to polymyxin-B. 
The expression of cj0423 was assayed at the transcriptional level by qRT-PCR in response to 
polymyxin-B shock over a 15-minute time period.  The data presented in (Figure 23) shows 
only a slight increase in cj0423 expression (2.5-fold) in response to polymyxin-B, which is less 








Figure 23: qRT-PCR analysis of cj0423 gene expression in response to polymyxin-B.  6 biological replicates 
of wild type C. jejuni were grown to an OD600nm of 0.5 and polymyxin-B was added to 3 of them at a final 
concentration of 25 µg ml-1, SDW was added to the control group.  The cells were incubated under normal 
conditions for 15 minutes and whole cell RNA was extracted and matched to 10 ng µl-1 in nuclease free water 
(RNA was also extracted prior to adding polymyxin-B) (Section 2.15).  qRT-PCR reactions were performed 
according to the methods described in (Section 2.15.1), the gyrA gene was used as an internal control.  The 
data is expressed as a fold change in cj0423 gene expression at 15 minutes compared to expression at 0 






3.2.12 Checking the cj0422c mutant strain for changes in gene expression. 
The data shown so far in this chapter has confirmed that while the cj0422c mutant strain is 
more sensitive to CAMPs than wild type C. jejuni, resistance to CAMPs is not restored in the 
complementation strain.  There appears to be no significant up-regulation of the rid operon in 
response to the model CAMP polymyxin-B and mutations in the rid genes of C. jejuni 81116 do 
not show much change in CAMP sensitivity.  Since so far all the data on the role of Cj0422c 
regarding gene regulation has come from the original microarray data (Figure 7), it was 
decided to analyse the expression of rid genes in the cj0422c mutant and complementation 
strains by qRT-PCR to determine whether the complementation strain is successfully 
repressing the rid genes as it should.  The data shown in (Figure 24) shows that the expression 
of cj0423 and cj0424 in the cj0422c are not strongly up-regulated, and are actually down-





Figure 24: qRT-PCR analysis of the cj0422c mutant strain compared to wild type C. jejuni 11168.  The 
expression of the Rid structural genes cj0423 and cj0424 was measured by qRT-PCR analysis of the 
cj0422c mutant.  Wild type C. jejuni 11168 and the cj0422c mutant were grown to an OD600nm of 0.5 
and whole cell RNA was extracted and matched to 10 ng µl-1 in nuclease free water (Section 2.15).  
qRT-PCR reactions were performed according to the methods described in (Section 2.15.1), the gyrA 
gene was used as an internal control.  The data is expressed as a fold change in cj0423 and cj0424 
expression in the cj0422c mutant compared to wild type, with wild type expression for each gene 





3.2.13 Checking the promoter of the cj0422c mutant strain for sequence changes  
The qRT-PCR data shown in (Figure 24) shows that cj0423 and cj0424 are not strongly up-
regulate in the cj0422c mutant, in contradiction to the microarray data.  This is the same 
mutant strain that was used to produce the microarray data shown in (Figure 7), it is also the 
same mutant that shows high sensitivity to CAMPs.  It was decided to sequence the promoter 
region of the cj0422c mutant strain to determine whether any secondary mutations may have 
affected gene expression.  The sequencing data, represented by (Figure 25), reveals that the 
cj0422c mutant is missing a 160bp fragment from the cj0423 promoter which would likely 
prevent gene expression.  Since the role of the Cj0422c protein is to bind at this promoter and 
repress expression, removal of cj0422c leads to a large increase in gene expression as shown in 
the original microarray (Figure 7).  This overexpression may be detrimental to the cell when 
grown under normal conditions, or it may simply be wasteful of resources.  It appears the 




Figure 25: Sequencing the Rid promoter region of the cj0422c mutant.  The original cj0422c mutant was 
generated by insertional activation of the gene by insertion of a chloramphenicol cassette (catR).  The cloning 
strategy is shown in (A) whereby the catR cassette was cloned into a unique NdeI site within the cj0422c gene.  
(B) represents what the mutant should look like when sequenced with the catR cassette inserted into the cj0422c 
gene and promoter region for cj0423 unaffected.  However, sequencing the region revealed that a 160bp 
fragment is missing from the genome.  This is shown in (C) where most of the promoter region between cj0423 





3.2.14 Re-isolation of the cj0422c mutant strain  
Since the cj0422c mutant strain which has so far been used in this project appears to have 
acquired a secondary mutation it calls into question the CAMP sensitivity data so far presented 
in this chapter.  However, it is worth noting that the high sensitivity to CAMPs seen in the 
cj0422c mutant strain shown in (Figure 20) may now be explained by the secondary mutation 
as the rid structural genes are no longer up-regulated as shown in (Figure 24), it may also 
explain why the complementation construct was unable to restore the wild type phenotype.  It 
was decided to re-isolate the cj0422c mutant from the original stock produced by Dr Ed 
Guccione in 2010.  Cell material from the original mutant sample was streaked on blood agar 
plates with 20 µg ml-1 chloramphenicol and 5 colonies were picked and grown for re-stocking 
and screening.  These 5 single isolates were first checked by DNA sequencing of the promoter 
region between cj0423 and cj0422c, all 5 contained the expected gene arrangement with no 
evidence of any secondary mutations (data not shown).  As a further check all 5 isolates were 
assayed for polymyxin-B sensitivity.  The data is shown in (Figure 26) and shows that a single 
variant within the original mutant strain appears considerably more sensitive to polymyxin-B. 
 
 
 Figure 26: Polymyxin-B sensitivity of the 5 re-isolated cj0422c mutants.  Microtitre sensitivity assays were 
performed using methods described in (Section 2.19) with the strains incubated for 2 hours.  The error bars 
show the standard deviation from at least 3 biological replicates for each data point.  The data shows that while 
4 out of the 5 strains showed no increase in sensitivity to polymyxin-B, a single isolate (∆cj0422c -1) shows high 





The data shown in (Figure 26) shows that a single seemingly random variant of the ∆cj0422 
strain from the original mutant stock is hyper-sensitive to polymyxin-B and presumably to 
other CAMPs (this was not tested).  This suggests that the earlier hypothesis about the 
polymyxin-B sensitivity seen in the cj0422c mutant being the result of the secondary mutation 
within the rid system (as shown in Figure 25), is in fact not true.  DNA sequencing of the rid 
regions from all 5 ∆cj0422 mutant strains from (Figure 26) shows that the regions are 
genetically identical within sequenced promoter region (data not shown).  This data leads to 
two conclusions; the high level of CAMP sensitivity seen earlier (Figures 20-21) is likely the 
result of a mutation or single nucleotide polymorphisms (SNPs) elsewhere in the genome, and 
also that the cj0422c mutant (with no secondary mutations or SNPs) is no more sensitive to 
polymyxin-B than wild type.  These data would still fit with the CAMP resistance model we 
have built as it solves a logic flaw in the original hypothesis that the cj0422c mutant 
overproduces other rid proteins and therefore should in theory be just as resistant if not more 
so that wild type. 
 
The whole rid system hypothesis rests primarily on the mutant strains ∆cj0423 and ∆cj0424 
being more sensitive to polymyxin-B and other CAMPs than wild type, this work was done by a 
previous student Halah Al-Haideri.  Following the data showing that the high CAMP sensitivity 
seen in the cj0422c mutant was not related to the rid system it was decided to repeat some of 
the polymyxin-B sensitivity assays in the other mutant strains.  Some of the data is shown in 
the next chapter.  In essence it was shown that the high sensitivity to polymyxin-B and other 
CAMPs observed in the cj0423 and cj0424 mutants was false, the reasons for this are still 
unclear.   
 
Strains of Campylobacter are known to be genetically variable (Gaynor et al., 2004), (SNPs) and 
phase variable genes mean that random phenotypes can be acquired or lost quickly, such as 
cell shape, growth rate or ability to colonise chickens.  This high rate of variation between 
strains of Campylobacter can in theory lead to mutant strains acquiring phenotypes which are 
not directly due to the mutation, this is likely due to producing mutants by selecting single 
colonies which may contain random variations when compared to the host wild type.  For 
many types of experiments this may not be a problem, however when assaying for survival 
under a stress condition, such as exposure to CAMPs, random variations between strains can 
lead to an apparent difference in sensitivity between mutants whereas this is actually due to 




may affect viability.  This is still a poorly understood area of microbiology yet it does have real 
consequences, DNA sequencing has proved that the polymyxin-B sensitivity seen in the 
cj0422c mutant is not related to the mutation or variations in another part of the rid system 
and is likely due to another genetic variation elsewhere in the genome. 
 
Due to these problems it was decided to re-isolate a fresh wild type C. jejuni NCTC11168 strain 
from an older laboratory -80°C frozen stock and to sequence the entire genome as a fresh 
starting point.  All the rid mutants would then be re-produced in this background strain which 
was renamed as C. jejuni NCTC11168 DJK.  Two of the cj0422c knockout strains shown in 
(Figure 26) would also be genome sequenced, the strain which is sensitive to polymyxin-B 
(∆cj0422c-1) and a strain which is resistant to polymyxin-B (∆cj0422c-2).  These were genome 
sequenced to try and determine how the extreme sensitivity seen in ∆cj0422c-1 originated.  
These strains would be genome sequenced alongside another wild type variant of C. jejuni, 
11168-H, which is known for being hypermotile (Karlyshev et al., 2002).  This strain is 
commonly used in chicken models as motility greatly increases the chance of colonisation 


















3.2.15 Whole genome sequencing (WGS) of C. jejuni  
Whole genome sequencing (WGS) of the 4 strains of Campylobacter was performed by 
MicrobesNG using the Illumina sequencing platform, the raw data was collected and 
assembled into a whole genome using the original NCTC11168 as a reference by Dr Roy 




What is immediately obvious from the WGS data shown in (Figure 27) is that the newly named 
WT DJK strain contains many SNPs and small difference compared to the reference sequence.  
Compared to the reference NCTC11168 sequence the WT-DJK strain contains 49 differences, 
the WT 11168-H strains contains 6 differences, the ∆cj0422c-1 strain contains 21 unique 
differences and the ∆cj0422c-2 strain contains 19.  Most of these differences are SNPs while 
some are slightly longer variations in sequence.  No large changes in the genome such as large 
fragment insertions or deletions could be detected.  The analysis of these genomes is shown 
below. 
Figure 27: Biodalliance web server showing the WGS data.  A screenshot example of the WGS data, the entire 
genome sequence extends across the width of the figure.  The figure shows Illumina sequencing read coverage 
(shown as graphs across the sequence) and variations within the genome (shown as blue and red markers for 
substitutions and deletions respectively).  Red arrows with short sequences show single insertions.  This figure 
shows summary data for 4 genomes JB1 (NCTC11168-RID wild type), JB3 (NCTC11168 DJK lab wild type), JB3 




Genome Sequencing Table-9: WT DJK strain, variations in intergenic regions 
Position Genes Strand Gene Names Description (C. jejuni NCTC11168 Annotation) 
Reference Poly 
Tract 
Reference Variant Variant Type 
Illumina Read 
Coverage 
199139 cj0203 - cj0204 + + _, _ Citrate Transporter, Oligopeptide Transporter GTTTTTTTG - T Insertion 12 
514227 cj0551 - cj0552 + + efp, _ Elongation Factor P, Hypothetical Protein ATTTTTTTA - T Insertion 20 
1338384 cj1403c - cj1404 - + gapA, NadD 
Glyceraldehyde 3-phosphate dehydrogenase, Nicotinate-nucleotide 
adenylyltransferase 
CAAAAAAAG - A Insertion 60 
1470420 cj1537c - cj1538c - - acs, _ Acetyl-CoA synthetase, Anion-uptake ABC transporter  G T Substitution 3 
1473189 cj1540 - cj1541 + + _, _ Tungstate transport system substrate binding protein, LamB / YcsF family protein  T - Deletion 20 
1546467 cj1618c - cj1619 - + _, kgtP Radical SAM domain-containing protein, apha-ketoglutarate permease  A T Substitution 29 
1603971 cj1681c - cj1682c - - cysQ, gltA 3' (2'),5'-bisphosphate nucleotidase, Citrate synthase  C T Substitution 31 
 
 
Genome Sequencing Table-10: WT DJK strain, in-frame amino acid changes 
Position Genes Strand Gene Names Description (C. jejuni NCTC11168 Annotation) Reference Variant Amino Acid Change 
Illumina Read 
Coverage 
108021 cj0099 + birA Biotin-protein ligase transcriptional regulator G A Ala 120 - Thr 62 
136901 cj0136 + infB Translation initiation factor IF-2 G A Asp 16 - Asn 75 
168234 cj0172c -  Saccharopine dehydrogenase A G His 260 - Arg 374 
199708 cj0204 +  Oligopeptide Transporter G A Gly 158 - Asp 439 
224012 cj0240c - iscS Cysteine desulfurase C T Pro 23 - Ser 198 
253191 cj0276 + mreB Rod shape-determining protein A G Asp 48 - Gly 448 
Table 9: Wild Type 11168 DJK strain intergenic region variations.  The table lists the variations found within intergenic regions of the new lab wild type strain.  Because these variations are found 




262345 cj0284c - cheA Chemotaxis histidine kinase T C Ile 290 - Thr 983 
554938 cj0597 + fba Fructose-biphosphate adolase C T Arg 296 - Cys 523 
643379 cj0688 + pta Phosphate acetyltransferase C T Ala 497 - Val 95 
753450 cj0802 + cysS Cysteinyl-tRNA synthetase A G Asp 69 - Gly 89 
759961 cj0807 +  7-alpha-hydroxysteroid dehydrogenase C T Ala 122 - Val 88 
760188 cj0807 +  7-alpha-hydroxysteroid dehydrogenase A G Lys 198 - Glu 126 
843351 cj0903c -  Amino acid transport protein C T Thr 124 - Ile 178 
861381 cj0927 + apt Adenine phosphoribosyltransferase T C Val 110 - Ala 148 
880877 cj0942c - secA Preprotein translocase subunit C T - 71 
1159310 cj1231 + kefB Glutathione-regulated potassium-efflux system protein G A Gly 48 - Asp 248 
1189659 cj1259 + porA Major outer membrane protein A G Glu 180 - Gly 950 
1190075 cj1259 + porA Major outer membrane protein G A Glu 319 - Lys 1868 
1434480 cj1502c - putP Sodium/Proline symporter G A Thr 357 - Ile 220 
1526322 cj1597 + hisG ATP phosphoribosyltransferase G A Glu 295 - Lys 114 







Table 10: Wild Type 11168 DJK strain in frame amino acid substitutions.  The table lists the SNPs which results in amino acid substitutions within the ORFs of the new lab wild type strain.  It is 
difficult to predict what, if any, changes these substitutions may have on protein function so no hypothetical changes are listed.  It is likely that most of them do not result in any significant 




Genome Sequencing Table-11: WT DJK strain, gene deletions 
Position Gene Strand 
Gene 
Name 




Reference Variant Variant Type Predicted Effect (Translation) 
Percentage 





87327 cj0076c - lctP L-lactate permease  - T Insertion Thr 465 - Tyr / Asn 468 - STOP 17% Probable loss of function 539 
97789 cj0088 + dcuA Anaerobic C4-dicarboxylate transporter  G - Deletion Trp 100 - Gly / Leu 105 - STOP 77% Complete loss of function 341 
291007 cj0319 + fliG Flagellar motor switch protein  C - Deletion Ser 290 - Leu / Frame Shift 15% Probable loss of function 627 
305103 cj0337c - motA Flagellar motor protein TGGGGGA G - Deletion Lys 206 - Asn / Leu 107 - STOP 21% Complete loss of function 391 
818022 cj0882c - flhA Flagellar biosynthesis protein  G - Deletion Asp 577 - Ile / Leu 582 - STOP 20% Complete loss of function 205 
859539 cj0923c - cheR Chemotaxis protein methyltransferase GAAAAAAAAAT A - Deletion Ile 5 - STOP 98% Complete loss of function 24 
933483 cj1002c -  
Phosphoglycerate/bisphosphoglycerate 
mutase 
TAAAAAAAC - A Insertion Leu 36 - Thr / Lys 38 - STOP 78% Complete loss of function 50 
1074329 cj1139c - wlaN Beta-1,3 galactosyltransferase TGGGGGGGGT G - Deletion Gly 113 - Val / Ile 131 - STOP 63% Complete loss of function 49 
1106849 cj1179c - fliR Flagellar biosynthesis protein  - A Insertion Met 80 - Asn / Gln 98 - STOP 68% Complete loss of function 140 
1219393 cj1287c -  Malate oxidoreductase  T - Deletion Tyr 200 - STOP 52% Complete loss of function 78 
1278680 cj1345c -  M99 family peptidase  A - Deletion Leu 57 - STOP 88% Probable loss of function 238 
1425977 cj1491c -  Two component regulator GAAAAAT A - Deletion Asn 184 - Met / Ile 187 - STOP 19% Probable loss of function 67 
1492035 cj1564 +  
Methyl-accepting chemotaxis signal 
protein 




Table 11: Wild Type 11168 DJK strain gene deletions.  The table lists the variations which will likely result in gene deletions in the new lab wild type strain.  The majority of these changes originate as 
SNPs which result in a frame shift and a subsequent change to an early stop codon.  The percentage lost/altered column details how much of the amino acid sequence is lost or severely altered as a 




Genome Sequencing Table-12: WT DJK strain, pseudogene re-activations 
Position Gene Strand 
Gene 
Name 
Description (C. jejuni NCTC11168 Annotation) 
Reference Poly 
Tract 





420550 cj0455c -  Hypothetical Protein (Pseudogene)  T C Substitution TAA (STOP) - CAA (Gln) Pseudogene active 243 
1001550 cj1064 + nfsB Oxygen-insensitive nitroreductase (Pseudogene)  - A Insertion Phe 112 - Ile / STOP 120 - Met Pseudogene active 106 
1404343 cj1470c - gspF 
General secretion pathway protein (T2 Secretion) 
(Pseudogene) 




Genome Sequencing Table-13: WT DJK strain, other variations 
Position Gene Strand 
Gene 
Name 




Reference Variant Variant Type Predicted Effect (Translation) Predicted Effect (Phenotype) 
Illumina Read 
Coverage 
180707 cj0184c -  
Serine/threonine protein 
phosphatase 
 GT - 2X Deletion 
Frame shift, 12 additional AAs added onto C-
terminal 
Minor or no effect on function 172 
221822 cj0238 +  
Mechanosensitive ion channel 
family protein 
 - G Insertion 
Frame shift, 23 additional AAs added onto C-
terminal 
Minor or no effect on function 108 
393542 cj0431 +  ATP/GTP-binding protein CATAAAAG T A Substitution 
Substitution alters stop codon, 41 additional 
AAs added onto C-terminal 
Both short and long versions of Cj0431 exist in 
NCBI database 
272 




CAAAAAAT T - Deletion 
Frame shift leads to stop codon 66% through 
the ORF 
Protein loses C-terminal CMP-Neu5Ac synthase 
domain, N-terminal domain remains intact. 
78 
Table 12: Wild Type 11168 DJK strain pseudogene re-activations.  The table lists the variations found within pseudogene loci which result in restoration of a complete open reading frame.  This 
occurs seemingly by SNPs causing a frame shift to remove a stop codon.  It is unknown whether these restorations of complete ORFs actually lead to a functioning protein as gene expression is 




1121265 cj1192 + dctA 
C4 dicarboxylate transport 
protein 
 G - Deletion 
Frame shift alters AA sequence for final 5% of 
sequence, protein shorter by 2 AA 
Minor or no effect on function 574 
 
Genome Sequencing Table-14: WT 11168-Hypermotile 
Position Gene Strand Gene Name 
Unique to 
11168-H 




Reference Variant Variant Type Predicted Effect (Translation) Predicted Effect (Phenotype) 
Illumina Read 
Coverage 
180707 cj0184c -  No 
Serine/threonine protein 
phosphatase 
 GT - 2X Deletion 
Frame shift, 12 additional AAs added 
onto C-terminal 
Minor or no effect on function 172 
393542 cj0431 +  No ATP/GTP-binding protein CATAAAAG T A Substitution 
Substituion alters stop codon, 41 
additional AAs added onto C-terminal 
Both short and long versions of Cj0431 
exist in databases 
272 
420550 cj0455c -  No 
Hypothetical Protein 
(Pseudogene) 
 T C Substitution TAA (STOP) - CAA (Gln) 
Internal stop codon altered to allow for 
complete ORF, gene function unknown. 
243 
760188 cj0807 +  No 
7-alpha-hydroxysteroid 
dehydrogenase 
 A G Substitution Lys 198 - Glu Minor or no effect on function 126 
1336117 cj1401c - tpiA Yes 
Triosephosphate 
isomerase 
 A G Substitution Asn 10 - Ser Minor or no effect on function 65 
1604692 cj1682c - gltA Yes Citrate synthase  C G Substitution Ala 187 - Tyr Minor or no effect on function 141 
 
 
Table 13: Wild Type 11168 DJK strain other strain variations.  The table lists variations found within the DJK strain genome which do not fall into any of the previous categories.  Those listed 
here show variations which may influence or modify protein function without a complete loss of function. 
  
Table 14: Wild Type 11168-H strain variations.  The table lists all 6 variations seen between the NCTC11168-RID strain and the reference 11168 genome.  Only two of the changes are unique to 





Genome Sequencing Table-15: Δcj0422c strains 









Reference Variant Variant Type Predicted Effect (Translation) 
Percentage 
Lost / Altered 







  2 
Citrate Transporter, Oligopeptide 
Transporter 
GTTTTTTTG - T Insertion Intergenic region - Minor or no effect on function 12 
199853 cj0204 +  1, 2 Oligopeptide transporter  - A Insertion Leu 207 - Thr, Glu 241 - STOP 64% Likely complete loss of function 424 
221827 cj0238 +  1, 2 Mechanosensitive ion channel  - T Insertion Ser 608 - Lys, Ser 610 - STOP 3% Minor or no effect on function 98 
234820 cj0256 +  1 
Lipid A 
ethanolaminephosphotransferase 
CTTTTTTA - T Insertion Leu 76 - Phe, Ser 82 - STOP 84% Likely complete loss of function 21 
613964 cj0653c -  1, 2 Aminopeptidase  T C Substitution Tyr 351 - His - Minor or no effect on function 438 
613974 cj0653c -  1, 2 Aminopeptidase  G A Substitution - - Minor or no effect on function 406 
613996 cj0653c -  1, 2 Aminopeptidase  T C Substitution Val 340 - Ala - Minor or no effect on function 388 
614021 cj0653c -  1, 2 Aminopeptidase  C T Substitution - - Minor or no effect on function 337 
614033 cj0653c -  1, 2 Aminopeptidase  A G Substitution Lys 328 - Glu - Minor or no effect on function 315 
614052 cj0653c -  1, 2 Aminopeptidase  C A Substitution - - Minor or no effect on function 312 
614128 cj0653c -  1, 2 Aminopeptidase  C T Substitution Ala 296 - Val - Minor or no effect on function 185 
614181 cj0653c -  1, 2 Aminopeptidase  T C Substitution - - Minor or no effect on function 138 
614249 cj0653c -  1, 2 Aminopeptidase  G A Substitution Glu 256 - lys - Minor or no effect on function 90 
614355 cj0653c -  1, 2 Aminopeptidase  C T Substitution - - Minor or no effect on function 38 
614473 cj0653c -  1, 2 Aminopeptidase  C T Substitution Ala 181 - Val - Minor or no effect on function 103 
615242 cj0654c -  1, 2 
Transmembrane transport protein 
(pseudogene) 
 C T Substitution - - Pseudogene remains inactive 133 
615250 cj0654c -  1, 2 
Transmembrane transport protein 
(pseudogene) 
 A G Substitution - - Pseudogene remains inactive 142 
 
93 
615268 cj0654c -  1, 2 
Transmembrane transport protein 
(pseudogene) 
 A G Substitution - - Pseudogene remains inactive 122 
615283 cj0654c -  1, 2 
Transmembrane transport protein 
(pseudogene) 
 C T Substitution - - Pseudogene remains inactive 116 
615621 cj0654c -  1 
Transmembrane transport protein 
(pseudogene) 
CTTTTTTTG - T Insertion - - Pseudogene remains inactive 32 
615635 cj0654c -  1, 2 
Transmembrane transport protein 
(pseudogene) 
 C T Substitution - - Pseudogene remains inactive 30 
639006 cj0685c - cipA 1 Invasion protein ACCCCCCCCCA C - Deletion His 296 - Ile, Leu 300 - STOP 33% Likely complete loss of function 50 
1545190 cj1617 + chuD 1 
Hemin uptake system substrate-
binding protein 
 TATTTTAAGACTT - 12X Deletion Leu 176 - Ile 179 Lost 1% Minor or no effect on function 53 
 
 
Table 15: Δcj0422c-1 and Δcj0422c-2 strain variations.  The table lists the variations which are unique to either one or both of the Δcj0422c strains.  Other variations are found but they are also 
found in the 11168-DJK strain and are not listed here.  Both the strains shown contain a chloramphenicol resistance cassette inserted within the cj0422c gene, which is also not shown here.   The 
table shows that the gene cj0653c and the upstream pseudogene cj0654c contain many SNPs with seemingly not change in function, the reason for so many SNPs within a single gene is 





3.2.16 Genomic analysis of the cj0422c mutant strains  
As shown by the data in (Figure 20) the original cj0422c mutant strain was highly sensitive to 
the CAMP polymyxin-B, however this was un-related to the intended mutation and in fact 
appears to have been acquired at some point as an unknown secondary mutation.  The whole 
genome analysis shown in (Table 15) reveals that the strain (∆cj0422c-1) contains a single SNP 
variation within the cj0256 ORF.  The insertion of an additional thymine nucleotide leads to a 
frame shift resulting in an early stop codon 16% through the open reading frame.  This almost 
certainly leads to a complete loss of function as the full gene is no longer translated.  The 
Cj0256 protein is annotated as a LipidA modification enzyme (Lipid A 
ethanolaminephosphotransferase) which has been studied in a previous publication (Cullen 
and Trent, 2010).  This work showed that Cj0256 is responsible for attaching pEtN 
(phosphoethanolamine) to not only Lipid A, but also to the flagellar rod protein (FlgG).  The 
study also showed that deletion of cj0256 resulted in a 20-fold increase in sensitivity to 
polymyxin-B.  This strongly suggests that the high sensitivity seen in the cj0422c mutant strain 
was the result of this randomly acquired mutation, the other genome sequenced cj0422c 
strain (∆cj0422c-2) does not contain this SNP and is polymyxin-B resistant.  Other members of 
the lab re-produced the cj0423 and cj0424 mutant strains in the new wild type DJK background 
strain and these showed no notable difference in sensitivity to polymyxin-B.  This leads to the 
conclusion that the cj0421c-cj0425 gene cluster is not involved in CAMP resistance and from 














3.3 Chapter 3 Discussion 
The initial aim of this chapter was to bioinformatically analyse the cj0421c-cj0425 gene cluster 
(previously known as the rid genes) to determine how widespread these genes are between 
Campylobacter strains.  Following this a series of mutant strains were created in C. jejuni 
81116 which are located within the same locus but are structurally different to the archetypal 
genes from C. jejuni 11168.  It was thought that the project would then focus on the roles of 
Cj0421c and Cj0422c and how they are able to respond to and defend against cationic 
antimicrobial peptides, however as the project proceeded the original data showing the gene 
cluster was involved in resisting CAMPs did not stand up to further scrutiny and much of the 
hypothesis broke down.  As such most of the data presented in this chapter was collected 
while assuming that the genes being studied were involved in CAMP resistance.  For this 
discussion I will re-assess the data shown in this chapter without assuming a role in CAMP 
resistance. 
 
3.3.1 Bioinformatic analysis of the rid operon 
Members of the Campylobacter genus are known for their high levels of genetic diversity 
(Meinersmann et al., 2002).  Much of the current research on the epidemiology of 
Campylobacter uses whole genome sequencing to assess which genes are required for transit 
through the food processing industry, the so called ‘farm to fork’ transit (Wassenaar, 2011).  As 
part of this work many complete Campylobacter genome sequences are available for analysis 
with data on when and where they originated (Sheppard et al., 2010).  The bioinformatic 
analysis shown in (Figure 11) used data kindly provided from the lab of Dr Sam Sheppard to 
assess how prevalent the cj0421c-cj0425 genes are in other Campylobacter strains.  It was 
initially thought that there may be some correlation between the presence of the genes and 
the animal source the strain was isolated from.  This turned out not to be the case, however it 
should be noted that the number of genomes analysed is comparatively small and that with 
ever larger numbers of Campylobacter genomes being sequenced a correlation with a certain 
source may emerge in the future.  The data did however show that the genes are (a) not found 
in all Campylobacter strains and (b) the structural genes cj0423-cj0425 are only found in 
around 40% of the strains analysed.  This led on to the analysis in (Figures 12-13) showing that 
there are 3 sub types of these gene clusters distributed between different Campylobacter 
strains, there may also be other groups that have not been found yet.  This adds complexity to 
the system as whatever the roles of these genes are, different Campylobacter species appear 




3.3.2 Cj0423 and holin like proteins 
The analysis of the protein sequences shown in (Figure 14) shows that between the gene 
clusters from different C. jejuni sub strains, a single family of small inner membrane proteins is 
conserved between them, making this the only protein type which is found in all 3 sub types.  
These proteins are all quite small and most of the length is composed of transmembrane 
domains (either 2 or 3) leaving little room for any other functional domains.  It was initially 
thought that these proteins may act as a way of stabilising the inner membrane in response to 
CAMP attack or possibly acting to repel positively charged CAMPs by the presence of some 
positively charged residues facing the periplasm.  Protein BLAST analysis of Cj0423 shows some 
similarity with T4 bacteriophage immunity proteins which exclude phage DNA to prevent 
superinfection from competing phage (Lu and Henning, 1989).  The T4 immunity protein is a 
similar length to Cj0423 and also contains 2 transmembrane domains so it may be that the 
BLAST similarity is due to the shared domain architecture rather than a shared role.  However, 
the other small transmembrane proteins from C. jejuni 81116 and RM1221 within the same 
operon do not show any homology to predicted phage immunity proteins.  The other family of 
proteins with asimilar domain architecture to Cj0423 are holins.  
 
Holins are small membrane spanning-proteins, generally produced by some bacteriophages 
that spontaneously form large flexible pores in the cytoplasmic membrane of both Gram-
positive and Gram-negative bacteria, sometimes up to the micron scale in diameter (Savva et 
al., 2014).  The term holin was first used to describe the ‘λS’ protein from λ phage which forms 
part of the λS-R lysis cassette (Young, 2014).  Deletion of the λs gene resulted in phage 
particles being unable to escape the host cell cytoplasm and the λR protein was shown to 
degrade peptidoglycan but could not be exported outside the cytoplasmic membrane without 
λS.  Further work showed holin proteins are associated with the timing of bacteriophage lysis, 
the holin protein is rapidly produced and permeabilises the cytoplasmic membrane allowing 
various peptidoglycan amidases to reach the cell wall and lyse the cell (Wang et al., 2000).  
Holins are often found with antiholin proteins which inhibit the formation of the pores, the 
antiholins are sometimes found within the same ORF as the holin where the two are co-
expressed from alternate start codons (Neely and Friedman, 1998, Tran et al., 2005).  This co-
expression of holins with antiholins causes the phage to enter a ‘lysis inhibition’ (Lin) state 
where the two proteins are in a state of equilibrium.  Through an as yet unknown mechanism 
the equilibrium suddenly shifts to favour the holins and spontaneous pores form in the 
membrane (Young et al., 2000).  The Lin equilibrium state can also be broken by the addition 
of energy inhibitors such as cyanide or dinitrophenol (Žiedaite et al., 2005), the authors 
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hypothesize that the loss ATP may act as a signal for the phage to lyse the host cells as the host 
is most likely near complete exhaustion at this point.  How cellular energy levels maintain this 
equilibrium is unknown.  The chaperone GroEL complex has been shown to bind to the λ phage 
antiholin at a 6:1 ration whereas the holin is bound at up to 350:1, both of which require ATP, 
this may be related to the timing of induced lysis (Deaton et al., 2004).  Holins typically contain 
one or more transmembrane domains and polymerize within the cytoplasmic membrane, 
there are thought to be up to 7 families of holins distributed throughout various phage 
genomes, all are characterized by containing one or more transmembrane domains (Reddy 
and Saier, 2013).   
 
As shown in (Figure 15) holins can contain a number of transmembrane domains and form 
pores by polymerising within the membrane.  The exact role of Cj0423 itself is not a part of this 
study so the data presented is only based on sequence analysis.  Several hypotheses about 
what the gene cluster may do are tested in later chapters, Cj0423 and the similar inner 
membrane proteins from other C. jejuni strains are assumed to be holing-like genes. 
 
3.3.3 Secondary mutations in the cj0422c mutant and whole genome sequencing 
The CAMP sensitivity data presented in this chapter aimed to show that deletion of the 
cj0422c mutant resulted in increased sensitivity to CAMPs and that complementation would 
restore the wild type resistant phenotype.  As shown in (Figures 20-21) the mutant strain does 
show increased sensitivity to CAMPs but could not be effectively complemented, this was 
shown to be due to a single SNP found within the cj0256 ORF as discussed in (Section 3.2.16).  
This data from the genome sequences of the two cj0422c mutant strains effectively dispels the 
entire CAMP resistance mechanism and explains why the western blot and qRT-PCR data 
shown in (Figures 22-23) show no up-regulation of the cj0423-cj0425 operon in response to 
polymyxin-B. 
 
Another interesting result from the cj0422c mutant genome sequences is that some of the 
genes which are differentially expressed in the microarray data (Figure 7) also contain SNPs 
from the sequencing data.  Expression of both cj0204 and cj0653c is altered in the microarray 
study (with cj0204 being down-regulated -4.4 fold and cj0653c being up-regulated +5.2 fold).  
In both the genome sequenced cj0422c mutant strains cj0204 contains an insertion that most 
likely leads to a loss of gene function (Table 15).  The cj0422c mutant strains also show 11 SNPs 
within the cj0653c ORF (making up almost half of all the unique SNPs within the cj0422c 
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mutant strains), this is a strangely large number of SNPs for a single gene and all of them are 
nucleotide substitutions.  Out of these 11 substitutions 6 of them result in amino acid changes 
and 5 result in no changes.  None of these amino acid changes are within the active site of the 
Cj0653c peptidase domain so it is unknown what if any changes in protein function these 
substitutions lead to.  It was first thought that these alterations in the cj0204 and cj0653c ORFs 
may be due to the cj0422c mutant altering their expression to such an extent that the genes 
are altered or removed to compensate (this theory is along the same lines as the data shown 
in (Figure 25) whereby the cj0423 promoter was naturally removed in response to being 
continuously overexpressed).  However, an alternative theory is that the changes in gene 
expression observed in the original microarray data are in fact because of the SNPs rather than 
causing them.  The microarray data relies on a fluorescent oligonucleotide probe, specific for 
individual genes, hybridizing to cDNA or RNA samples.  The relative difference between the 
fluorescence of each gene is calculated to produce a fold change in gene expression.  This 
assumes that the nucleotide sequence between each strain is identical as the probes are 
usually designed from an annotated genome sequence.  It also assumes that even if the probe 
sequence is slightly different then the differences will cancel out as the two strain will share 
the same differences.  However, should the two strains have a different sequence for the same 
gene, this could lead to an artificial difference in recorded gene expression, where in fact it is 
due to variations in the genome sequence rather than a difference in cDNA or RNA levels of 
that particular gene.  This theory is tested in the next chapter where a new cj0422c mutant 
strain is produced in the new WT-DJK background strain and qRT-PCR is performed to validate 
the microarray data. 
 
3.3.4 Genomic analysis of the wild type DJK strain  
Whole genome sequencing of the 2010 laboratory wild type strain has revealed many 
interesting differences between the lab strain and the original C. jejuni wild type NCTC11168-
GS which was first sequenced in 2001 (Parkhill et al., 2000).  The data shown in (Tables 9-13) 
show the 49 changes between the two strains.  These are split up into SNPs in intergenic 
regions, in frame amino acid changes, gene deletion, potential pseudogene re-activations and 
other changes.  Many of these changes are likely the result of randomly acquired variations 




3.3.5 Wild type DJK strain intergenic regions and in frame substitutions  
The WT DJK lab strain contains 7 SNPs within intergenic regions, since these changes are not 
within any ORFs it is difficult to predict what if any effects these changes may have.  Some may 
affect gene expression by altering the promoter regions.  The data is shown in (Tables 9-10).  
The lab strain also contains 21 nucleotide substitutions within ORFs, the majority of which 
result in a single amino acid change.   It is possible that some of these amino acid changes may 
affect protein function. 
 
3.3.6 Wild type DJK strain gene deletions 
The WT DJK strain contains 13 nucleotide changes within ORFs that lead to frame shift changes 
which likely lead to a loss of gene function.  The list of these changes is shown in (table 11).  
From these 13 genes 4 are involved in flagellar production and 2 are involved in chemotaxis 
which explains why the lab strain is non motile, a feature which is common amongst heavily 
passaged Campylobacter lab strains (Gaynor et al., 2004).  The loss of motility and chemotaxis 
is likely due to the lack of any need for motility in laboratory environments and the large 
amount of resources expended on assembling and maintaining a functional flagellar.  This may 
also explain why non motile laboratory strains of Campylobacter are able to grow at a faster 
rate than wild type strains under the same conditions as all the resources saved from the 
motility apparatus can be used elsewhere.  Another common feature of laboratory adapted 
Campylobacter strains is the loss of the spiral shape (Gaynor et al., 2004).  Formation of the 
spiral shape in Campylobacter has been shown to involve specific modifications of 
peptidoglycan chains (Frirdich et al., 2014).  The Cj1345c protein shows some homology to an 
M99 family peptidase which has been shown to be responsible for modifying peptidoglycan in 
Helicobacter pylori (Kim et al., 2014).  Since this is the only known peptidoglycan modification 
enzyme which is altered in this new genome sequence, its removal may be responsible for the 
lack of a spiral shape.  The DJK strain also shows further adaptations to the lab environment as 
2 genes involved in nutrient transport have been lost, both the lctP and dcuA genes (L-lactate 
permease and C4-dicarboxylate transporter respectively) contain frame shift mutations.  This is 
likely because the strain is routinely cultured on rich growth media and so does not require all 
available carbon sources when easier to use alternatives (such as serine) are present.  The lack 





3.3.7 Wild type DJK strain pseudogene re-activations 
The WT DJK strain contains 3 SNPs within pseudogene loci which when analysed show a 
restoration of the full ORF, the 3 genes are shown in (Table 12).  This is not a well-studied area 
of microbiology and the reasons for these genes becoming re-activated is unknown.  
Pseudogene formation in bacteria is thought to be the result of generally random SNPs 
forming within coding regions causing a frame shifts or early stop codon formation (Lerat and 
Ochman, 2005).  While it was generally thought that a pseudogene would typically be lost from 
the normally efficient bacterial genome reasonably quickly, due to the wastefulness of 
producing fragmented gene products and replicating unused DNA (Goodhead and Darby, 
2015), there is some evidence suggesting that pseudogenes may be longer lasting in some 
microbial populations than previously thought (Goodhead and Darby, 2015).  However, the 
authors note that this may be because the pseudogenes are under some (if small) form of 
selection pressure due to either a fragmented gene product or possibly even RNA interference 
affecting gene expression elsewhere.  The concept of a pseudogene re-activating by a single 
SNP within the ORF is by its very nature highly unlikely.  Single random SNPs almost anywhere 
within an open reading frame could render a gene non-functional (as seen in Table 12), while 
the 3 genes are shown here as ‘re-activating’ because of a single incredibly specific nucleotide 
changes (1 has a substitution and 2 have insertions) to become functional again.  DNA 
sequence BLAST analysis shows that the SNPs within these ORFs causing them to be annotated 
as pseudogenes are only found in the original annotated NCTC11168-GS sequence.  It seems 
much more likely that the original genome sequence contains errors which led to these 3 
genes being mis-annotated as pseudogenes. 
 
3.3.8 Wild type DJK strain other variations 
The remaining 5 SNPs within the new DJK strain (Table 13) occur inside ORFs and their effects 
are harder to categorise.  Four of these SNPs cause the gene to become slightly longer or 
shorter which may not have much of an effect on gene function (this also may be due to the 
original NCTC11168 sequence containing sequence errors as discussed previously).  One of the 
changes however might have interesting effects.  A nucleotide deletion in cj1143c encoding a 
bifunctional beta-1,4 N-acetylgalactosiminyltransferase / CMP-Neu5Ac synthase (at the N and 
C-terminal ends respectively) may cause the final product to lose the C-terminal domain of the 




3.3.9 Genomic analysis of the NCTC 11168-Hypermotile strain  
The hypermotile variant of C. jejuni NCTC11168 was originally isolated in a study looking at 
phase variable motility genes, cultured isolates of C. jejuni NCTC11168 were assayed for 
spontaneous changes in motility (Karlyshev et al., 2002).  This led to the culture of the 
NCTC11168-Hypermotile strain which is presented here.  This strain is used as a good model 
organism for studying Campylobacter in chicken colonisation studies as motility is required for 
effective colonisation.  This strain is used by other lab members to study the roles of Cj0423 
and Cj0424 in chicken colonisation experiments.  The data is shown in chapter 4. 
 
At this point in the project it was decided to use the newly sequenced wild type NCTC11168-
DJK strain as a fresh starting point in order to determine what the roles of Cj0421c and Cj0422c 
are in regulating the cj0423-cj0425 operon.  The roles of the Cj0423, Cj0424 and Cj0425 

















4 Chapter 4 – Testing the potential roles of the cj0421c-cj0425 cluster by 
mutagenesis. 
 
4.1 Chapter 4 Introduction 
Data presented in the previous chapter showed that the 5 gene cluster spanning the cj0421c-
cj0425 region of the C. jejuni NCTC1168 genome is not involved in resistance to cationic 
antimicrobial peptides as was previously hypothesised.  Following on from this it was decided 
to re-sequence the genome of the laboratory strain used in this study, now named 
Campylobacter jejuni NCTC 11168-DJK, which is now the default wild type for the rest of the 
study unless otherwise stated.  The primary aim of this chapter is to determine the roles of 
Cj0421c and Cj0422c in regulating the rest of the operon.  Other lab members working on the 
same project area will focus on the roles of the individual structural proteins Cj0423, Cj0424 
and Cj0425. 
 
Cj0422c is a DNA-binding Helix-Turn-Helix domain protein which has been shown to bind to a 
specific 18bp palindromic repeat sequence found slightly upstream of cj0423 thereby blocking 
transcription (Hitchcock, 2011).  Microarray data from the cj0422c mutant (Figure 7) shows 
that a broad range of genes are differentially expressed throughout the genome in the mutant 
strain.  However, the recent analysis of the cj0422c mutant genome sequence suggests this 
may be an artifact caused by seemingly random SNPs, this is discussed in (Section 3.3.3).  This 
chapter aims to more accurately dissect the role of Cj0422c as a master regulator by producing 
a new mutant construct and assaying any changes in gene expression by qRT-PCR.  The other 
main focus of this project is the role of Cj0421c, a protein that contains 6 transmembrane 
regions within the N-terminal domain and a cytoplasmic facing globular domain at the C-
terminal end.  BLAST searches of the C-terminal domain have shown no strong hits though 
there is some weak homology to a class of proteins containing GGDEF motifs.  This class of 
proteins are diguanylate cyclases which produce the second messenger cyclic-di-GMP which 
typically controls the switch from motile to sessile states in bacteria (Romling et al., 2013).  
Two conserved motifs within this family of proteins (the GGDEF active site and the RXXD 
inhibition site) are essential for the enzymatic activity of these proteins.  The Cj0421c protein 
does not possess either the conserved GGDEF or RXXD motifs associated with this family of 
proteins.  Further still there are other families of proteins that are associated with c-di-GMP 
signaling in bacteria, such as the c-di-GMP degrading HD-GYP and EAL domains and the c-di-
GMP sensing PilZ domain.  The genome of Campylobacter jejuni NCTC11168 shows no close 
homologies with any of these families of c-di-GMP related proteins, indicating that even if 
Cj0421c was a degenerate GGDEF binding protein, C. jejuni could not have a working c-di-GMP 
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signaling pathway.  The roles of the Cj0421c and Cj0422c proteins are examined in detail in 
Chapter 6, this chapter will focus primarily on mutagenesis and complementation of the two 
genes.  Since the new genome sequenced lab strain is now being used as the primary wild type 
for studying these genes, this chapter will also focus on producing mutant strains in cj0423, 
cj0424 and cj0425.  A series of further mutant strains will be also be produced to delete 
multiples of these genes, a double mutant will delete both the regulatory genes cj0421c and 
cj0422c.  A triple mutant will delete all 3 structural genes cj0423, cj0424 and cj0425.  And a 
quintuple mutant will delete the entire gene cluster cj0421c-cj0425. 
  
The first aim of this chapter is to confirm the role of Cj0422c as a master regulator by qRT-PCR 
analysis of the mutant strain.  The chapter then moves onto determining the roles of the 
individual genes by mutagenesis, and to assay for differences between the strains.  The biggest 
challenge is that there is currently no evidence to even suggest or imply a role for most of 
these genes.  Over the course of the work described in this chapter a variety of experiments 
were performed to test for phenotype difference under a variety of conditions and stresses.  
Since there is no overall theory being tested here the hypothesis behind each experiment is 
explained throughout the chapter. 
 
During the course of the work described in this chapter the crystal structure of Cj0425 was 
solved to a 2 Å resolution by Halah Al-Haideri and Dr John Rafferty (Unpublished data).  The 
protein shows strong similarity to a class of cysteine protease inhibitor proteins known as 
cystatins.  The structure revealed that protein possesses a disulfide bond and is composed of 4 
antiparallel ß-sheet strands wrapped around a central α-helix.  Cystatin proteins are a class of 
cysteine protease inhibitors, cysteine proteases such as papain hydrolyse peptide bonds using 
a reactive thiol group from a cysteine residue.  In papain a reactive ion pair is formed by the 
interaction between a Cys free thiol group and a protonated His residue.  The imidazole group 
on the His residue is protonated by the action of a nearby Trp residue (Polgár, 1973), other 
cysteine proteases function in a similar way using Cysteine and Histidine residues.  The cystatin 
family act to inhibit cysteine proteases by competitively blocking the cysteine containing active 
site; since there are many types of cysteine proteases the Kd binding constant between 
cystatins and proteases can vary between different proteins (Turk and Bode, 1991).  Cystatins 
are well studied in eukaryotes as they can often play a crucial role in disease progression, the 
role of cystatins in higher eukaryotes appears to be as a way to post translationally regulate 
the action of cysteine proteases (Turk et al., 2008).  Eukaryotic cystatins appear to be 
reasonably non-specific inhibitors and do not differentiate between different cysteine 
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protease enzymes (though they can differentiate between endo and exo-peptidase enzymes), 
typically cystatins inhibit cysteine proteases in a 1:1 ratio (Jenko et al., 2003). 
 
Cystatins are not well studied in bacteria, probably due to the lack of annotated cystatins in 
microbial genomes (Kordiš et al., 2009), it may be that many bacteria contain cystatins but 
they cannot be identified bioinformatically.  Many bacteria also encode other families of 
cysteine protease inhibitors such as chagasins (Rigden et al., 2002), which are structurally 
different from cystatins.  One of the better studied examples of a microbial cystatin is the E. 
coli protein YebF, which is secreted outside the cell and acts to protect against the secreted 
toxin colicin-M (Gérard et al., 2011).  This toxin is also secreted by E. coli strains so YebF acts as 
an immunity protein as part of a secreted toxin-antitoxin system.  The YebF cystatin has been 
shown to be folded by the DsbA oxidase in the periplasm and then exported by outer 
membrane porins into the extracellular environment (Prehna et al., 2012).   
 
The protein sequence for Cj0425 encodes a periplasmic signal sequence and 2 cysteine 
residues which are likely oxidized to form a disulfide bond by the DsbA system in the C. jejuni 
periplasm.  There is no evidence to suggest that Cj0425 is exported outside the periplasm since 
western blot analysis of culture media could not find any evidence of Cj0425 export.  This work 
was performed by Halah Al-Haideri (data not shown).  The potential role of this protein as part 

















4.2 Chapter 4 Results 
4.2.1 Generation of mutant and complementation strains in C. jejuni 11168-DJK 
 
4.2.2 Construction of cj0421c and cj0422c mutants in C. jejuni 11168-DJK 
The mutant constructs were generated by isothermal assembly cloning using methods 
previously described in (Section 2.11) and previously used in chapter 3 (Section 3.2.6). 
Figure 28: Plasmid maps of the cj0421c and cj0422c  knockout vectors.  All plasmids shown were produced 
by ISA cloning in the same way as (Figure 16).  The cj0421c mutant (A) used the kanamycin resistance 
cassette (kanR) and the cj0422c mutant (B) used the chloramphenicol resistacne cassess (catR).  Both 







Figure 29: Mutagenesis of cj0421c and cj0422c in C. jejuni 11168-DJK.  The ISA vectors shown in (Figure 28) 
were transformed into C. jejuni 11168 to remove most of the genes of interest.  (A) shows the gene 
arrangements of WT 11168 and the 2 mutant strains following removal of the gene and insertions of the 
kanamycin resistance cassette for cj0421c and the chloramphenicol resistance cassette for cj0422c.  The 
mutants were confirmed by PCR analysis.  The numbers correspond to the PCR products expected using the 
knockout screening primers.  The PCR confirmation bands are shown in (B).  The lane numbers correspond to 
the numbers shown above the arrows, the band sizes also correspond to the arrow lengths.  The expected PCR 
product sizes in bp are 1-2306, 2-822, 3-1285, 4-1769, 5-911.  The PCR primers were designed to be outside 
the flanking primers used to produce the constructs; this was to show that the construct was correctly 





4.2.3 Construction of cj0423, cj0424 and cj0425 mutants in C. jejuni 11168-DJK 
The mutant constructs were generated by isothermal assembly cloning using methods 









Figure 30: Plasmid maps of the cj0423, cj0424 and cj0425 knockout vectors.  All plasmids shown were 
produced by ISA cloning in the same way as (Section 3.2.6) by Dr Andrew Hitchcock and Halah Al-Haideri, 
all constructs shown used the kanamycin resistance cassette (kanR).  The maps show the knockout 
constructs for cj0423 (A), cj0424 (B) and cj0425 (C).  All plasmids were confirmed by DNA sequencing of the 




Figure 31: Mutagenesis of cj0423, cj0424 and cj0425 in C. jejuni 11168-DJK.  The ISA vectors shown in (Figure 
30) were transformed into C. jejuni 11168 to remove the genes of interest.  (A) shows the gene arrangements 
of WT 11168 and the 3 mutant strains following removal of most of the gene and insertions of the kanamycin 
resistance cassettes.  The mutants were confirmed by PCR analysis.  The numbers correspond to the PCR 
products expected using the knockout screening primers.  The PCR confirmation bands are shown in (B).  The 
lane numbers correspond to the numbers shown above the arrows, the band sizes also correspond to the 
arrow lengths.  The expected PCR product sizes in bp are 1-2170, 2-747, 3-1863, 4-1041, 5-1413, 6-1698, 7-
826.  The PCR primers were designed to be outside the flanking primers used to produce the construct, this 
was to show that the construct was correctly inserted in the correct orientation and that the double 







4.2.4 Construction of double, triple and quintuple mutants in C. jejuni 11168-DJK 
The mutant constructs were generated by isothermal assembly cloning using methods 






Figure 32: Plasmid maps of the double, triple and quintuple knockout vectors.  All plasmids shown were 
produced by ISA cloning in the same way as (Figure 16), plasmids (B and C were produced by Dr Jonathan 
Butler.  All constructs shown used the kanamycin resistance cassette (kanR).  The maps show the knockout 
constructs for the double mutant (cj0421c-cj0422c) (A), the triple mutant (cj0423-cj0424-cj0425) (B) and 
the quintuple mutant (cj0421c-cj0422c-cj0423-cj0424-cj0425) (C).  All plasmids were confirmed by DNA 




Figure 33: Production of the double, triple and quintuple mutants in C. jejuni 11168-DJK.  The ISA vectors 
shown in (Figure 32) were transformed into C. jejuni 11168 to remove the genes of interest.  (A) shows the 
gene arrangements of WT 11168 and the 3 mutant strains following removal of most of the gene and 
insertions of the kanamycin resistance cassettes.  The mutants were confirmed by PCR analysis.  The numbers 
correspond to the PCR products expected using the knockout screening primers.  The PCR confirmation bands 
are shown in (B).  The lane numbers correspond to the numbers shown above the arrows, the band sizes also 
correspond to the arrow lengths.  The expected PCR product sizes in bp are 1-822, 2-1072, 3-732, 4-752, 5-
1030, 6-752.  The PCR primers were designed to be outside the flanking primers used to produce the 
construct, this was to show that the construct was correctly inserted in the correct orientation and that the 





4.2.5 qRT-PCR analysis of the cj0421c and cj0422c mutants 
Much of the previous work on the cj0422c mutant is based on the microarray results shown in 
(Figure 7).  This shows that the Cj0422c protein acts to repress the cj0423-cj0425 operon under 
normal growth conditions.  The new mutant strains produced in the NCTC11168-DJK 
background strain were tested for changes in gene expression by qRT-PCR analysis.  As 
mentioned in the previous chapter the cj0422c mutant contained a variety of secondary 
mutations, including a complete loss of the cj0423 promoter region (Figure 25).  To try and 
prevent this happening again frozen stocks of the mutant strains were produced quickly from 
individual colonies from the transformation plates.  Four of these individual colonies were 
analysed by qRT-PCR for changes in cj0423 gene expression.  There was some evidence from 
previous work that Cj0421c may have a role in affecting gene expression, this hypothesis was 
also tested by qRT-PCR analysis. The data in (Figure 34) shows a strong up-regulation of cj0423 
in the cj0422c mutant strain (around 50-fold) and a similar up-regulation in the double mutant 
(around 30-fold).  There is a slight drop in expression in the cj0421c mutant (around 0.5-fold).  
Figure 34: Quantitative Reverse Transcriptase PCR analysis of cj0423 in the cj0421c and cj0422c mutants.   
Whole cell RNA was extracted and analysed using methods described previously (Section 2.15).  4 separate 
biological replicates of the cj0421c, cj0422c and the double mutants were analysed by assaying the expression of 
cj0423, the data was matched to the wild type expression which is given a value of 1.  The error bars show 




4.2.6 Construction of complementation constructs by Isothermal Assembly Cloning 
(ISA) 
Following construction and screening of the mutant strains, complementation constructs were 
produced for cj0421c and cj0422c.  The complementation system used in C. jejuni involves 
inserting the gene of interest into the pseudogene locus cj0046.  This is achieved by using a 
family of plasmids known as the pK/C46 plasmids (Thomas et al., 2011).  Theses plasmids 
contain either a kanamycin or chloramphenicol resistance cassette located between two 
fragments of the cj0046 pseudogene locus.  The gene of interest is usually amplified by PCR 
with a BsmBI restriction site at either end, this is then ligated into the BsmBI site located 
between the cj0046 fragments within the plasmid.  The genes of interest can either be cloned 
into the plasmid downstream of the metK Promoter (medium level constitutive expression), 
the fdxA promoter (Iron inducible promoter) or they can be cloned with the native promoter 
(Van Vliet et al., 2001).  The native promoter is always used for complementation if possible or 
unless there is a particular reason not to.  Typically, C. jejuni complementation requires cloning 
into the BsmBI restriction site of one of the p46 plasmids; however the BsmBI (or Esp3I) 
restriction enzyme is not very efficient at digesting DNA.  Since no additional antibiotic 
selection markers are being inserted into the vector, the plasmid will often re-ligate with no 
insertion since the BsmBI sticky ends are compatible.  Since ISA cloning has proved so efficient 
at producing knockout constructs for Campylobacter, as part of this project I attempted to 
improve the complementation system employed in the lab by modifying the complementation 
protocol to use ISA cloning.   
 
The ISA system is efficient at incorporating multiple linear DNA fragments into a single vector, 
thereby eliminating the need for multiple restriction enzyme cloning steps.  For this to work 
the DNA products need to be amplified by high fidelity PCR with overlapping ‘adapter’ 
fragments attached to each end of the sequence.  These complementary adapters act like 
longer sticky ends and allow the fragments to attach during the ISA reaction.  This technique 
was employed to insert a single fragment into the p46 family of vectors.  Since the p46 families 
of vectors contain a single antibiotic resistance marker (kanamycin or chloramphenicol) the 
transformants cannot be selected for using a newly inserted marker.  To overcome this, the 
resistance marker already in the plasmid was amplified as two separate fragments by high 
fidelity PCR, the fragments contained a 20bp overlapping adapter region which allowed for the 
ISA reaction to re-incorporate the two fragments into a complete resistance marker.  This 
allowed the resistance cassette to act as a selective marker whereas before it could not.  This is 





Using this new cloning method means that a fully formed plasmid can only be made if the ISA 
reaction has successfully incorporated the gene of interest and it becomes much less likely to 
form an empty vector.  It also allows for the gene of interest to be attached to the small 
Figure 35: Generation of a complementation construct by Isothermal Assembly (ISA) cloning.  (A-B-C) all 
show the normal restriction site cloning method for producing complementation plasmids in pC46.  (A) shows 
the location of the BsmBI restriction site within the pC46 plasmid.  (B) shows the plasmid after digestion with 
BsmBI and (C) shows the ligation step to insert cj0421c into the vector.  This method is slow and often results 
in very low product yield as the BsmBI enzyme is inefficient at digesting DNA.  (D-E-F) all show the new 
method for producing complementation vectors used in this study.  (D) shows the linearised pC46 plasmid, 
high fidelity PCR reactions amplify the two fragments shown by the orange and blue arrows (the orange arrow 
continues around the rest of the pC46 plasmid).  These two fragments can then be used in an ISA reaction.  (E) 
shows the ISA fragments used in a typical reaction.  The cj0421c fragment is amplified from genomic DNA with 
adapter fragments on either end to allows for ligation into the plasmid.  (F) shows the completed plasmid 





fragment (pC46 Frag-2) by overlap extension PCR which makes it practically impossible for the 
plasmid to re-form without the gene of interest.  This technique is used in the next chapter.  
This method also allows for the large and small fragments to be re-used in later cloning 
procedures and since the small fragments contain the different promoter regions used in the 
cj0046 complementation system these can be interchanged at will.  This cloning system was 
used for each of the complementation vectors produced in this study and it did not once result 
in a reformed empty vector. 
 
Since this study is primarily focused on the roles of Cj0421c and Cj0422c only these genes have 
been complemented.  cj0422c contains its own promoter immediately upstream of the gene, 
so the complementation construct will include the native promoter and will be produced in the 
pK46 plasmid with a kanamycin resistance marker as the mutant was produced using the 
chloramphenicol marker.  The cj0421c gene is located in an operon downstream of cj0422c so 
it cannot be complemented under its own promoter, instead it will be complemented using 
the metK promoter in the pC46-metK plasmid.  The Cj0421c protein is predicted to contain 6 
transmembrane domains and a cytoplasmic C-terminal domain.  For this reason, I decided to 
produce 2 complementation strains for cj0421c with one using the complete gene under the 
metK promoter and a second construct only producing the C-terminal cytoplasmic domain, 









The transmembrane regions are highlighted in blue and the cytoplasmic domain is highlighted 
in yellow, for the C-terminal only complementation an extra methionine was added at the start 
of the domain as shown below.  This is the same domain sequence used for the heterologous 
















Figure 36: Plasmid maps of the cj0421c and cj0422c complementation plasmids.  (A) shows the empty 
pC46 plasmid, (B) shows the full length cj0421c complementation plasmid cj0421c located downstream of 
the MetK promoter.  (C) shows the truncated cj0421c gene as described in the previous section.  (D) shows 
the cj0422c complementation plasmid in pK46 with its native promoter.  The BsmBI cloning sites are all 
located at the top of the plasmid maps.  All plasmids shown were produced by ISA cloning in the same way 
as described in (Figure 35).  All plasmids were confirmed by DNA sequencing of the inserted fragments 




Figure 37: Production of cj0421c and cj0422c complementation strains in C. jejuni 11168-DJK.  The ISA 
vectors shown in (Figure 36) were transformed into the cj0046 pseudogene locus of respective C. jejuni 11168 
mutant strains.  (A) shows the gene arrangements of WT 11168 and the 3 complementation strains following 
insertion of the genes and the resistance cassettes.  The strains were confirmed by PCR analysis.  The numbers 
correspond to the PCR products expected using the p46 screening primers, the PCR confirmation bands are 
shown in (B).  The lane numbers correspond to the numbers shown above the arrows, the band sizes also 
correspond to the arrow lengths.  The expected PCR product sizes in bp are 1-544, 2-2195, 3-1622, 4-1676. 
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4.2.8 qRT-PCR analysis of the cj0421c and cj0422c complementation strains 
The complementation plasmids were transformed into their respective mutant strains using 
methods described in (Section 2.14).  To further analyse the role of Cj0421c in controlling gene 
expression the two cj0421c complementation strains were analysed by qRT-PCR analysis.  It 
was hypothesised that Cj0421c may act as a ‘sensor’ domain for whichever signal activates the 
operon.  While the cj0421c mutant shows no large change in cj0423 gene expression, it may be 
that the C-terminal domain is able to influence gene expression either by interactions with the 
Cj0422c master regulator or by affecting gene expression directly.  The data shown in (Figure 
38) shows no significant changes in the expression of cj0422c or cj0423 in the cj0421c mutant 
and complementation strains compared to wild type.  The data shown in (Figure 39) shows 
that the expression of the cj0423-5 operon is up-regulated in the cj0422c mutant while the 
expressions of cj0204, cj0653c and cj0864 are not significantly altered. 
 
 
Figure 38: Quantitative Reverse Transcriptase PCR analysis of the cj0421c mutant and complementation 
strains.   Whole cell RNA was extracted and analysed using methods described previously (Section 2.15).  The 
red bars show the expression of cj0422c and the green bars show the expression of the cj0423-cj0424 operon 
by using primers within each gene, the primers are listed in (Table 7).  The error bars show the standard 
deviations from 3 technical repeats of 3 separately cultured biological repeats.  The results for the mutant and 








Figure 39: Quantitative Reverse Transcriptase PCR analysis of the cj0422c mutant and complementation 
strains.   Whole cell RNA was extracted and analysed using methods described previously (Section 2.15).  (A) 
shows that in the cj0422c mutant the expression of cj0421c is unchanged (blue bars) and the expression of the 
cj0423-cj0425 operon is strongly up-regulated (green and orange bars).  The red bar shows the expression of 
cj0422c itself in its own mutant strain.  This was achieved by designing primers which bind upstream of the 
chloramphenicol insertion in the mutant thereby allowing transcription to be measured.  (B) shows the 
expression of cj0204, cj0653c and cj0864 in the cj0422c mutant and complementation strains, showing no real 
difference in gene expression in any of the genes.  All primers are listed in (Table 7).  The error bars show the 
standard deviations from 3 technical repeats of 3 separately cultured biological repeats.  The results for the 







The data shown in (Figure 38) reveals that Cj0421c does not appear to have any direct effect 
on gene expression.  While Cj0421c is still hypothesised to act as a ‘sensor’ protein for the 
gene cluster, it may need to be ‘activated’ in order to affect expression.  The data shown in 
(Figure 39) shows that while Cj0422c does act as a repressor of the cj0423-5 operon it does not 
seem to have any effect on the expression of Cj0204, cj0653c or cj0684.  These 3 genes 
appeared to be differentially expressed in the microarray data shown in (Figure 7), which 
formed part of the hypothesis shown in (Figure 9) about CAMP resistance.  The lack of any 
changes in gene expression shown here implies that the microarray data was inaccurate since 
qRT-PCR is a more sensitive and accurate way to determine gene expression.  The reason for 
this inaccuracy is explained in the previous chapter (Section 3.3.3) whereby SNPs occurring 
within these genes may have altered the sensitivity of the microarray probes. 
 
Following this confirmation of the cj0422c mutant phenotype I decided to continue looking for 
any changes in phenotype these mutants may possess.  Initially this work focused on 
examining the mutant strains for any growth defects or any changes in antimicrobial 
sensitivity.  It was decided that the cj0422c mutant is the best strain to use for detecting any 
changes in phenotype as the cj0423-cj0425 operon is strongly repressed by Cj0422c under 
standard conditions, so in practical terms there is little difference in the expression of the 
structural genes between their respective mutant strains and wild type cells.  Whereas in the 
cj0422c mutant strain the structural genes are strongly up-regulated making it useful as a way 


















4.2.9 The cj0421c and cj0422c mutant strains do not show any growth defects  
To determine if the genes within the cj0421c-cj0425 cluster have any effect on growth rate the 
cj0421c and cj0422c mutant strains were grown under normal conditions in broth cultures to 
measure growth rate.  The 2X, 3X, and 5X mutant strains were also tested for any changes in 
growth rate.  The data in (Figure 40) shows no appreciable difference in growth rate between 
the wild type DJK strain and the mutant strains. 
Figure 40: Growth curves of the cj0421c-cj0425 mutant strains.  Cells grown on blood agar plates were re-
suspended in MHS broth to a starting OD600nm of 0.1 and cultured over 24 hours with OD600nm measurements 
taken at 0, 2, 4, 6, 8 and 24 hours (Section 2.17).  (A) shows the individual cj0421c and cj0422c mutants.  (B) 
shows the (cj0421c-cj0422c) 2X, (cj0423-cj0425) 3X and (cj0421c-cj0425) 5X mutant strains being tested.  The 







4.2.10 The cj0421c, cj0422c and cj0424 mutant strains do not show any change in 
sensitivity to some antibiotics or CAMPs 
The mutant strains were tested for sensitivity to the cell wall acting ampicillin and the 
membrane acting colistin sulphate (also known as polymyxin-E).  All the mutant and 
complementation strains were tested against these antibiotics using disc diffusion assays 
where sensitivity is determined by the size of the zone of inhibition (Section 2.18).  The cj0422c 
mutant and complementation strains were also tested by growth curve analysis for sensitivity 
to a range of ampicillin concentrations.  The data shown in (Figure 41) shows no biologically 
significant difference in sensitivity between the wild type and mutant strains. 
Figure 41: Antibiotic sensitivity of the cj0421c and cj0422c mutant strains.  (A) shows the sensitivity profiles of 
the cj0421c and cj0422c mutant and complementation strains against ampicillin and polymyxin-E.  (B) shows a 
more thorough test of the cj0422c mutant and complementation strains sensitivity to a range of ampicillin 








The cj0422c and cj0424 mutant strains were also assayed by microtiter sensitivity to the model 
CAMP polymyxin-B, the human cathelicidin LL37, the chicken cathelicidin fowlicidin-2 and SDS 
as a control.  The data shown in (Figures 42 and 43) shows some variations between the strains 





Figure 42: Polymyxin-B sensitivity of the cj0422c and cj0424 mutant strains.  Microtitre sensitivity assays were 
performed using methods described in (Section 2.19), with the strains incubated for 2 hours.  The error bars 
show the standard deviation from at least 3 biological replicates for each data point.  (A) shows the cj0422c 




















Figure 43: LL37, Fowlicidin-2 and SDS sensitivity of the cj0422c mutant and complementation strains.  Microtitre 
sensitivity assays were performed using methods described in (Section 2.19), with the strains incubated for 4 hours 
(2 hours for SDS).  The error bars show the standard deviation from at least 3 biological replicates for each data 
point.  (A) shows the cj0422c mutant and complementation strains sensitivity to the human cathelicidin LL-37, (B) 
the cj0422c mutant and complementation strains sensitivity to the chicken cathelicidin Fowlicidin-2.  (C) shows the 







4.2.11 Investigating the rigidity of the cell membrane in the cj0422c mutant 
The data presented in the previous section (Figures 42-43) shows that while there are some 
minor variations in sensitivity to antimicrobial compounds between wild type NCTC11168-DJK 
and the new mutant strains theses are relatively minor and inconsistent.  While this work was 
being done other work on the Cj0424 MORN domain protein showed that it is able to bind to 
lipid membranes and that when mixed with liposomes it is able to provide some degree of 
protection against leakage of a fluorescent dye marker inside the liposomes.  This work is still 
ongoing but since the cj0422c mutant shows a strong up-regulation of the Cj0424 protein (as 
well as Cj0423 and Cj0425), it was decided to use this strain to analyse any effect these 
proteins may have on the C. jejuni membrane.  Since the Cj0424 protein is able to protect 
against liposomal membrane leakage it was thought that it may help to order the outer 
membrane lipids (other work has shown Cj0424 is anchored to the inner leaflet of the outer 
membrane).  To test this the strains were tested for membrane rigidity using methods 
described in (Section 2.22).  Membrane rigidity is a method of determining the relative order 
of the membrane by examining the relative polarization of the hydrophobic dye DPH (1,6-
diphenyl-1,3,5-hexatriene) when bound to the membrane.  How polarized the DPH molecule is 
depends on how freely it is able to move when located in the hydrophobic part of the lipid 
membrane.  The more freely the molecule is able to move the lower the polarization value will 
be as the DPH molecules spend less time in any one particular orientation.  Other studies have 
shown that increased temperature or changes in membrane lipid composition can make a 
membrane less rigid which leads to a drop in the relative polarization.  The data shown in 
(Figure 44) shows no statically significant difference in the membrane polarization of the 
















Figure 44: Membrane rigidity of the cj0422c mutant and complementation strains and the cj0424 mutant 
strain.  The assay was performed using methods described in (Section 2.22).  (A) shows data for the strains 
cultured overnight under standard conditions before being assayed.  (B) shows data for the strains grown to 
mid-log phase (OD600nm 0.5-0.6) and then assayed.  The error bars show the standard deviations from 3 







4.2.12 Investigating the integrity of the cell membrane in the cj0422c mutant 
The data shown in the previous section shows that the rigidity of the membrane structure is 
not altered by the presence Cj0424.  However, the lipid binding Cj0424 protein may still act to 
stabilize the outer membrane in other ways.  This hypothesis was tested using two assays 
designed to test how ‘leaky’ the outer membrane is.  These assays were performed by Dr 
Jonathan Smart using the cj0422c mutant strain I produced shown earlier in this chapter.  The 
nitrocefin assay can be used as an indicator of outer membrane integrity by measuring the 
amount of ‘leaked’ periplamic proteins following quick osmotic shock treatment, the protocol 
is explained in (Section 2.23).  Briefly, overnight cultures of C. jejuni were matched to an 
OD600nm of 0.5 and the periplasmic fraction collected by a short osmotic shock.  Variations in 
membrane integrity are assayed by measuring the activity of periplasmic ß-lactamase enzymes 
using nitrocefin as the substrate.  The data is expressed as the rate of change in absorbtion at 
495 nm.  The data (Figure 45) shows a slight but biologically insignificant difference between 
the wild type and cj0422c mutant strains. 
 
Another method for testing the integrity of the outer membrane is by measuring cell 
sensitivity to lysozyme.  This peptidoglycan hydrolase is unable to effectively cross the outer 
membrane of Gram-negative bacteria and so increased sensitivity to lysozyme indicates a 
defective outer membrane.  The methods are described in (Section 2.24), briefly, overnight 
cultures of C. jejuni were matched to an OD600nm of 0.5 and lysozyme added to the cells to a 
final concentration of 0.5 mg ml-1.  The OD600nm was then measured over 3 minutes.  The bile 
acid sodium deoxycholate was added to a final concentration of 10 mM to increase the rate of 
cell lysis.  The experiment was performed by Dr Jonathan Smart using both wild type 11168 
and the cj0422c mutant strains.  The data shown in (Figure 46) shows some variations between 
























Figure 45: Determination of the activity of periplasmic ß-lactamase in the wild type and cj0422c mutant 
strains.  3 independently grown replicates of the wild type and cj0422c mutant strains were grown overnight 
under standard conditions, the cultures were matched to an OD of 0.5 and the periplasmic fractions were 
extracted.  The integrity of the outer membrane was measured by assaying the activity of the periplasmically 
located ß-lactamase from 3 technical replicates of the 3 biological replicates.  The activity of this enzyme was 
measured using methods described in (Section 2.23).  The error bars represent the standard deviations from 
the mean of 9 replicates.  The experiment was performed by Dr Jonathan Smart.  Statistical analysis does show 










The data shown in (Figures 45-46) do not show biologically significant differences in outer 
membrane integrity between the wild type and cj0422c mutant strains.  It is worth noting that 
when assaying for membrane integrity or stability the wild type is usually the more stable 
control and a mutant strain would normally show a decrease in stability.  In this case however 
the hypothesis being tested is that the mutant strain makes the membrane more stable by up-
regulating Cj0424.  Since there is no obvious increase in membrane stability between the 
strains it was decided to discontinue this line of enquiry and to focus on what role the cj0423-








Figure 46: Lysozyme sensitivities of wild type and the cj0422c mutant strains.  Strains were grown overnight 
under standard conditions and back diluted to an OD600nm of 0.5.  Lysozyme was added to a final 
concentration of 0.05 mg ml-1 and the decrease in OD600nm measured over 3 minutes.  Sodium deoxycholate 
was added to increase the rate of uptake of the lysozyme.  The data shown is matched to the starting OD600nm 
after adding the lysozyme.  The points show the average from 3 independently grown cultures with the error 







4.2.13 Chicken colonisation studies using the cj0423-4 mutant strain in the C. jejuni 
11168-Hypermotile wild type. 
As discussed in the previous chapter the laboratory wild type strain of Campylobacter (C. jejuni 
11168-DJK) is non motile due to multiple SNPs within the structural components of the motility 
apparatus.  Since motility is required for successful colonisation of chickens, some of the 
mutant strains produced earlier in the chapter were re-produced in the hypermotile variant of 
Campylobacter (Table 14).  The strains tested were the cj0424 mutant strain and a newly 
produced cj0423-4 double mutant strain, both produced by Dr Jonathan Butler.  These strains 
were tested for chicken colonisation in collaboration with Professor Mark Stevens and Cosmin 
Chintoan-Uta at the Roslin Institute.   Briefly, 1 day old White Ledgehorn chicks were orally 
challenged with 50 µl C. jejuni culture which had been diluted in PBS to 104 and 106 CFU ml-1.  
Caecas were collected from 4-6 birds at weekly intervals for 3 weeks post challenge and 1 
gram samples were re-suspended in Bolton Broth (Oxoid) and serially diluted to determine the 
CFU / gram caecal contents by plasting on mCCDA selective agar.  All chicken colonisation 
experiments were performed by Cosmin Chintoan-Uta according to home office guidelines and 
using all standard controls and procedures. 
 
The chicken colonisation data shown below and other data not shown here, shows no 
difference in the ability of the mutant strains to colonise chickens compared to the wild type 
hypermotile strain.  In order to successfully colonise chickens C. jejuni needs to be able to 
successfully resist a large number of potential stresses including acid shock, osmotic shock, bile 
salts, CAMPs and other components of the immune system.  While this experiment does not 
provide any answers about the roles of the cj0423-cj0425 operon, the lack of any colonisation 
defect in the mutant strain does imply that the genes are not involved directly in the process 














Figure 47: Chicken colonisation profile of wild type 11168-H and the cj0423-4 double mutant and 
complementation strains.  The 3 strains were tested against 1 day old chicks with (A) 104 CFU ml-1 and (B) 106 
CFU ml-1 starting dose.  6 birds were sampled per strain at each of the weekly time points and the error bars 
represent the standard error of the means.  The experiment was performed by Cosmin Chintoan-Uta in the 







4.2.14 Examining the peptidoglycan structure of the cj0422c mutant strain 
The other primary structural component of the Gram-negative cell envelope, apart from the 
membrane layers, is the peptidoglycan cell wall.  The structure of the C. jejuni peptidoglycan 
layer is discussed in the introduction.  Part of the reason for studying the peptidoglycan layer is 
that the crystal structure of Cj0425 revealed that it contains a cystatin like fold, this class of 
proteins act as cysteine protease inhibitors which directly bind to the active site regions of 
cysteine proteases such as papain.  The protein structure and active site regions of some 
peptidoglycan modification enzymes is similar to that of cysteine proteases (Sanz-Gaitero et 
al., 2014) so it was decided to look for any changes in the peptidoglycan structure of the 
cj0422c mutant to determine if an up-regulated Cj0425 might affect peptidoglycan turnover.  
To examine this hypothesis, the peptidoglycan structure of both wild type and the cj0422 
mutant strains was examined by HPLC analysis.  This work was performed by Dr Jonathan 
Butler in collaboration with Dr Stéphane Mesnage. 
 
The C. jejuni peptidoglycan was purified using standard extraction techniques based on 
(Glauner, 1988).  The extraction was performed by Dr Jonathan Butler.  The peptidoglycan was 
then digested with the N-acetylmuramidase enzyme mutanolysin (Sigma) which breaks apart 
the β-N-acetylmuramyl-(1→4)-N-acetylglucosamine linkage of the bacterial cell wall 
peptidoglycan-polysaccharide.  The soluble peptidoglycan fragments were separated on a 
Thermo Scientific Hypersil GOLD aQ column (250 x 4.6 mm, 3 µm particle size), using a Waters 
HPLC system.  The HPLC analysis was performed by Dr Stéphane Mesnage.  The HPLC traces for 
wild type 11168 and the cj0422c mutant strain are shown in (Figure 48), the traces show no 
significant difference between the size or concentration of the peptidoglycan fragments 
between wild type C. jejuni or the cj0422c mutant (Dr Stéphane Mesnage personal 
communication).  The size of the peaks in (Figure 48) does vary as does the elution time for the 
peaks, however the size is relative to the volume loaded onto the column and the ‘drift’ seen 



























Figure 48: HPLC trace of the peptidoglycan fragments from wild type 11168 and the cj0422c mutant strain.  
The mutanolysin digested peptidoglycan fragments from a single wild type 11168 (black) and the cj0422c 
mutant (red) were separated by HPLC and the Abs202nm measured over time to produce a trace of the C. jejuni 
peptidoglycan fragments.  The peaks correspond to different peptidoglycan fragments though which fragments 








4.2.15 Examining the potential role of the cj0423-cj0425 operon as a defense against 
the antibacterial type VI secretion system 
Because the C. jejuni peptidoglycan structure is apparently not altered in the cj0422c mutant 
strain and because pull down assays do not show any probable binding partners or targets for 
Cj0425 from C. jejuni cell free extracts (data shown in Chapter 6), it may be that Cj0425 does 
not inhibit or interact with any of the cysteine protease enzymes native to Campylobacter.  
Because of this I decided to look for potential ways in which foreign cysteine protease enzymes 
may enter the periplasm of C. jejuni.  One potential source is via the antibacterial type VI 
secretion system (T6SS), this system is used by some Gram-negative bacteria to compete 
against other un-related Gram-negative bacteria.  The T6SS is able to inject toxic effector 
proteins directly into the periplasm of neighboring cells whilst expressing immunity proteins to 
prevent self-damage (Ho et al., 2014).  The type VI secretion system of Gram-negative bacteria 
is reviewed in the introduction.  
 
As discussed earlier the periplasmic protein Cj0425 possesses a similar structure to cystatin like 
proteins which inhibit cysteine protease enzymes.  These enzymes are similar in structure to 
some peptidoglycan degrading enzymes exported by the T6SS of some bacteria 
(Srikannathasan et al., 2013).  Because of this similarity I decided to examine the possibility 
that Cj0425 may act to inhibit foreign peptidase enzymes.  While preparing to test this 
hypothesis, I developed a model showing how the other genes in the operon (cj0423 and 
cj0424) may also be involved in defence against the T6SS.  This model is based on Cj0423 
acting to inhibit the formation of pores by pore forming toxins and Cj0424 acting to inhibit the 
activity of secreted phospholipase enzymes potentially by blocking access to the membrane.  







Figure 49: Proposed model for Cj0423-4-5 acting to defend against the type VI secretion system.  The figure 
shows the proposed model for how the three proteins may individually help defend against different types of toxic 
effectors secreted by the type VI secretion system.  The T6SS apparatus is represented by the grey tube connectin 
the cytoplasm of the ‘predator’ cell with the periplasm of the ‘prey cell’.  (A) Cj0423 is localised to the inner 
membrane and may act to inhibit or prevent the formation of pores from the T6SS secreted pore forming toxins. 
(B) Cj0424 which binds to the inner leaflet of the outer membrane may inhibit the action of phospholipase enzymes 
secreted by the T6SS.  (C) Cj0425 which possesses a cystatin like structure may inhibit peptidoglycan degrading 







4.2.16 Campylobacter jejuni is sensitive to the Serratia marcescens type VI secretion 
system 
In order to test the effectiveness of the T6SS toxins on C. jejuni I was kindly given a wild type 
and T6SS mutant strain of S. marcescens from Dr Sarah Coulthurst (University of Dundee).  S. 
marcescens is a useful model for the T6SS as the system is continuously expressed (in other 
strains such as Pseudomonas aeruginosa it needs to be induced) and it exports a peptidoglycan 
degrading endopeptidase enzyme which contains a catalytic cysteine residue in the active site 
(Murdoch et al., 2011, Srikannathasan et al., 2013).  The T6SS mutant strain contains a silent 
deletion of the tssE gene which forms part of the baseplate complex, removal of this 
completely abolishes the activity of the type VI secretion system (English et al., 2012).   
 
Assays have previously been developed in a number of labs to study how effective at killing 
foreign cells T6SS possessing strains are, these typically involve simply spotting mixtures of 2 
strains (predator and prey cells) onto solid agar plates and after a short incubation serially 
diluting the cells and plating onto selective media.  Often using this method, the ‘prey’ strain 
contains a resistance marker allowing it to be cultured on selective agar while the ‘predator’ 
strain cannot (Dr Sarah Coulthurst personal communication).  Since Campylobacter is relatively 
slow growing (compared to Serratia) and can only be cultured in a microaerobic environments, 
several trial and error experiments were performed to determine the best way to assay cell 
killing by the T6SS.  The final assays protocol is described in (Section 2.21).  Briefly, 
Campylobacter and Serratia strains were cultured on blood agar and MH agar respectively and 
then scrapped off and diluted in MHS broth to an OD600nm of 0.5 and incubated 
microaerobically for 1 hour.  Aliquots of the cultures were mixed together at a 50:1 ratio 
(Campylobacter : Serratia) and 25 µl spotted onto pre-warmed MH agar (with no selective 
antibiotics).  These plates were incubated microaerobically at 37°C for 24 hours.  The spots 
were then scraped off the plates into phosphate buffered saline, serially diluted in a 96 well 
plate and spotted onto mCCDA agar plates (containing 10 µg ml-1 Amphotericin-B and 32 µg 
ml-1 Cefoperazone).  These were incubated at 42°C for 2 days and the colonies counted.  The 
procedure for counting the number of Serratia cells was identical apart from using standard 
Mueller-Hinton agar plates instead of mCCDA and incubating aerobically.  The data is 
expressed as CFU ml-1 for the final cell count or as a percentage survival of the C. jejuni strain 
against wild type Serraita compared to the tssE mutant strain.  The data shown in (Figure 50) 
shows that wild type C. jejuni 11168 is killed by S. marcescens which is dependent on an active 





Figure 50: The S. marcescens type VI secretion system is active against C. jejuni.  Interbacterial competition 
assays were performed using methods described in (Section 2.21).  (A) shows the CFU ml-1 of recovered C. 
jejuni WT11168 after incubation with wild type Serratia marcescens (SMA DB10), the tssE mutant (∆tssE) and a 
C. jejuni only control.  The asterisks show a P value <0.01.  (B) shows the average CFU ml-1 of the recovered S. 
marcescens strains, this shows no large difference between the strains implying that the decrease seen in 
figure (A) is the result of the T6SS rather than other factors.  (C) shows the percentage survival of wild type 
11168 from the SMA DB10 strain compared to the tssE mutant strain as a control.  All data points are the 
means of 2 technical replicates from 2 biological replicates with the error bars showing standard deviations.  







4.2.17 Different C. jejuni wild type strains vary in sensitivity to the Serratia marcescens 
type VI secretion system. 
3 different laboratory strains of C. jejuni were assayed for sensitivity to the S. marcescens type 
VI secretion system.  The new laboratory 11168-DJK strain, the highly virulent 81-176 strain 
and the 81116 strain.  The 3X deletion strain in C. jejuni 81116 (produced in for the previous 
chapter (Section 3.2.6) was also used.  The data shown in (Figure 51) shows statistically 
significant type VI dependent killing of all C. jejuni strains testes.  The data also shows that the 
degree of killing between 11168 and 81116 is significantly different but the degree of killing 
between the 81116 wild type and the 81116 3X deletion strain is not. 
Figure 51: C. jejuni wild type strains vary in sensitivity to the T6SS.  (A) Final CFU ml-1 counts of wild type 
11168, 81-176, 81116 and the 3X deletion of 81116 after assaying for sensitivity to the SMA T6SS.  3 sterisks 
represent a P value <0.01.  (B)  The percentage survival of each strain (comparing the CFU ml-1 of recovered C. 
jejuni cells from the wild type SMA DB10 to the CFU ml-1 of recovered C. jejuni cells from the ∆tssE strain.  2 
Asterisks represent a P value <0.05.  All data points are the means of 4 replicates (2 technical of 2 biological) 






The colony counts of S. marcescens strains were also counted to ensure that the difference in 
the degree ok T6SS dependent killing was not the results of differences in the numbers of S. 
marcescens present in the assay.  The data shown in (Figure 52) shows no significant difference 










Figure 52: The competition assays do not affect the final viable counts of S. marcescens:  The bars show the 
final CFU ml-1 counts of Serratia marcescens after assaying with Campylobacter.  The data shows that there is 
no change in viability between assays or with the negative control.  This acts as a control for the standard 
competition assay showing that the numbers of Serratia predator cells remains constant.  All data points are 







4.2.18 The cj0423-4-5 genes do not appear to provide resistance to the S. marcescens 
type VI secretion system 
The T6SS competition assay was used to determine how sensitive the cj0422c, cj0423, cj0424, 
cj0425 and 3X deletion strains are to the S. marcescens type VI secretion system.  The data 
shown in (Figure 53) shows that there is a degree of variation between the wild type and 
mutant strains however these variations are not consistent with the hypothesis that the 
cj0423-5 operon is able to defend against the S. marcescens T6SS.  The data shows that only 
the 3X deletion strain shows a statistically significant change in sensitivity to the S. marcescens 
T6SS compared to wild type 11168.  The 3X deletion strain shows a slight increase in resistance 
















Figure 53: Susceptibility of the cj0422c-cj0423-cj0424-cj0425 and 3X mutant strains to the S. marcescens type 
VI secretion system.  (A)  The bars show the final CFU ml-1 counts for the C. jejuni mutant strains after assaying 
for sensitivity to the S. marcescens T6SS.  (B) The percentage survival of each strain (comparing the CFU ml-1 of 
recovered C. jejuni cells from the wild type SMA DB10 to the CFU ml-1 of recovered C. jejuni cells from the ∆tssE 
strain.  All data points are the means of 4 replicates (2 technical of 2 biological) and the error bars show 








4.3 Chapter 4 Discussion 
The aim of this chapter was to produce all necessary mutant strains in the newly sequenced 
11168-DJK lab strain of C. jejuni and to either confirm or disprove any phenotypes associated 
with these mutant strains.  At the end of the previous chapter it was established that the 
increased sensitivity to cationic antimicrobial peptides was likely the result of a single SNP 
variant within the cj0256 ORF and that the transcriptome microarray data on the Cj0422c 
mutant strain may have been affected by a large number of SNPs elsewhere in the genome.  
After re-producing the new cj0421c and cj0422c mutant strains and assaying by qRT-PCR it was 
shown that while the Cj0422c protein is responsible for repression of the cj0423-5 operon, it 
does not appear to affect the expression of cj0653c, cj0864 or cj0204 as the microarray initially 
suggested.  It appears then that the cj0421c-cj0425 gene cluster is not part of a master 
regulatory network and it likely has a self-contained role. 
 
4.3.1 Antimicrobial sensitivity of the mutant strains 
Without any further information on the possible roles of the cj0421c-cj0425 gene cluster I 
decided to initially assess whether the knockout mutations showed any growth defect or 
increased sensitivity to some antimicrobial compounds.  The data shown in (Figures 40-41) 
shows that the mutant strains do not show any growth defect when cultured under normal 
conditions nor do they show any increased sensitivity to some basic antimicrobial compounds.  
I also tested the cj0422c and cj0424 mutant strains against the cationic antimicrobial peptides 
polymyxin-B, human cathelicidin LL37 and fowlicidin-2 in order to finally confirm that the 
genes are not involved in CAMP resistance.  The data shown in (Figures 42-43) shows no 
biologically relevant change in sensitivity to these CAMPs or to the SDS control.  This data 
implies that the gene cluster is not involved in the normal growth of C. jejuni nor are they 
involved in resistance to antimicrobial compounds.  Following this it was decided to examine 
the roles of the individual genes more closely to try and find clues about their function. 
 
4.3.2 Membrane integrity of the mutant strains 
Without any clear hypothesis about the role of the gene cluster as a whole I decided to 
examine the possible roles of the individual genes.  Since the expression of the primary operon 
(cj0423-cj0424-cj0425) is strongly up-regulated in the cj0422c mutant strain (around 100-fold) 
it was decided that this strain is likely to show the largest change in phenotype compared to 
wild type C. jejuni as the operon is strongly repressed under normal conditions.  The Cj0424 
protein contains 7 MORN repeat domains and the crystal structure showed the protein is 
arranged into a ‘ladder like’ structure with 15 antiparallel ß-sheets.  A paper published in 2015 
showed that MORN domain proteins bind to lipid membranes (Habicht et al., 2015) and data 
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from other members of the lab has shown that Cj0424 does indeed bind to a range of lipid 
membranes.  The authors also explained that MORN domain proteins are often attached to 
other domains, some with known functions and others without, therefore it is assumed that 
the MORN domains may act to localize these domains to the membrane without the need for 
transmembrane regions or lipid anchors.  The mature Cj0424 protein however does not 
contain any other domains and appears to be localised to the inner leaflet of the outer 
membrane in C. jejuni.  Protein-protein interaction analysis by pull-down assays have not 
revealed any native binding partners for Cj0424 (though that does not rule out a potential 
foreign binding partner).  Since all the evidence suggest that Cj0424 alone binds to the outer 
membrane it was decided to examine the integrity of the outer membrane by membrane 
polarization and cell leakage assays to determine if Cj0424 binding causes changes in the 
membrane structure.  The membrane rigidity assays shown in (Figure 44) showed no change in 
light polarization between the wild type and cj0422c or cj0424 mutant strains which implies 
that the presence of the Cj0424 protein does not significantly alter the stability of the outer 
membrane.  The nitrocefin cell leakage assay shown in (Figure 45) showed no significant 
difference between the wild type and cj0422c mutant strain.  The lysozyme assay shown in 
(Figure 46) showed slight variations between the strains but the changes are not large enough 
to be considered significant. 
 
4.3.3 Chicken colonisation of the mutant strains 
In order to successfully colonise chickens Campylobacter strains possess multiple colonisation 
factors including efflux pumps, motility and chemotaxis, protein glycosylation, bile resistance 
mechanisms, heat shock response, invasion proteins, iron regulation, oxidative and nitrosative 
stress, and various metabolic pathways.  All of which appear essential for successful 
colonisation (Hermans et al., 2011).  To assess whether the cj0421c-cj0425 gene cluster is 
involved in chicken colonisation a cj0423-4 double mutant and complement strain were 
produced in the NCTC11168-Hypermotile background.  These strains were produced by Dr 
Jonathan Butler and Halah Al-Haideri and the chicken colonisation experiments were 
performed by Cosmin Chintoan-Uta in the laboratory of Professor Mark Stevens.  The data 
shows no apparent change in the colonising ability of the mutant strain compared to wild type.  
While this does not suggest a role for these genes it does imply that these genes are not 
chicken colonisation factors nor are they involved with other colonisation factor. 
 
4.3.4 Peptidoglycan structure of the cj0422c mutant 
Since the Cj0425 cystatin is exported into the C. jejuni periplasm and there is no evidence to 
suggest it is secreted, it is expected that the hypothetical ‘target’ protein for Cj0425 is also 
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localised in the periplasm.  Because not all strains of C. jejuni possess a copy of cj0425 (though 
there may well be other cystatins that are un-annotated elsewhere in the genome) and 
because there appears to be no obvious growth defect in the mutant strains, it seems Cj0425 is 
not essential for growth in standard conditions.  The biochemical role of the Cj0425 protein is 
examined in greater detail in chapter 6. 
 
The Gram-negative peptidoglycan layer forms a crucial component of the cell envelope and 
allows the cell to maintain a rigid structure which aids in virulence and motility (Frirdich et al., 
2014).  Controlling peptidoglycan synthesis and maintenance is a complex process requiring 
multiple enzymes and regulatory stages.  The Gram-negative peptidoglycan structure is 
discussed in the introduction (Section 1.7).  The peptidoglycan structure is primarily composed 
of an amino-sugar based backbone and short peptide side chains (which contain both L and D 
amino acids).  These peptide side chains are often targets for degradation as part of normal 
peptidoglycan turnover or as targets for antibacterial proteins (Park and Uehara, 2008).  The 
CHAP domain is a family of peptidoglycan degrading enzymes which contains a cysteine reside 
in the active site region, similar to other cysteine proteases (Bateman and Rawlings, 2003).  
The crystal structure of the CHAP domain protein LysK from a Staphylococcal bacteriophage 
showed it contains a papain like topology and the mechanism of action is likely very similar to 
that of papain (papain is the archetypal cysteine protease) (Sanz-Gaitero et al., 2014). 
 
While this project is not primarily about the peptidoglycan structure of Campylobacter jejuni 
the peptidoglycan targeting cysteine peptidase enzymes in the periplasm of Gram-negative 
bacteria may act as a suitable binding target for Cj0425 and many of these are likely involved in 
peptidoglycan modification or turnover (Park and Uehara, 2008).  In order to assess whether 
Cj0425 acts to inhibit a cysteine protease like peptidoglycan modification enzyme the 
peptidoglycan structure of wild type 11168 and the cj0422c mutant strain was analysed by 
HPLC.  The analysis showed no observable change in the peptidoglycan structure of the 
cj0422c mutant.  From this it is possible to conclude that Cj0425 does not act upon any of the 
native C. jejuni peptidoglycan enzymes in the periplasm, therefore, it may be that the ‘target’ 
protein for Cj0425 is in fact a non-native cysteine protease like enzyme. 
 
4.3.5 The potential role of the cj0421c-cj0425 gene cluster in defence against the type 
VI secretion system 
The Gram-negative type VI secretion system (T6SS) is a recently discovered mechanism for 
directing effector toxins into the periplasm of a neighboring competitor cell (Ho et al., 2014).  
The topic is reviewed in greater detail in the introduction (Section 1.13).  The T6SS acts as an 
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export system for antibacterial toxins which are often active in the periplasm of other Gram-
negative bacteria.  These toxins can attack the prey cell in multiple ways, by degrading the cell 
membrane by lipase action or by pore forming toxins, degrading the cell peptidoglycan layer 
by amidase or muramidase action, or entering the cytoplasm and degrading prey DNA (Russell 
et al., 2014).  The bacteria which produce these T6SS toxins often produce antitoxins to defend 
against toxins from closely related species, one example is the VgrG3 protein from Vibrio 
cholerae which acts as both a structural component of the T6SS and as a peptidoglycan 
degrading muramidase. Immediately downstream of the vgrG3 gene is the gene tsaB which 
encodes an antitoxin that binds to and inhibits VgrG3 (Brooks et al., 2013).  The presence of 
these toxin-antitoxin systems allows bacteria to not only prevent accidental self-killing from 
their own toxins but also to defend against toxins from closely related strains.  After several 
trial and error experiments I managed to develop an assay to measure how sensitive different 
strains of C. jejuni are to the S. marcescens type VI secretion system.  The data presented in 
(Figure 50) shows that wild type C. jejuni is indeed killed by S. marcescens wild type DB10 and 
that this is dependent on a functional T6SS.  The data shown in (Figure 51-53) shows that 
different sub strains of C. jejuni differ in sensitivity to the S. marcescens T6SS.  The reason for 
this difference is unknown, it is known that different strains of Campylobacter possess 
different lipooligosaccharide structures and these can also be varied by phase variation or by 
external factors such as temperature shock (Semchenko et al., 2010, Gilbert et al., 2002).  The 
variation in the LOS structure between strains may contribute to the variation in sensitivity to 
the T6SS seen between C. jejuni strains.  It may also be due to differences in the composition 
of the periplasm or more simply due to differences in growth rate between the strains. 
 
The cj0422c, cj0423, cj0424, cj0425 and 3X gene deletion strains were also assayed for 
sensitivity to the S. marcescens type VI secretion system.  The hypothesis was that the Cj0425 
cystatin like protein may inhibit the action of one or more cysteine protease like 
endopeptidase enzymes exported into the C. jejuni periplasm by the T6SS.  The other proteins 
Cj0423 and Cj0424 may also inhibit or interact with other toxic effector proteins secreted by S. 
marcescens.  The hypothesis would predict that deletions in cj0425 would make the strain 
more sensitivity to the T6SS and that the cj0422c deletion (where Cj0425 is up-regulated) may 
lead to increased resistance to the T6SS.  However, the data shown in (Figure 50-53) does not 
agree with this.  The data appears to show no change in sensitivity between the wild type 
strains and the cj0422c, cj0423 or cj0424 mutant strains.  There does appear to be a slight 
increase in resistance observed in both the cj0425 and 3X deletion strains, however this is the 
opposite to what would be expected and is likely the result of random variation.  Since the 
type VI secretion system is widespread throughout Gram-negative bacteria (Russell et al., 
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2014), the data presented here does not disprove the potential role of Cj0425 acting as a 
peptidoglycan cysteine protease inhibitor.  This would need to be tested in-vitro before any 
conclusion about the possible role of Cj0425 is to be uncovered. 
 
This chapter sought to assign a role to the cj0421c-cj0425 gene cluster by analysis of mutant 
phenotypes, unfortunately no observable phenotype could be found.  The qRT-PCR data 
presented in this chapter implies that this 5 gene cluster is best thought of as an isolated 
cluster with little to no impact on genes elsewhere in the C. jejuni genome.  The lack of any 
observable effect on growth rate, antimicrobial sensitivity or chicken colonising ability does 
suggest that whatever role these genes play it is likely highly specific, possibly to a very 
particular environmental niche.  The fact that the cj0423-5 operon is repressed during normal 
growth implies that there should be some kind of activating signal.  In order to screen for 
potential ‘activation’ signals a lacZ reporter construct was generated to look for gene induction 























5 Chapter 5 – Screening for potential inducers of the cj0423-cj0425 operon 
 
5.1 Introduction 
The data presented in the previous chapter has so far failed to assign any role to the cj0421c-
cj0425 operon. qRT-PCR data from the cj0422c mutant strain has shown that the expression of 
the cj0423-5 operon is strongly repressed during growth under normal conditions (Figure 39), 
and that the expression of cj0423 is increase around by around 100-fold at the transcriptional 
level in the cj0422c mutant.  Data from previous work in the Kelly lab has shown that the 
Cj0422c protein binds to an 18bp palindromic repeat sequence located upstream of cj0423 
(Hitchcock, 2011) unpublished data.  This binding site is located slightly behind the -10 box 
within the promoter and so likely prevents RNA-polymerase from effectively transcribing the 
operon.  This implies that the role of Cj0422c is to repress the transcription of the cj0423-5 
operon and that some kind of stimulus leads to the operon being expressed, presumably by 
the release of Cj0422c from the promoter region.  Since there is currently no obvious role for 
the genes within the operon there is no obvious condition or chemical stimuli to test for gene 
induction.  I decided to begin screening a large range of physical and chemical conditions to 
see if any up-regulation of the operon could be observed. 
 
As a tool to screen multiple conditions I produced a series of plasmids using the E. coli lacZ 
gene as a reporter construct.  The expression of the lacZ gene can be quickly assayed using 
methods described in (Section 2.20) which are based on (Zhang and Bremer, 1995).  The lacZ 
gene was cloned downstream of the cj0422c and cj0423 promoter regions and inserted into 
the wild-type genome as a single copy at the cj0046 pseudogene locus used for 
complementation in C. jejuni.  The cj0423::lacZ construct also was tested by transforming the 
plasmid into the cj0422c mutant from the previous chapter, where a strong up-regulation 
should be observed. 
 
The aim of this chapter was to screen potential conditions for induction of the cj0423-5 
operon.  Initially, the lacZ reporter constructs were produced and tested to ensure that they 
functioned as expected.  Following successful construction of the reporter strains a series of 
antimicrobial compounds and various other membrane stressing compounds were tested for 
induction.  As a way of testing multiple compounds simultaneously a novel assay method was 
developed using the Biolog© Phenotype Microarray system.  These 96 well plates contain a 
range of compounds and are typically used to look for changes in cell growth rate when 
incubated with various different nutrient sources.  For this study the plates were used to look 
for potential inducers of the cj0423 operon. 
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5.2 Chapter 5 Results 
5.2.1 Construction of the lacZ reporter strains in C. jejuni 
 
The lacZ reporter constructs were generated using isothermal assembly cloning using methods 
described previously (Section 2.11).  The constructs were generated in the p46 






Figure 54: Generation of a lacZ reporter construct by Isothermal Assembly (ISA) cloning.  (A) the intergenic 
region between cj0422c and cj0423 was amplified using high fidelity Phusion polymerase.  The primers were 
designed to amplify up the promoter region just before the predicted RBS and contained 30bp adapter regions 
to allow for ISA cloning (Table 7).  (B) The promoter region was attached upstream of the lacZ gene (amplified 
from the pRS415 plasmid) by overlap extension PCR.  (C) the ISA reaction was performed using the same 
technique described in the ISA complementation protocol (Section 4.2.6).  (D) shows the fragments after 

















Figure 55: Plasmid maps of the lacZ reporter constructs.  (A) shows the empty pK46 plasmid.  (B) shows the 
standard lacZ reporter plasmid which contains the cj0423 promoter region upstream of the lacZ gene.  The 
promoter region is shown by the green arrow labelled pF.  (C) shows the the lacZ reporter construct again 
downstream of the cj0423 operon but using the pC46 vector with the chloramphenicol resistance marker.  (D) 
shows the lacZ reporter construct downstream of the cj0422c promoter (which is the same DNA fragment as 






Figure 56: Production of the lacZ reporter constructs in C. jejuni 11168-DJK.  The ISA vectors shown in (Figure 
55) were transformed into the cj0046 pseudogene locus of C. jejuni 11168.  (A) shows the gene arrangement of 
the lacZ pF pK46 strain containing the forward facing promoter region with a kanamycin resistance marker and 
the lacZ pR pC46 strain containing the reverse facing promoter region with a chloramphenicol resistance 
marker.  Successful transformation of the constructs was confirmed by the agarose gel shown in (B).  The lane 
number correspond with the arrows shown in (A).  Both bands are expected to be 725 bp in length.  
 
150 
5.2.2 Confirmation of the lacZ reporter strains 
Unless otherwise stated all the data presented for the lacZ reporter constructs is expressed in 
Miller units.  These are arbitrary units of ß-galactosidase expression which measures the 
amount of o-nitrophenol liberated from the lactose analog ortho-nitrophenyl-ß-galactoside by 
LacZ.  The o-nitrophenol strongly absorbs light at 420nm giving it a bright yellow colour.  The full 
assay is described in (Section 2.20) which is based on (Zhang and Bremer, 1995).  The 
absorbance at 420nm is calculated as relative to the absorbance at 600nm to give an estimation 
of lacZ expression per cell density.  The assay was altered slightly between testing different 
compounds and conditions; these variations are explained for each individual assay. 
 
As a start to the investigation three lacZ strains were tested for gene expression during a 
normal growth curve.  The cj0423::lacZ strain contains the lacZ gene under the cj0423 
promoter with a kanamycin resistance marker.  The cj0422::lacZ strain contains the lacZ gene 
under the control of the cj0422c promoter with a chloramphenicol resistance marker.  The 
∆cj0422c cj0423::lacZ strain contains the same construct as the cj0423::lacZ strain but was 
transformed into the cj0422c mutant strain.  This strain acted as a positive control strain where 
in theory the expression of lacZ under the cj0423 promoter should be strongly up-regulated 
when transformed into the cj0422c mutant strain.  The strains were grown overnight on blood 
agar plates under normal conditions and the cell material scraped off and diluted to a starting 
OD600nm of 0.05 in MHS broth with no selective antibiotics.  The cultures were incubated 
under standard conditions for 24 hours with measurements being take at 0, 2, 4, 6, 8 and 24 
hours.  The expression of lacZ was calculated at each time point and the data is shown in 
(Figure 57).  As a negative control a sample of wild type C. jejuni 11168-DJK was also tested for 
lacZ expression.  The 11168 genome does not contain a homologue of lacZ and there was no 
detectable change in the absorbance at 420nm (data not shown). 
 
The data presented in (Figure 57) shows that the expression from the cj0423 promoter is 
tightly repressed under normal conditions and can fluctuate between around 50-150 Miller 
units.  It also shows that the expression is at its lowest point during log phase growth.  The 
expression from the cj0422c promoter is comparatively quite high and fluctuates between 
200-300 Miller units.  This is consistent with the role of Cj0422c as a repressor protein as high 
expression will lead to stronger repression of the cj0423 promoter.  The expression of lacZ 
under the control of the cj0423 promoter when expressed in the cj0422c mutant is much 
higher and fluctuates between 2000 and up to 4000 Miller units.  Unless otherwise stated only 
the cj0423::lacZ  strain in the wild type background is used form this point onwards and all 




Figure 57: Expression of the lacZ reporter during normal growth.  The expression of the lacZ gene was 
measured at time points 0, 2, 4, 6, 8 and 24 over a 24-hour growth curve.  (A) shows the expression of the lacZ 
gene (expressed in Miller units) while under the control of the cj0423 promoter.  (B) shows the expression of 
the lacZ gene under the control of the cj0422c promoter.  (C) shows the expression of the lacZ gene under the 
control of the cj0423 promoter but expressed in the cj0422c mutant strain.  The error bars show the standard 
deviations from 3 separately grown replicates. 
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5.2.3 Assaying antimicrobial compounds for induction of the cj0423-5 operon 
Having confirmed that the lacZ reporter strains are functional and that the expression was up-
regulated as expected in the cj0422c mutant strain I began to test a series of antimicrobial 
compounds for possible up-regulation of the cj0423-5 operon in wild type cells.  These were 
chosen specifically to target different parts of the cell, including the cell wall, the cell 
membrane and protein synthesis.  The data shown in (Figure 58) shows the expresson of lacZ 
when cells were challenged with Ampicillin, Gentamycin, Erythromycin and the model CAMP 
Polymyxin-B; none of these antimicrobials produced an up-regulation of the lacZ strain.  The 
strain was also challenged with non-therapeutic antimicrobials including SDS, Taurocholic acid 
(a bile acid), 1,2-Benzisothiazole-3(2H)-one (BIT) and ethanol (Figure 60), again none of these 
produced any significant up-regulation in gene expression.  The expression of LacZ is 
apparently reduced in some of the data presented however since the operon is tightly 
repressed during normal growth this is likely due to the inhibitory effect of the antimicrobials 
being tested.  The LacZ expression (in Miller units) appears to increase with increasing SDS 
concentrations (Figure 59) however this is due to the cells being lysed rather than because of 


















Figure 58: Expression of the lacZ reporter when challenged with antibiotics.  The lacZ reporter strain was 
grown to a starting OD600nm of 0.5 and the antibiotics added.  The cultures were incubated for 6 hours with 
ampicillin and gentamycin (A and C respectively) or 4 hours with erythromycin and polymyxin-B (B and D 
respectively).  The concentration ranges are shown on the individual graphs.  The 0 concentrations were used 




Figure 59: Expression of the lacZ reporter when challenged with SDS and bile acid.  The lacZ reporter strain 
was grown to a starting OD600nm of 0.5 and the SDS and Taurocholic acid added.  (A) shows both the 
calculated Miller units and the OD600nm values for the reporter strain when challenged with SDS.  The error 
bars show the standard deviations from 3 biological replicates.  (B) shows the gene expression in response to 








Figure 60: Expression of the lacZ reporter when challenged with BIT and ethanol.  The lacZ reporter strain 
was grown to a starting OD600nm of 0.5 and the 1,2-Benzisothiazole-3(2H)-one (BIT) and Ethanol added.  (A) 
shows the expression in Miller units at 15 and 60 minutes post challenge with BIT.  The data is from single 
replicates of at each concentration.  (B) shows the expression in Miller units at 1 hour and 2 hours post 
challenge with ethanol.  The error bars show the standard deviations form 2 biological replicates. 
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5.2.4 Assaying sera and peptidoglycan fragments for induction of the cj0423-5 operon  
Since none of the antimicrobials tested for induction have produced a detectable up-
regulation I decided to test some other compounds and conditions which C. jejuni may 
encounter during chicken colonisation or during the human infection cycle.  C. jejuni has been 
shown to be sensitive to human serum in-vitro (Pennie et al., 1986) and it was thought the 
cj0423-5 operon may help provide resistance.  Both human and chicken sera were purchased 
from Sigma-Aldrich and tested as potential inducers of the operon.  Since sera is quite opaque 
and may interfere with the OD600nm readings the cultures were incubated with sera and at the 
appropriate time points 1 ml of culture was quickly centrifuged and re-suspended in an equal 
volume of MHS broth prior to the OD600nm reading being taken.  The data is shown in (Figure 
61) and shows no significant change in LacZ expression. 
 
As discussed in the previous chapter (Section 4.2.14) Cj0425 may act as an inhibitor of 
peptidoglycan degrading or modification enzymes.  In order to test whether degradation of 
peptidoglycan induces the cj0423-5 operon, 3 peptidoglycan specific non proteinogenic amino 
acids D-Alanine, D-Glutamic acid and diaminopimelic acid (mDAP) were tested as potential 
inducers of the operon.  The data is shown in (Figure 61) and while there is a slight increase in 












Figure 61: Expression of the lacZ reporter when challenged with sera and peptidoglycan derived amino 
acids.  The lacZ reporter strain was grown to a starting OD600nm of 0.5 and the sera and peptidoglycan 
fragments added.  (A) shows the expression in Miller units at 30 and 60 minutes’ post challenge with both 
human and chicken sera.  The error bars show the standard deviation from 2 biological replicates.  (B) shows 
the expression in Miller units at 2 hours post incubation with 10 mM of D-alanine, D-glutamic acid and 




5.2.5 Assaying environmental stress conditions for induction of the cj0423-5 operon 
As well as antimicrobial compounds Campylobacter will likely encounter non-specific stress 
conditions such as oxidative stress, osmotic stress, variations in pH and temperature changes.  
Oxidative stress was tested as a potential inducer by mixing the reporter strain with hydrogen 
peroxide and by transferring the reporter strain to increasing atmospheric oxygen 
concentrations (substituted with nitrogen), the data is shown in (Figure 62).  No biologically 
significant increases in LacZ expression was observed when the reporter strain was incubated 
with hydrogen peroxide and only minor changes were observed when incubated under 
different atmospheric oxygen conditions. 
 
Both positive and negative osmotic shock were tested as potential inducers for the cj0423-5 
operon.  For positive osmotic shock the reporter strain was cultured under normal conditions 
in MHS broth with increasing concentrations of NaCl.  To test for potential induction under 
negative osmotic stress the reporter strain was centrifuged and re-suspended in pre-
equilibrated sterile distilled water (SDW) with increasing NaCl concentrations, the data is 
shown in (Figure 63).  Neither positive nor negative osmotic shock produced a biologically 
significant increase in LacZ expression. 
 
Changes in pH were tested as a potential inducer of the cj0423-5 operon, the reporter strain 
was centrifuged and re-suspended in MHS broth containing either 100 mM MES or TRIS 
buffers which had been adjusted to a range of acidic and basic pH.  The data is shown in 
(Figure 64) and shows no biologically significant increase in LacZ expression between the pH 
values.  The pH of each media was also tested after the experiment to ensure the pH had not 
altered during the experiment. 
 
Temperature shock was tested as a potential inducer of the cj0423-5 operon.  This was tested 
because the Cj0422c protein is unstable when chilled to below 20°C, this is discussed further in 
Chapter 6.  Because the Cj0422c regulatory protein is unstable at low temperatures it was 
thought that a sudden drop in temperature may cause the protein to become unbound from 
the cj0423 promoter region and therefore allow for increased expression of the cj0423-5 
operon.  The reporter strain was grown under normal conditions and then transferred to a 
range of temperature incubators, the data is shown in (Figure 65) and shows no biologically 








Figure 62: Expression of the lacZ reporter when challenged with H2O2 and atmospheric oxygen.  The lacZ 
reporter strain was grown to a starting OD600nm of 0.5 and mixed with hydrogen peroxide or incubated in 
varying atmospheric conditions.  (A) shows the expression in Miller units at 15 and 60 minutes’ post challenge 
with hydrogen peroxide.  The error bars show the standard deviation from 3 biological replicates.  (B) shows 
the expression in Miller units at 0 and 2 hours post incubation at different oxygen concentrations.  The error 




Figure 63: Expression of the lacZ reporter when challenged by positive and negative osmotic shock.  The lacZ 
reporter strain was grown to a starting OD600nm of 0.5 and mixed with varying salt concentrations.  (A) shows 
the expression in Miller units at 15 and 60 minutes’ post challenge with increasing salt concentrations.  The 
error bars show the standard deviation from 3 biological replicates.  (B) shows the expression in Miller units at 
15 and 60 minutes’ post challenge with decreasing salt concentrations.  The cells were cultured in MHS media 
and briefly centrifuged and re-suspended in sterile distilled water that had been pre-equilibrated to normal 
















Figure 64: Expression of the lacZ reporter when challenged by acidic and basic pH.  The lacZ reporter strain 
was grown to a starting OD600nm of 0.5 and briefly centrifuged and re-suspended in fresh MHS media with 
either 100 mM MES (2-(N-morpholino)ethanesulfonic acid) for acidic pH adjustment or 100 mM TRIS 
(Tris(hydroxymethyl)aminomethane) for basic pH adjustment.  The medias were adjusted to the correct pH 
with 1 M of HCl or NaOH.  The data shows the expression in Miller units at 1 hour and 2 hours’ post incubation 




Figure 65: Expression of the lacZ reporter when challenged by temperature change.  The lacZ reporter strain 
was grown to a starting OD600nm of 0.5 and incubated at various temperatures.  (A) shows the expression in 
Miller units at 30, 60 and 120 minutes’ post incubation at varying temperatures.  The error bars show the 
standard deviation from 2 biological replicates.  (B) shows the expression in Miller units at 15 and 30 minutes’ 
post incubation at -20°C, 45°C and 50°C which would likely lead to quick cell death.  The error bars show the 




5.2.6 High throughput screening of the lacZ reporter strain using the Biolog Phenotype 
Microarray system 
The induction assays up to this point have failed to identify a condition or compound that 
causes the up-regulation of the cj0423 operon. So far the Miller assays used to screen for 
potential inducers have focused on one individual compound or condition at a time.  In order 
to screen multiple compounds at once it was decided to utilise the phenotype microarray 
system from BiologTM to screen for potential inducers of the cj0423 operon.  The phenotype 
microarray system is based on a series of commercially available 96 well plates where each 
well contains a different compound such as different Carbon, Nitrogen or Sulphur sources.  
Typically, the phenotype microarray plates are used to screen strains of bacteria for changes in 
metabolism, an example of this in Campylobacter is a 2010 publication where the authors used 
the carbon source phenotype microarray plates to look for changes in amino acid utilization in 
response to temperature variation (Line et al., 2010). 
 
10 phenotype microarray plates (PM1-PM10) were used to screen up to 950 different 
compounds (some plates contain duplications) for induction of the cj0423 promoter.  The 
reporter strain was cultured in the modified MCLMAN minimal media system (Section 2.6.1), 
this was done to ensure that any up-regulation is the result of the individual compound being 
tested.  All the phenotype microarray assays were performed using the methods described in 
(Section 2.20.1). The compounds in each of the phenotype microarray plates are listed in the 
appendix (Section 8.2), the data is also available at (http://www.biolog.com/pdf/pm_lit/PM1-
PM10.pdf), at the time of writing.  The data is shown in (Figure 66-69) and shows the 
expression (in Miller units) for each individual well.  The data shows a reasonably large degree 
of variation in the expression of each well.  None of the individual compounds produced a 
strong (>5 fold) up-regulation of LacZ so the assay has not definitively shown any single 
compound to be the ‘inducer’ for the cj0423-5 operon.  
 
In order to calculate a fold change in expression, the average expression of all the wells 
(excluding the blank well) for each individual plate was calculated.  The difference between 
each individual well and the plate average was then calculated and expressed as a fold change 
in expression.  This method of determining the fold change is reasonably conservative but the 
Biolog plates only contain a single negative well which must be used as a blank for measuring 
the OD600nm and OD420nm.  This means that there are no reference values to use as a negative 
control, so it is assumed that the total average value for each individual plate is close enough 
to the theoretical un-induced control to act as a reference, a >2-fold cutoff was considered 
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significant enough to warrant further analysis.  The average Miller unit values for each plate 
are listed in the figure legends. 
 
In total 14 individual wells out of 950 showed a >2-fold change in expression compared to the 
individual plate average, these represented with black stars on the individual bars in (Figure 
66-69) and are listed in (Table 16).  It should be noted that the largest increase in expression is 
3.94-fold (plate PM4 well C10) which is not a large increase and is considerably less than the 
50-fold increase in LacZ expression seen in the cj0422c mutant (Figure 57).  Out of the 14 
individual wells which showed as >2-fold increase, 6 contained compounds which are 
duplicated in other wells and did not produce a >2- fold increase in expression (the fold 
changes in the duplicated wells are listed in (Table 16).  These 6 wells were discounted as they 























Figure 66: Expression of the lacZ reporter when cultured on different carbon sources.  The lacZ reporter 
strain was grown to a starting OD600nm of 0.9 and re-suspended in the MCLMAN minimal media to an 
OD600nm of 0.4 and incubated for 2 hours under normal conditions.  The cultures were then transferred to the 
individual wells of the phenotype microarray plates and incubated for 2 hours under standard conditions with 
gentle shaking.  (A and B) show the expression in Miller units for the wells in the PM1 and PM2 respectively 
which both contain various carbon sources (the PM1 plate average is 102.93 Miller units) (the PM2A plate 




Figure 67: Expression of the lacZ reporter when cultured on nitrogen, phosphorus and sulphur sources.  The 
lacZ reporter strain was grown to a starting OD600nm of 0.9 and re-suspended in the MCLMAN minimal media 
to an OD600nm of 0.4 and incubated for 2 hours under normal conditions.  The cultures were then transferred 
to the individual wells of the phenotype microarray plates and incubated for 2 hours under standard 
conditions with gentle shaking.  (A) shows the expression in Miller units for the wells in the PM3 plate which 
contains various nitrogen sources (the PM3 plate average is 114.89 Miller units).  (B) shows the expression in 
Miller units for the wells in the PM4 plate which contains phosphorus and sulphur sources (the PM4 plate 
average is 130.98 Miller units).  (C) shows the expression in Miller Units for the wells in the PM5 plate which 
contains a range of standard nutritional supplements (the PM5 plate average is 97.39 Miller units).  Stars 
represent individual wells with a >2-fold increase in LacZ expression. 
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Figure 68: Expression of the lacZ reporter when cultured on di/tri peptides.  The lacZ reporter strain was 
grown to a starting OD600nm of 0.9 and re-suspended in the MCLMAN minimal media to an OD600nm of 0.4 
and incubated for 2 hours under normal conditions.  The cultures were then transferred to the individual wells 
of the phenotype microarray plates and incubated for 2 hours under standard conditions with gentle shaking.  
(A, B and C) all show the expression in Miller units for the wells in the PM6, 7 and 8 plates respectively, all of 
which contain various di and tri peptides (the PM6 plate average is 83.72 Miller units) (the PM7 plate average 




Figure 69: Expression of the lacZ reporter when cultured on different osmolytes and pH sources.  The lacZ 
reporter strain was grown to a starting OD600nm of 0.9 and re-suspended in the MCLMAN minimal media to an 
OD600nm of 0.4 and incubated for 2 hours under normal conditions.  The cultures were then transferred to the 
individual wells of the phenotype microarray plates and incubated for 2 hours under standard conditions with 
gentle shaking.  (A) shows the expression in Miller units for the wells in the PM9 plate which contains various 
osmolytes (the PM9 plate average is 117.5 Miller units).  (B) shows the expression in Miller units for the wells 
in the PM10 plate which contains different buffering systems set to a variety of pH values (the PM10 plate 
average is 83.96 Miller units).  Stars represent individual wells with a >2-fold increase in LacZ expression. 
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PM1 / A9 2.85 D-Alanine Also found in PM3-C3 (1.13 fold) and PM5-D6 (1.19 fold) 
PM1 / H7 2.07 Glucuronamide Also found in PM3-E6 (0.81 fold) 
PM2 / D10 2.03 𝛾-Amino Butyric Acid   
PM3 / A2 2.17 Ammonia  
PM3 / D3 2.68 L-Pyroglutamic Acid Also found in PM2-H3 (0.9 fold) 
PM3 / D8 2.22 Ethylamine  
PM3 / E2 2.01 ß-Phenylethyl-amine  
PM4 / B9 2.08 Guanosine 3’-monophosphate  
PM4 / C2 2.30 Phospho-Glycolic Acid  
PM4 / C10 3.94 Cytidine-5’-monophosphate  
PM4 / F4 2.10 Tetrathionate  
PM9 / E7 2.38 Urea (2%) Also found in PM3-A5 (0.82 fold) and in PM9 wells E8-
E12 (3%, 4%, 5%, 6%, 7% respectively) (1.3, 1.53, 1.42, 
0.98, 1.2 fold respectively). 
PM9 G10 2.18 Ammonium Sulfate pH8 (20 mM) Found in PM9 wells G9-G12 (10, 20, 50, 100 mM 
respectively) (1.48, 2.18, 2.2, 1.94 fold respectively) 
PM9 G11 2.20 Ammonium Sulfate pH8 (50 mM) Found in PM9 wells G9-G12 (10, 20, 50, 100 mM 





In total 8 of the compounds from the phenotype microarray plate produced a >2-fold increase 
in LacZ expression (after discounting those which were duplicated elsewhere).  These 8 
compounds (𝛾-Amino Butyric Acid, Ammonia, Ethylamine, ß-Phenylethyl-amine, Guanosine 3’-
monophosphate, Phospho-Glycolic Acid, Cytidine-5’-monophosphate and Tetrathionate) are 







Table 16: Individual compounds producing a >2-fold increase in LacZ expression.  14 separate wells from the 
Biolog phenotype microarray plates showed a greater that >2-fold increase in LacZ expression.  The Individual 
wells are highlighted by black stars in (Figures 66-69) and the fold changes are listed here.  The table shows 
the plate and well numbers as well as the fold change in Miller units and the individual compounds.  The table 




5.2.8 Screening for the up-regulation of the cj0423-5 operon when cj0423 is artificially 
up-regulated 
The phenotype microarray screening system failed to identify a particular compound or 
condition that would ‘activate’ the cj0423-5 operon.  Since so many external compounds and 
conditions have been assayed as potential inducers of the operon I decided to examine the 
possibility that the induction signal may be the presence of the Cj0423 protein itself.  The inner 
membrane spanning Cj0423 is potentially a holin like protein and it may be that up-regulation 
of Cj0423 may be detrimental to the cell.  While the previous chapter has established there are 
no growth defects in the cj0422c mutant strain (where cj0423 is up-regulated) it may still be 
that up-regulation of Cj0423 is detrimental to the cell in non-laboratory conditions.  As 
discussed in (Section 3.3.2) the holing-like proteins are also the only family of proteins found in 
all C. jejuni strains that have this operon structure thereby indicating that their role may be 
essential to the role of the operon as a whole. 
 
In order to test this hypothesis a complementation construct was produced where cj0423 was 
under the control of the iron inducible fdxA promoter.  This construct was produced using the 
same methods as a normal complementation as described in (Section 4.2.6).  This construct 
was transformed into wild type C. jejuni 11168 and the gene induced with 50 µM ammonium 
Iron (II) sulphate.  As a negative control the expression of the fdxA promoter was repressed by 
the addition of 20 µM desferrioxamine-B (DES).  The expression of both cj0423 and cj0424 was 
measured by qRT-PCR, the data is shown in (Figure 71).  Unfortunately, the expression of 
cj0423 was not significantly different between the iron-limited (DES) and iron-induced (Fe(II)) 
conditions.  This may be due to the high levels of iron in the MHS media or some other 
compound interfering with DES and it would be worth repeating the experiment using an iron-
limited minimal media.  Because there was no significant increase in cj0423 expression the 













5.2.9 Construction of the iron inducible cj0423::fdxA construct in 11168 
Figure 70: Construction and screening of the iron-inducible cj0423+ strain.  (A) the plasmid map of the 
pCFdxA46::cj0423 construct generated by ISA cloning.  The FdxA promoter is represented by the green arrow 
upstream of the cj0423 ORF.  (B) The gene arrangement in the ISA construct prior to transformation into wild 
type C. jejuni 11168-DJK.  (C) following transformation the strain was screened by PCR using the cj0046 

























Figure 71: qRT-PCR analysis of cj0423 and cj0424 gene expression in the cj0423-fdxA construct.  6 
biological replicates of the cj0423-fdxA+ strain were grown to an OD600nm of 0.4, 20 µM 
desferrioxamine-B (DES) was added to 3 and 50 µM ammonium iron (II) sulphate (Fe(II)) was added to 
3.  The cultures were incubated under normal conditions for 1 hour prior to RNA extractions.  Whole 
cell RNA was extracted and matched to 10 ng µl-1 in nuclease free water (Section 2.15).  qRT-PCR 
reactions were performed according to the methods described in (Section 2.15.1), the gyrA gene was 
used as an internal control.  The data is expressed as a fold change in cj0423 and cj0424 gene 
expression between the two conditions.  The data shows no significant changes in expression between 




5.3 Chapter 5 Discussion 
The aim of this chapter was to produce a reporter strain of C. jejuni to screen for potential 
inducers of the cj0423-5 operon using a lacZ reporter strain.  Unfortunately, no such potential 
inducer was found to strongly up-regulate the cj0423 promoter.  The lacZ reporter strain was 
shown to be a viable method for screening different conditions as the cj0422c mutant control 
strain showed strong up-regulation and to the best of the authors knowledge this is the first 
time the Biolog phenotype microarray system has been used as a high throughput screening 
method using a reporter strain in this way. 
 
5.3.1 Construction of the lacZ reporter strain using the cj0046 complementation 
system 
There are numerous examples in the literature of lacZ reporter strains being used in bacteria 
to test for changes in gene regulation, there are also some examples of using the system in 
Campylobacter species (Van Vliet et al., 2001, Bayliss et al., 2012).  The data shown in (Figure 
57) shows that when the reporter construct is transformed into wild type 11168 the 
expression is relatively low which is consistent with the qRT-PCR data from Chapter 4.  The 
transformation of the reporter strain into the cj0422c mutant acted as a positive control to 
show that the reporter strain is able to successfully mimic the regulation of the cj0423 
promoter.  The very high level of lacZ expression seen in the cj0422c mutant strain (3000-4000 
Miller units) does imply that the cj0423 promoter sequence is a strong promoter when not 
repressed, which may have some use to overexpress other genes in C. jejuni should a very high 
expression be required.  As an example the expression of the T7 promoter used for 
recombinant protein expression in E. coli can go up to 50,000 Miller units when expressed 
using the pET vector system (though that is when expressed from multiple plasmid promoters) 
(Chao et al., 2001).  The qRT-PCR data shown in the previous chapter showed the expression of 
cj0423 is up-regulated around 100-fold at the RNA level in the cj0422c mutant (Figure 39).  The 
data presented here shows that translates to an approximately 50-fold increase at the protein 
level.  
 
5.3.2 Screening therapeutic antimicrobial compounds using the lacZ reporter system 
A series of commonly used antimicrobials were screened as potential inducers of the cj0423-5 
operon.  The data shown in (Figure 58) screened a range of standard antibiotics as inducers.  
These included the model CAMP polymyxin-B and erythromycin which is commonly used to 
treat Campylobacter infections (Anders et al., 1982).  Polymyxin-B was tested as it is a cationic 
antimicrobial peptide and though it has been tested for induction before in Chapter 3 (Figures 
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22-23), it was decided to re-test it as part of this chapter.  The macrolide antibiotic 
erythromycin was tested as there is some evidence in the literature that erythromycin may 
cause the up-regulation of Cj0425.  A study from 2013 showed that the expression of cj0425 
may be up-regulated in response to erythromycin (Xia et al., 2013).  These results should be 
treated with some caution as the increased expression was only detected by microarray 
analysis and could not be replicated with qRT-PCR.  The data presented in (Figure 58) shows 
that there is no up-regulation of the cj0423-5 operon in response to erythromycin, though it is 
worth noting that the paper only mentioned cj0425 as being up-regulated not the whole 
operon. 
 
5.3.3 Screening non-therapeutic antimicrobial compounds using the lacZ reporter 
system 
In addition to screening antibiotics which can be used as treatments for induction I decided to 
screen a series of non-therapeutic antimicrobials for potential induction of the cj0423-5 
operon.  The membrane targeting anionic surfactant compound sodium dodecyl sulfate was 
tested as a potential inducer as it non-specifically disrupts the outer membrane at low 
concentrations.  The data shown in (Figure 59) does show an apparent up-regulation of LacZ in 
response to higher concentrations of SDS, however this is because the SDS is rapidly lysing the 
cells and due to the way the Miller units are calculated this artificially increases the apparent 
level of expression when in fact the expression of LacZ has not changed. 
 
The bile acid (taurocholic acid) was also tested as C. jejuni is likely to encounter bile acids 
following ingestion.  The bacteriostatic antimicrobial 1,2-Benzisothiazole-3(2H)-one (BIT) and 
ethanol were also tested as potential inducers.  BIT is an isothiazole based antimicrobial which 
can transverse the membrane layers of Gram-negative bacteria and targets free thiol groups 
thereby inhibiting growth (Diehl and Chapman, 1999).  Ethanol and other organic solvents non-
specifically permeable the membranes of Gram-negative bacteria thereby causing cell death 
(Heipieper and De Bont, 1994).  The data presented in (Figure 59-60) shows no significant 
change in gene regulation in the lacZ reporter strain when challenged with SDS, taurocholic 
acid, BIT or ethanol. 
 
5.3.4 Screening Human and Chicken sera and peptidoglycan fragments using the lacZ 
reporter system 
Blood sera contains components of the innate and adaptive immune system in higher 
organisms, as part of an infection cycle C. jejuni may encounter blood sera and potentially 
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need to resist components of the immune system.  Human serum has been shown to be 
bactericidal in-vitro at 10% final concentration (Pennie et al., 1986) and since C. jejuni is known 
as a coloniser of chickens, chicken serum was also tested.  The data is shown in (Figure 61) and 
does not show any significant change in LacZ expression. 
 
As discussed in Chapter 4 the crystal structure of Cj0425 has revealed it to share structural 
homology with a class of cysteine protease inhibitors known as cystatins.  Since cysteine 
protease enzymes are structurally similar to some peptidoglycan hydrolase enzymes (Section 
4.1).  I decided to use a mixture of peptidoglycan fragments as potential inducers of the 
cj0423-5 operon, only the non-proteinogenic amino acids found in gram negative 
peptidoglycan were used for this assay (Park and Uehara, 2008).  D-Alanine, D-Glutamic acid 
and diaminopimelic acid (mDAP) were mixed together and mixed with the LacZ reporter strain 
to a final concentration of 10 mM each.  The data is shown in (Figure 61) and shows a very 
slight increase in expression but since it is less that 2-fold it is not considered biologically 
significant. 
 
5.3.5 Screening oxidative stress, osmotic stress, pH and temperature changes using the 
lacZ reporter system 
The chicken colonisation data presented in Chapter 4 strongly suggests that the cj0423-5 
operon is not required for survival in the chicken digestive tract (Figure 47).  Because C. jejuni 
will at some point have to survive outside the chicken gut in order to re-colonise another bird 
or cause infection it will probably need to cope with atmospheric oxygen levels, osmotic stress 
and sudden changes in pH and temperature.  The response of C. jejuni to all of these 
environmental stress conditions has been previously studied in a range of publications, some 
of which have focused on the transcriptomic response of C. jejuni to these conditions (Palyada 
et al., 2009, Cameron et al., 2012, Reid et al., 2008, Stintzi, 2002).  None of these publications 
showed any notable change in the expression of cj0421c-cj0425 in response to the stress 
conditions tested.  The data presented in (Figures 62-65) agrees with this as no significant 








5.3.6 High throughput screening of compounds using phenotype microarray plates 
with the lacZ reporter system 
The phenotype microarrayTM (Biolog) system is a screening system designed to screen for 
changes in metabolic profiles between strains.  The system uses 96 well plates containing a 
variety of potential metabolites.  When used for analysing microbial strains the cells are 
cultured with a buffer containing a tetrazolium dye which when reduced absorbs at 590nm and 
can be quantified.  The production of NADH during normal cellular metabolism causes the 
irreversible reduction of the tetrazolium dye, so a signal can only be detected when the cell is 
respiring.  Various metabolites can be screened using the phenotype microarray plates to 
generate a metabolic profile of an organism (Bochner et al., 2001).  For this study the process 
was adapted so that the plates could be used to screen up to 950 different compounds for 
induction of the lacZ reporter strain.  To the best of our knowledge this is the first time the 
phenotype microarray system has been used in this way.  The lists of phenotype microarray 
plates used are listed in (Section 8.2).  The data for all 10 plates used is shown in (Figures 66-
69), unfortunately there does not appear to be any particular compound that strongly up-
regulates the operon.  Some of the individual wells did show a slight increase in LacZ 
expression however upon closer examination many of these compounds produced at most 
only a 2-3-fold increase in LacZ expression.  Since the ‘activated’ operon has been shown to be 
up-regulated 50-fold (Figure 57), a 2-3-fold increase is not considered biologically significant, 
especially since this is a high throuphput screen with only one replicate per well.  Many of the 
wells also contained compounds which produced a colour change in the media and as such 
produced anomalous results.  These wells were listed during the experiment and this was 
taken into account when analysing the data.  The well which showed the highest increase in 
LacZ expression is shown in (Figure 67), plate PM4, well C-10 which contains cytidine-5’-
monophosphate, was measured at 517 Miller units compared to the plate average of 130.  This 
approximate 4-fold increase is still far short of the 50-fold increase seen in the cj0422c mutant 
strain though it may be worth re-evaluating this compound in the future.  The full list of the 
compounds tested in each individual plate can be found at 










5.3.7 Attempted artificial overexpression of cj0423  
Because no apparent chemical or physical inducer of the cj0423-5 operon has yet been found I 
decided to examine the possibility that the inducer may in fact be the inner membrane 
spanning Cj0423 protein itself.  As discussed in (Section 3.3.2) Cj0423 may act as a holin like 
protein, though overexpression of cj0423 in the cj0422c mutant does not cause any apparent 
growth defect (Figure 40,) it may still be detrimental to the cell outside of laboratory 
conditions.  My hypothesis was that the expression of cj0423 is tightly regulated by Cj0422c 
and that the operon is either repressed or de-repressed to maintain some kind of equilibrium 
of Cj0423 in the inner membrane.  In order to test this, I constructed a vector which placed 
cj0423 under the control of the iron inducible fdxA promoter.  Unfortuately as the data in 
(Figure 71) shows this construct did not successfully up-regulate the expression of cj0423 and 
so I can draw no firm conclusions about the hypothesis either way.  It may be worth re-
producing the vector where cj0423 is under a stronger promoter region or possibly repeating 
the experiment in a minimal media setting where the concentration of iron can be better 
controlled. 
 
This chapter aimed to elucidate the inducing compound or condition which causes an up-
regulation of the cj0423-5 operon.  Unfortunately, despite extensive testing no compound or 
condition has been found.  Since there is still no assigned function to the operon as a whole It 
was decided to continue with biochemical and structural analysis of the individual proteins 
within the operon.  It was hoped that by assigning functions to some of the proteins within the 
















6 Chapter 6 – Biochemical and structural characterisation of Cj0421c, Cj0422c and 
Cj0425 
 
6.1 Chapter 6 Introduction 
Thus far the role of the cj0421c-cj0425 gene cluster has remained elusive.  The data presented 
in chapters 4 and 5 has not revealed any potential role for the cluster even after extensive 
screening of potential inducer compounds and conditions in chapter 5.  While there is no 
coherent hypothesis about the role of the gene cluster as a whole, the individual proteins do 
have some characterised functions.  It is assumed that the roles of Cj0421c and Cj0422c are 
linked as they appear in an operon together in strain NCTC 11168 and are nearly always found 
together in other strains (Figure 11).  The role of Cj0422c as a master regulator has been well 
characterised by both previous work and by the data presented in chapters 3, 4 and 5.  The 
role of Cj0421c is assumed to be as a sensor protein, though deletion of the gene produces no 
detectable change in expression of the operon, the current hypothesis is that Cj0421c interacts 
with Cj0422c to de-repress the operon upon receiving a currently unknown stimulus.   
 
The crystal structure of Cj0425 has been solved by Halah Al-Haideri in collaboration with Dr 
John Rafferty.  The Cj0425 protein is exported to the C. jejuni periplasm and contains a single 
disulfide bond.  The structure revealed that Cj0425 is similar at the structural level to a class of 
proteins known as cystatins.  These proteins act as cysteine protease inhibitors and are widely 
distributed in eukaryotes but are not well studied in bacteria, largely due to a lack of sequence 
homology between bacterial cystatins and their eukaryotic counterparts (Kordiš et al., 2009).  
Phylogenetic analysis of cj0425 distribution has not revealed any potential binding partners 
within the C. jejuni 11168 genome.  This analysis was performed by Dr Roy Chaudhuri where 
4699 publicly available C. jejuni genomes were examined to see if any other c. jejuni genes 
correlate with the presence or absence of cj0425 (Data not shown).  Cj0425 has been shown by 
a previous student (Al-Haideri, 2015) to inhibit the cysteine protease papain in-vitro but the 
data was inconclusive about how strong this effect was. 
 
The aim of this chapter was to clone, overexpress and purify Cj0421c, Cj0422c and Cj0425 to 
try and assign specific roles to the proteins.  Attempts were made to crystalise both Cj0421c 
and Cj0422c to try and determine the structure of both proteins.  The role of Cj0421c as a 
sensor protein was tested by screening potential binding ligands for Cj0421c using the high 
throughput thermal shift (thermofluor) assay.  The potential for Cj0421c and Cj0422c to 
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interact with each other was also tested by protein crosslinking experiments.  While previous 
work has shown that Cj0425 inhibits the cysteine protease papain, the inhibition is weak and 
the data is inconclusive about how effectively Cj0425 is able to inhibit papain.  These 
experiments were repeated and since Cj0425 only weakly inhibits papain another cysteine 
protease cathepsin-B was also tested.  Cathepsin-B is a commercially available cysteine 
protease that is structurally similar to papain and is found in humans, so it may be a more 


















































Figure 73: Plasmid maps of the cj0421c, cj0422c and cj0425 overexpression plasmids.  All plasmids shown 
were produced using restriction enzyme cloning methods described in (Section 2.10.6).  (A) and (B) show 
the overexpression constructs for the C-terminal of cj0421c and cj0422c respectively.  Both were cloned 
into pET28a which contains a kanamycin resistance marker.  (C) shows the overexpression construct for 
cj0425 in pET22b which contains the pelB leader sequence and an ampicillin resistance marker.  The T7 
promoter is represented by the green arrow in all 3 maps.  All constructs were confirmed by DNA 




6.2.2 Overexpression and purification of the C-terminal of Cj0421c 
The pET28cj0421c::Kan plasmid was transformed into the E. coli strain Bl21-(DE3), a series of 
overexpression trials were performed to determine the best condition to use for high protein 
expression (data not shown).  The Cj0421c overexpression strain was grown to an OD600nm of 
0.6 in LB broth containing 50 µg ml-1 kanamycin and induced with 0.5 mM IPTG.  The cultures 
were incubated at 37°C for 3 hours and harvested by centrifugation.  The cell free extract was 
extracted from the pellets using methods described in (Section 2.26.3).  The resuspension 
buffer contained 20 mM sodium Phosphate buffer pH 7.4 with 20 mM imidazole and 500 mM 
sodium chloride.  The protein was separated from the cell free extract using a His-Trap 
chromatography column where the imidazole concentration was steadily increased from 20-
500 mM.  The overexpression and His-trap purification of Cj0421c is shown in (Figure 74).  The 
gel filtration and mass spectrometry analysis of Cj0421 is shown in (Figure 75).  The gel 
filtration was initially performed by Dr Dr Svetlana Sedelnikova and the protein elutes from the 
column as a monomer (data not shown).  All chromatography steps were performed using an 
AKTA Prime Plus chromatography system with the associated columns and buffering systems.  
The protein was then concentrated using 10 kDa cutoff concentration columns (GE Life 
Sciences).  The purified protein was analysed by mass spectrometry and was shown to have a 
molecular weight of 17136.84 Da which is consistent with the predicted molecular weight of 
the protein without the starting methionine (17136.6 Da).  The protein has a predicted 







































Figure 75: Gel filtration and mass spectrometry analysis of Cj0421c.  (A) shows UV spectroscopy traces from 
the gel filtration of the C-terminal of Cj0421c.  The blue line represents the Abs280nm and the red line shows the 
conductivity.  The Cj0421c peak is labelled, the fractions containing the protein were collected and mixed.  (B) 
shows a 14% SDS-PAGE gel loaded with the mixed fractions from (A).  (C) shows the mass spectrometry trace of 




6.2.3 Screening Cj0421c for potential ligands using thermofluor 
Since no information about the role of Cj0421c is available I decided to screen for potential 
ligand binding partners.  The C-terminal of Cj0421c shows no strong homology to any known 
family of proteins (there is some homology to diguanylate cyclase proteins but as discussed in 
(Section 4.1) Cj0421c is probably not one of these).  As such there are no obvious ligands to 
screen for so a range of metal ions were tested as well as polymyxin-B, EDTA and cyclic-di-
GMP.  Polymyxin-B was tested as this experiment was performed when it was thought that 
Cj0421c was involved in resistance to cationic antimicrobial peptides.  EDTA was tested as it 
was thought that the protein may already be bound to an unknown metal ion.  Cyclic-di-GMP 
was tested to show that Cj0421c is probably not a c-di-GMP diguanylate cyclase.  The 
thermofluor screen is a method of comparing the thermal denaturation profile of proteins 
when bound or unbound to ligands (Niesen et al., 2007).  The theory is that if a protein is 
bound to a ligand then it is more stable and thus will denature at a higher temperature.  The 
thermofluor method allows for high throughput screening of potential ligands and binding 
partners for proteins.  The full method is described in (Section 2.28).  The thermofluor data 
was analysed using publicly available Microsoft excel and graphpad files produced to analyse 
the raw data, which are available at (ftp://ftp.sgc.ox.ac.uk/pub/biophysics).  The data is shown 
in (Figure 76) and shows no increase in the thermal stability of Cj0421c when assayed with any 
of the compounds.  The thermal melt curve for Zinc, and to a lesser extent Copper and Cobalt 
ions caused a negative shift in thermal stability, possibly due these metals denaturing the 













6.2.4 Attempted crystalisation of Cj0421c 
Because no role could be assigned to Cj0421c attempts were made to crystalise the protein.  
The protein was concentrated to approximately 10 mg ml-1 and was screened for crystalisation 
in the PACT, JCSG+, Ammonium Sulphate, Proplex, MPD and classic crystal screens (Qiagen).  
Microdrops of 200 nl protein and 200 nl precipitant were set up in sitting drop vapour diffusion 
trials using a Matrix Hydra II Plus One crystalisation robot in collaboration with Dr John 
Rafferty and Rachel Plumb.  Unfortunately, no crystals grew in any of the conditions tested, it 
may be that the C-terminal domain of Cj0421c cannot be crystallised or it may require further 
optimization of the conditions to produce successful crystals. 
 
 
Figure 76: Thermal denaturation profile of the C-terminal of Cj0421c with added ligands.  Each 50 µl well 
contained 50 µM purified Cj0421c in 20 mM sodium phosphate buffer with 500 mM NaCl pH7.4 and 5 µl 
of the 10X SYPRO orange dye (Invitrogen).  The colours correspond to the different compounds tested.  
Each data set is the mean result of 3 technical replicates.   The data was processed using the Boltzmann 
equation to calculate the relative thermal denaturation profile.  The data was normalized to the maximum 




6.2.5 Overexpression and purification of Cj0422c 
When purifying proteins, it is usual to keep the protein chilled at all times to inhibit 
contaminating proteases from degrading the protein of interest, or to prevent the growth of 
any contaminating microorganisms.  When purified, the Cj0422c protein was found to 
precipitate out of solution when chilled below 18-20°C.  This precipitation means that the 
Cj0422c protein had to be kept at room temperature or higher at all times.  To accomplish this 
the protein was never chilled below 25°C when being purified or concentrated.  The 
pET28cj0422c::Kan plasmid was transformed into the E. coli strain Bl21-(DE3), a series of 
overexpression trials were performed to determine the best condition to use for high protein 
expression (data not shown).  The Cj0422c overexpression strain was grown to an OD600nm of 
0.7 in LB broth containing 50 µg ml-1 kanamycin and induced with 1 mM IPTG.  The cultures 
were incubated at 37°C for 3 hours and harvested by centrifugation.  The cell free extract was 
extracted from the pellets using methods described in (Section 2.26.3).  The resuspension 
buffer contained 50 mM Tris-HCl buffer pH 7.4 with 20 mM imidazole and 500 mM sodium 
chloride.  The protein was separated from the cell free extract using a His-Trap 
chromatography column.  The Cj0422c protein binds unusually strongly to the His-trap column, 
initial attempts to purify the protein using a 20-500 mM imidazole gradient did not produce 
any purified protein despite the protein being visible on SDS-PAGE gels.  The protein could only 
be purified using up to 700 mM imidazole and this was achieved in a single step.  After loading 
the His-trap column with the cell free extract the column was washed with buffer containing 
300mM imidazole and then the protein eluted by running 700 mM imidazole through and the 
fractions collected.  This 2-step purification method means the protein was already highly pure 
after only a single purification step.  (Figure 77) shows the 2 step purification method being 
performed on an AKTA prime plus. 
 
To remove the imidazole, the Cj0422c protein sample was dialysed using a 5 kDa cutoff dialysis 
tubing (Sigma).  The protein was dialysed overnight in 50 mM Tris-HCl pH7.4, 500 mM NaCl 
buffer containing 10 mM EDTA and 0.2% sodium azide.  The EDTA was added because the 
protein binds so tightly to the His-trap column it may pull some nickel out from the column.  
The sodium azide was added to prevent the growth of microorganisms in the buffer as the 
dialysis was performed at 30°C (because the protein precipitates below 20°C).  The protein was 
then re-dialysed in 50 mM TRIS-HCl pH7.4 and 500 mM NaCl to remove the EDTA and sodium 



















6.2.6 Do Cj0421c and Cj0422c interact 
Both Cj0421c and Cj0422c are encoded in the same operon and are nearly always encoded as 
linked genes in the same strains of C. jejuni (Figure 11).  The role of Cj0422c as a DNA binding 
repressor is well established from a previous student (Hitchcock, 2011) however the role of 
Cj0421c is elusive.  Protein-protein crosslinking reactions were performed with purified 
Cj0421c and Cj0422c to test if the C-terminal domain of Cj0421c interacts with Cj0422c.  
Initially both Cj0421c and Cj0422c were crosslinked individually to determine if they form 
dimers or multimers, Cj0422c is predicted to form a dimer as this is typical of helix-turn-helix 
proteins.  The protein samples were mixed with the crosslinking reagent dithiobis(succinimidyl 
propionate (DSP) (Thermo-Fisher) at either 0.5 or 2 mM and incubated for 30 minutes at 25°C.  
The samples were then separated on 16% SDS-PAGE tricine gels.  The experiment was 
repeated using Cj0421c and Cj0422c mixed together to assess if they bind to each other.  
Cj0421c was concentrated to 100 µM while Cj0422c was concentrated to 60 µM.  The 
concentration of Cj0421c was kept constant and the concentration of Cj0422c was increased.  
The crosslinking reaction SDS-PAGE gel shown in (Figure 78) shows that Cj0422c does indeed 
form a dimer and may form higher oligomers, though this may be a by-product of the 
crosslinking reaction.  Cj0421c did show some higher band sizes after crosslinking but the 
majority of the protein remained in monomeric form, implying that the protein does not 
dimerise.  This is backed up by gel filtration purification of Cj0421c (Figure 75) where Cj0421c 
elutes as a single peak at the expected molecular weight (Data not shown).  The crosslinking 
reaction SDS-PAGE gel shown in (Figure 79) shows that Cj0421c and Cj0422c may interact at 
the protein level, the data shows that the monomeric Cj0422c band completely disappears 
when crosslinked with Cj0421c, and a larger band appears at a size consistent with the 
combined molecular weights of Cj0421c and Cj0422c (about 27.7 kDa).  Unfortunately, the 
assay did not go as expected as after adding the DSP crosslinking reagent to the mixed protein 
a precipitant formed (most likely Cj0422c) which is visible at the top of the gel as an insoluble 
protein band.  The Cj0421c band intensity is seen decreasing as the concentration of CJ0422c is 
increased across the gel.  This may be because the precipitated Cj0422c is non-specifically 
binding to Cj0421c, which means no firm conclusions can be drawn about whether Cj0421c 








Figure 78: Chemical crosslinking of Cj0421c and Cj0422c.  (A) 16% SDS-PAGE tricine gel loaded with 100 µM 
Cj0421c and 60 µM Cj0422c after crosslinking with DSP.  Lane 1 is Cj0421c with 0.5 mM DSP, lane 2 is Cj0421c 
with 2 mM DSP.  Lane 3 is Cj0422c with 0.5 mM DSP and lane 4 is Cj0422c with 2 mM DSP).  (B) is the same SDS-
PAGE gel but silver stained.  The blue arrow shows the potential dimerization of Cj0421c and the red arrows 





Figure 79: Chemical crosslinking of Cj0421c and Cj0422c together.  (A) 16% SDS-PAGE tricine gel loaded with 
100 µM Cj0421c alone (lane1) and 60 µM Cj0422c alone (lane2).  The following list is the Cj0421c:Cj0422c 
proteins at increasing ratios.  Lanes 3 and 4 are at a 1:1 with 0.5 and 2 mM DSP respectively.  Lanes 5 and 6 are 
at a 1:2 ratio with 0.5 and 2 mM DSP respectively.  Lanes 7 and 8 are at a 1:4 ratio with 0.5 and 2 mM DSP 





6.2.7 Crystalisation of Cj0422c 
6.2.7.1 Crystalisation of the native C-terminal His tagged Cj0422c protein 
Initially work on the Cj0422c protein involved using the C-terminal His tagged construct which 
was produced by Dr Ed Guccione.  This construct was generated in pET21a where the protein 
contains a 6-histidine tag at the C-terminal end of Cj0422c (data not shown).  This protein was 
overexpressed and purified using similar methods to those described in (Section 6.2.5) with 
the exception that the buffer used was PBS buffer with 500 mM NaCl at pH7.4.  The protein 
could be purified but the yield was low (typically around 1 mg of pure protein could be 
obtained from 1 litre of culture).  The protein could not be concentrated above around 5 mg 
ml-1 as precipitate formed at higher concentrations and the protein could not be chilled.  The 
purified protein was screened for crystalisation using microdrops of 200 nl protein and 200 nl 
precipitant which were set up in sitting drop vapour diffusion trials using a Matrix Hydra II Plus 
One crystalisation robot in collaboration with Dr John Rafferty.  Crystals formed in the PACT 
crystal screen (Qiagen) well C2 which contained 0.1 M PCB, pH5, 25% PEG1500.  The protein 
was re-purified and crystals were generated using hanging drop crystal trials where 3 µl of 
protein and 3 µl of precipitant were mixed onto siliconized coverslips and allowed to vapour 
diffuse with 1 ml of the crystalisation buffer.  The crystals typically formed after 1 week at 17°C 
and were stored in cryoprotectant (the crystalisation buffer with 2% more PEG 1500 and 20% 
ethylene glycol) and sent to the Diamond Light Source (Oxfordshire) for X-ray diffraction 
analysis, the crystals are shown in (Figure 80).  The data was collected from 7 individual 
crystals on beamline I03 with a beam size of 50 X 35 µm, the analysis was performed by Dr 
John Rafferty.  The crystals produced good diffraction patterns but the structure could not be 
solved due to the phase problem. The crystal unit cell dimensions are a = 38 Å, b = 67 Å, c= 72 
Å,  α = γ = 90q, β = 95q with each unit composed of 2 copies of the monomer.  Which implies 













Figure 80: Looped crystal of the C-terminal His tagged Cj0422c protein.  Image taken from the I03 beamline at 
Diamond light source.  The crosshair highlights the exact position of the X-ray beam (beam size 50 X 35 µm).  (A) 
and (B) shown different magnifications of the same crystal in different orientations. 
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6.2.7.2 Overexpression and purification of selenomethionine incorporated Cj0422c 
When producing protein samples for X-ray crystallographic analysis heavy elements can be 
incorporated into the protein to solve the phase problem.  There are several ways of doing this 
but one of the most popular is producing protein samples where selenomethionine has been 
incorporated into the protein.  The method for production of selenomethionine incorporated 
protein is described in (Section 2.26.2).  Despite numerous attempts high concentrations of 
selenmethionie incorporated Cj0422c could not be produced.  This was attempted using the C-
terminally tagged Cj0422c construct produced by Dr Ed Guccione.  Because of this I decided to 
move the His tag to the N-terminal end of the protein and to re-attempt the crystalisation 
process.  The construction of the N-terminally tagged Cj0422c protein and its purification are 
described in (Section 6.2.5).  The N-terminal protein tag proved to be more stable and could be 
produced in higher concentrations than the C-terminal tag (typically 3-4 mg of protein 
produced per liter). 
 
The native Cj0422c-N protein was purified and screened for crystalisation using the same 
methods described in (Section 2.33).  Crystals formed after 1 week in the Proplex B7 (0.2 M 
ammonium acetate, 0.1 M sodium acetate, pH4, 15% PEG4000) and the PACT D1 ( 0.1 M MMT, 
pH5, 25% PEG1500) wells.  The crystals were re-generated using hanging drop trials in both of 
these conditions with the crystals in the PACT D1 conditions growing faster and producing 
better quality crystals. 
 
The N-terminally tagged Cj0422c protein was then produced with selenomethionine 
incorporation, the purification method is the same as described in (Section 6.2.5 ).  Both the 
regular protein and selenomethionine incorporated protein were checked by mass 
spectrometry analysis.  Because the N-terminal methionine is often cleaved off the protein the 
predicted molecular weight for both the non-incorporated and selenomethionine incorporated 
Cj0422c without the starting methionine is 10601.97 Da and 10742.67 Da respectively.  The 
mass spectrometry data shown in (Figure 81) confirms this and suggest that the 
selenomethionine has been successfully incorporated into the protein.  The native Cj0422c 
protein has a predicted isoelectric point of pH 8.9 and a predicted extinction coefficient of 











Figure 81: Mass spectrometry analysis of Cj0422c and selenomethionine-incorporated Cj0422c.  (A) shows the 
molecular weight of the purified Cj0422c protein 10602.28 Da (predicted MW is 10601.97 Da).  (B) shows the 




6.2.7.3 Crystalisation of selenomethionine incorporated Cj0422-N 
Part of the problem with crystalising Cj0422c (a problem with both the C and N terminally 
tagged proteins) is that the protein is difficult to concentrate past 5 mg ml-1 and cannot be 
chilled to lower than 20°C without the protein precipitating out of solution.  To prevent this 
the protein was kept above 25°C at all times and the siliconized cover slips were warmed up 
using the underside of a standard lab metallic heating block when the protein solution and 
crystalisation buffer were mixed together.  The crystalisation trays were then stored at 37°C 
for 24 hours, then at 30°C for 24 hours, then at 25°C for 24 hours before being stored at 17°C 
until crystals formed.  This was designed to keep the protein in solution while the nascent 
crystals form around a nucleation site.  These hanging drop trials of the selenomethionine 
incorporated Cj0422c-N protein produced many small crystals, which were too small to 
provide reliable diffraction data.  Because of this I decided to use the small crystals as a seed 
stock to produce larger cystals.  The crystals were broken up by vortexing with small glass 
beads and were serially diluted 10-fold in cryoprotectant (the same buffer as the crystalisation 
buffer with 4% more PEG1500.  The 10-3 and 10-5 dilutions were mixed with the next 
crystalisation buffer before adding the Cj0422c protein solution.  Unfortunately, this did not 
result in any change in the size of the crystals.  Another method for generating bigger crystals 
is to use a whole or partial crystal as a ‘macro seed’, which involves looping a fully formed 
crystal and transferring it to a new hanging drop where the protein in solution should form 
around the existing crystal in preference to forming new crystals.  This method was attempted 
and did produce bigger crystals, but these did not produce diffractions pattern to a low enough 













6.2.8 Overexpression and purification of Cj0425 
The Cj0425 protein had already been purified by a previous student Halah Al-Haideri so the 
overexpression and purification procedure was already established.  The pET22cj0425::Amp 
plasmid was transformed into the E. coli strain Bl21-(DE3).  The Cj0425 overexpression strain 
was grown to an OD600nm of 0.6 in LB broth containing 50 µg ml-1 ampicillin and induced with 
0.5 mM IPTG.  The cultures were incubated at 25°C overnight and harvested by centrifugation.  
The cell free extract was extracted from the pellets using methods described in (Section 
2.26.3).  The resuspension buffer contained 20 mM sodium phosphate buffer pH 7.4 with 20 
mM imidazole and 500 mM sodium chloride.  The protein was separated from the cell free 
extract using a His-Trap chromatography column where the imidazole concentration was 
steadily increased from 20-300 mM.  The Cj0425 protein was not initially pure and so was 
further purified by hydrophobic interaction chromatography and then by gel filtration 
chromatography, all of which are shown in (Figure 83).  The protein was then concentrated 
using 10 kDa cutoff concentration columns (GE Life Sciences).   All chromatography steps were 
performed using an AKTA Prime Plus chromatography system with the associated columns and 
buffering systems.  The protein has a predicted molecular weight of 14790 Da, a predicted 
isoelectric point of pH 5.6 and a predicted extinction coefficient of 14565 M-1 cm-1 assuming 








































6.2.9 Checking purified Cj0425 for the formation of a disulfide bond 
The Cj0425 protein contains a single disulfide bond, the protein is expressed in the periplasm 
of E. coli to allow to bond to form and the protein to fold correctly.  To test that the disulfide 
bond is formed the molar concentration of free thiol groups was assayed using the DTNB assay 
or (Ellman’s reagent) as described in (Section 2.29), this reagent reacts with free thiol groups 
and then absorbs at 412nm.  A standard curve of free thiols was generated using acetylcysteine 
with the results shown in (Figure 84).  The molar concentration of free thiols in the purified 
Cj0425 sample was calculated using the standard curve.  BSA was used as a control as purified 
BSA should contain 1 free thiol group (it contains other cysteine residues but these form 
disulfide bonds).  The calculated free thiol concentration in Cj0425 was calculated as 0.85 µM 





Figure 84: The concentration of free thiols in purified Cj0425.  (A) the standard curve showing the Abs 412nm of 
increasing concentration of acetylcysteine.  The equation of the line was calculated as Abs412nm=0.017 X + 
0.0086.  (B) shows the molar concentration of free thiols in Cj0425 and the BSA positive control.  The BSA 




6.2.10 Cysteine protease inhibitory activity of Cj0425 
Previous work on Cj0425 had shown it to inhibit the cysteine protease papain, though the 
inhibition was small and attempts to titrate the binding of Cj0425 to papain were unsuccessful.  
The hydrolytic activity of papain can be assayed using BAEE-coumarin (Sigma) which is cleaved 
by papain and releases the flurogenic substrate 7-amino-4-methyl coumarin, the assay is 
described in (Section 2.30).  As part of this assay the concentration of active papain (Sigma) 
was determined by titrating with a cysteine protease inhibitor E64 [1-[N-[(L-3-trans-
carboxyoxirane-2-carbonyl)-L-leucyl]amino]-4-guanidinobutane].  This inhibitor irreversibly 
binds to the active thiol residue in cysteine proteases thereby permanently inhibiting protease 
activity (Kim et al., 1992).  The rate of reaction is measured in moles of 7-amino-4-methyl 
coumarin liberated per minute where one unit of papain will hydrolyse 1 µmol BAEE per 
minute at 25°C pH 6.2.  The temperature of the reaction was increased to 37°C to try and 
ensure the Cj0425 protein is active as C. jejuni is adapted to this temperature.  The titration of 
papain with E64 is shown in (Figure 85) and shows a linear decrease in the rate of reaction with 
increasing concentration of E64.  Because E64 irreversibly binds to papain in a 1:1 ratio the 
concentration of E64 that results in a reaction rate of 0 is equimolar to the concentration of 
active papain.  This was calculated as 177.36 nM papain.  This concentration was used for all 






Figure 85: Titration of papain with E64.  The rate of reaction was calculated as the nmoles of coumarin 
liberated per minute.  Increasing the concentration of E64 generates a linear decrease in the rate of reaction.  
The concentration of papain in the final reaction is calculated at the point the line of best fit crosses the X 




The same experimental procedure was repeated using purified Cj0425 and E64 as a control.  
The experiment was performed initially using a high concentration of Cj0425 relative to papain 
(initially using 1 µM Cj0425 final concentration.  The experiment failed to show any decrease in 
the rate of reaction.  The data shown in (Figure 86) shows only a very small change in the rate 
of reaction of papain when compared to the reaction with no inhibitor present.  Given that the 
concentration of Cj0425 in the reaction is around 5 times that of the active papain this implies 
that Cj0425 is not inhibiting the reaction.  Cysteine proteases need to be ‘activated’ prior to 
use by reducing agents such as cysteine, ß-mercaptoethanol.  It was thought that this may 
break the disulfide bond in Cj0425 thereby inactivating it, so the reaction was repeated where 
the papain was ‘activated’ in a reducing buffer and then transferred to a non-reducing buffer 









Figure 86: Fluorescence spectroscopy of the hydrolysis of BAEE-coumarin by papain with Cj0425 and E64.  
The cysteine protease activity of papain alone is shown by the black line and clearly shows the hydrolysis of 
BAEE-coumarin.  The blue line shows the lack of any rate when inhibited with near equimolar E64.  The 
yellow line shows the rate when mixed with a near 5-fold excess of Cj0425.  The concentration of papain was 
calculated previously as 177 nM.  Each data point is the result of 2 replicates.  The fluorescence is measured 




Because the data in (Figure 86) shows almost no inhibition of papain by Cj0425, it was decided 
to repeat the experiment using a different cysteine protease.  Because papain is a plant 
cysteine protease it was decided to use the human cysteine protease cathepsin-B (Sigma) as it 
is commercially available and C. jejuni is more likely to encounter an animal derived cysteine 
protease than a plant enzyme.  The assay for measuring the protease activity of cathepsin-B is 
similar to papain but uses a different substrate ZAA-Coumarin.  The assay is described in 
(Section 2.31) and is based on (Barrett, 1980).  The Cj0425 protein was re-purified and re-
assayed for formation of the disulfide bond.  The assay was initially performed again using a 
high concentration of Cj0425 and E64 (15 µM each) to look for any inhibition of cathepsin-B.  
The data shown in (Figure 87) again shows a complete inhibition of cathepsin-B when mixed 
with E64 and no discernible difference in the rate of reaction when mixed with Cj0425.  The 
concentration of cathepsin-B was not calculated by titration as no inhibition could be observed 
when assayed in the presence of Cj0425.  The rate of ZAA-coumarin hydrolysis was found to be 
considerably slower with cathepsin-B than with papain, so the assays were performed over a 






Figure 87: Fluorescence spectroscopy of the hydrolysis of ZAA-coumarin by cathepsin-B with Cj0425 and 
E64.  The cysteine protease activity of cathepsin-B alone is shown by the black line and clearly shows the 
hydrolysis of ZAA-coumarin.  The blue line shows the lack of any rate when inhibited with 15 µM E64.  The 
yellow line shows the rate when mixed with 15 µM of Cj0425.  Each data point is the result of 2 replicates.  




6.2.11 Does Cj0425 have any binding partners in C. jejuni 
Because Cj0425 shows no inhibitory activity against the cysteine protease enzymes papain or 
cathepsin-B, it may be that Cj0425 is not a cysteine protease inhibitor.  Though it shows 
structural similarity to cystatins it may act as an inhibitor of a different kind of enzyme or 
potentially has a completely different role.  It was decided to examine the C. jejuni genome for 
potential binding partners.  A sample of 4699 publicly available C. jejuni genomes was analysed 
to look for potential Cj0425 binding partners.  The data was collected and analysed by Dr Roy 
Chaudhuri and shows no apparent positive or negative correlation between the presence of 
cj0425 and any other genes (apart from cj0423 and cj0424) (data not shown). 
 
I decided to screen for potential interaction partners using pull down assays, using both 
purified Cj0425 and natively expressed Cj0425 in C. jejuni 11168.  To screen for potential 
interaction partners using recombinant Cj0425, 2 litres of wild type C. jejuni were cultured 
under normal conditions and the total soluble protein extracted into 20 mM sodium 
phosphate buffer and 100 mM NaCl at pH 7.4.  The total soluble protein was passed through a 
His trap column and washed with the loading buffer with 20 mM imidazole and 300 mM 
imidazole.  All the elutions were collected as a single fraction.  The column was then washed 
with loading buffer and the purified recombinant Cj0425 protein was loaded onto the column.  
The total C. jejuni cell free extract was then re-loaded onto the column and the process 
repeated.  All fractions were collected and separated on SDS-PAGE gels to look for any 
differences.  Any proteins which bind to Cj0425 should, in theory, be visible in lane 9 but not in 
lane 4.  The SDS-PAGE gel shown in (Figure 88) shows no immediately obvious binding partner 













Figure 88: His trap pulldown of recombinant Cj0425 with C. jejuni soluble proteins.  (A) 14% SDS-PAGE gel 
showing the elution fractions from the pulldown of Cj0425 with soluble C. jejuni proteins.  Lane 1 is the C. jejuni 
CFE prior to loading, lane 2 is after washing with loading buffer (no imidazole), lane 3 is after washing with 20 
mM imidazole, lane 4 after washing with 300 mM imidazole.  Lane 5 is the recombinant Cj0425 protein (14.7 
kDa), lane 6 is the re-mixed soluble C. jejuni proteins.  Lane 7 is re-washing with loading buffer, lane 8 with 20 





Because the pulldown assay shown in (Figure 88) shows no potential binding partner for 
recombinant Cj0425 it was decided to repeat the experiment using native Cj0425 under the 
iron inducible fdxA promoter.  The complete cj0425 ORF was cloned into the pCFdxA vector 
where 6 Histidine residues were attached to the C-terminal end of the protein by designing the 
codons into the primer sequence (Table 7).  The construct was produced using methods 
described previously (Section 4.2.6), (Figure 89) shows the construction and screening of the 










Figure 89: Construction and screening of the iron inducible cj0425+ strain.  (A) the plasmid map of the 
pCFdxA46::cj0425-His construct generated by ISA cloning.  The FdxA promoter is represented by the green 
arrow upstream of the cj0425 ORF.  (B) The gene arrangement in the ISA construct prior to transformation into 
wild type C. jejuni 11168-DJK.  (C) following transformation the strain was screened by PCR using the cj0046 
screening primers, which are represented by the arrow in (B).  The expected band size is 455 bp for lane 1 and 




The pull down assay using the fdxA expressed Cj0425 protein was performed in a similar way 
to the pulldown using the recombinant protein.  The cell free extract was loaded onto the His 
trap column and steadily increasing concentrations of imidazole were passed through the 
column.  Unfortunately, there was no detectable peak from the UV trace of the assay and 
























6.3 Chapter 6 Discussion 
The aim of this chapter was to overexpress and purify Cj0421c, Cj0422c and Cj0425 and to 
biochemically characterize them.  Unfortunately, the roles of Cj0421c and Cj0425 have not 
been determined by biochemical methods, since there is currently no hypothesis about what 
the role of the cj0421c-cj0425 gene cluster is, the role of Cj0421c as a regulatory protein is 
difficult to test.  Previous structural studies on Cj0425 have showed that it is structurally 
similar to the cystatin family of cysteine protease inhibitors.  The data presented here shows 
that Cj0425 does not inhibit either papain or cathepsin-B and so it may not actually be a 
classical cysteine protease inhibitor. 
 
6.3.1 Metal binding analysis of cj0421c 
The melt curve thermofluor analysis of Cj0421c shown in (Figure 76) did not identify any 
potential ligands or binding partners.  The analysis of Cj0421c was performed when it was 
thought that the role of the gene cluster was as an antimicrobial peptide defense mechanism.  
The antimicrobial peptide defence mechanism in Salmonella typhimurium  (the PhoP/Q sensor 
regulator system) is activated by both acidic pH and CAMPs displacing divalent metal ions from 
the outer membrane which is sensed by PhoQ (Prost et al., 2007).  The protein was tested for 
binding to a range of divalent metal cations as well as the model CAMP polymyxin-B which 
produced no detectable increase in protein stability.  Cj0421c shows no strong homology to 
any proteins in the NCBI genomes database outside of Campylobacter species (as of 
September 2016).  The closest match is to the cyclic-di-GMP diguanylate cyclase enzymes 
which produce the second messenger cyclic-di-GMP (Romling et al., 2013).  As discussed in 
(Section 4.1) C. jejuni does not possess any other cyclic-di-GMP related proteins which implies 
that Cj0421c does not bind to cyclic-di-GMP.  The thermofluor data supports this as there was 
no change in the thermal stability of Cj0421c when mixed with cyclic-di-GMP which implies 
that it does not bind the second messenger (Figure 76).  Attempts to crystalise Cj0421c using 
both the C- and N-terminal His-tagged protein produced no viable crystals despite testing 
numerous conditions.  The Cj0421c protein is relatively easy to overexpress and purify and 
protein yields are generally high (>10 mg per litre), the protein is also stable during medium 
term storage and does not degrade easily or precipitate.  The purification procedures for this 





6.3.2 Interaction between Cj0421c and Cj0422c 
The Cj0422c protein is challenging to work with as it cannot be concentrated to >5 mg ml-1 and 
will precipitate out of solution when chilled below 20°C.  The protein can be kept in solution by 
re-heating however attempts to crystalise the protein after precipitation and re-solubilising 
have not been successful so it is assumed that the conformation of the protein is altered after 
precipitation has occurred.  Because of this there is only a short window of opportunity to 
study the protein after purification.  Prokaryotic helix-turn-helix transcriptional regulators like 
Cj0422c often form dimers and typically bind to palindromic repeat sequences, some are 
soluble as monomers and only form dimers when bound to DNA.  Other H-T-H proteins bind to 
DNA as single monomers or sometimes tetramers but dimers appear the most common 
(Huffman and Brennan, 2002).  Chemical crosslinking reactions have shown that Cj0422c forms 
a dimer in solution and previous work has shown that it binds to an 18 bp palindromic repeat 
sequence upstream of the cj0423 ORF.  It is likely then that 2 copies of the protein bind to each 
other in the cytoplasm and then bind to the palindromic repeat sequence in opposing 
orientations.  This shows that Cj0422c is a typical prokaryotic transcriptional regulator but 
does not explain how the cj0423-5 operon is controlled.  Chemical crosslinking of Cj0421c 
alone did show some higher bands that may indicate dimerization, however the bands were 
very faint and were only visible after silver staining (Figure 78), and since Cj0421c is membrane 
bound and not normally free in solution the band may just be non-specific binding.  The 
crosslinking reaction between Cj0421c and Cj0422c is harder to interpret as the Cj0422c 
protein appeared to precipitate out of solution and a large amount of insoluble protein is 
visible at the top of the SDS-PAGE gel (Figure 79).  The data suggests that the two proteins may 
not interact with each other directly, however because of the Cj0422c precipitation and 
because the Cj0421c globular domain is not membrane bound in-vitro it may not be 
functioning or folding correctly so further work, possibly using in-vivo methods such as two 
hybrid analysis may be needed to thoroughly analyse any interactions between the two 
proteins. 
 
6.3.3 Crystalisation of Cj0422c 
The N-terminally His tagged Cj0422c protein can be crystalised with relative ease, however the 
difficulty in producing highly concentrated protein means that producing large enough crystals 
is difficult.  Initital crystallization trials using the C-terminally tagged Cj0422c protein were 
relatively successful in that high resolution diffraction patterns were produced.  However, 
selenomethionine derivatives of this protein were unstable and could not be purified in large 
enough quantities to produce crystals.  Switching the His tag to the N-terminal end of the 
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protein did produce more stable selenomethionine crystals which could be grown to a 
reasonable size for X-ray diffraction analysis.  Unfortunately, despite numerous attempts these 
crystals did not generate good enough diffraction patterns to construct a structural model of 
Cj0422c.  Future work on the Cj0422c protein should involve trying to find a way to increase 
the yield and concentration of the protein and maybe attempting to find a buffer condition 
where the protein does not precipitate when chilled. 
 
6.3.4 Cj0425 does not inhibit the cysteine proteases papain or cathepsin-B 
The Cj0425 protein had already been purified and crystalised by a previous student, the crystal 
structure was solved using selenomethionine incorporated Cj0425 to a 2 Å resolution by Dr 
John Rafferty.  The structure of the protein shows strong homology to cysteine protease 
inhibitor proteins known as cystatins.  Cystatins are well studied in humans as they can often 
play a crucial role in disease progression, the role of cystatins in higher eukaryotes appears to 
be as a way to post translationally regulate the action of cysteine proteases (Turk et al., 2008).  
Eukaryotic cystatins appear to be reasonably non-specific inhibitors and do not differentiate 
between different cysteine protease enzymes (though they can differentiate between endo 
and exo peptidase enzymes), typically cystatins inhibit proteases in a 1:1 ratio (Jenko et al., 
2003).  The role of cystatins in prokaryotic systems is less well studied, this may be because 
cystatins are classed by their structure rather than by specific residues or domains, therefore 
they are difficult to predict bioinformatically.  It may be that cystatins are very widespread in 
bacteria but with highly divergent protein sequences.  The Cj0425 protein sequence showed 
that it is periplasmic but showed no sequence homology to other cystatins (either microbial or 
eukaryotic).  This chapter aimed to elucidate how effective Cj0425 is as a cysteine protease 
inhibitor by titrating it against the cysteine protease papain.  Unfortunately, when tested for 
inhibitory activity against papain, no detectable decrease in activity could be measured.  Steps 
were taken to ensure that the Cj0425 protein was correctly folded and still no inhibitory 
activity could be observed.  The same experiment was repeated using the human cysteine 
protease cathepsin-B.  Again, no decrease in activity was observed even with a very large 
increase in the concentration of Cj0425 relative to the cathepsin-B.  While it is feasible that the 
purified protein was not folded correctly or may have been damaged in some way, the data 
suggests that Cj0425 may not be a cysteine protease inhibitor.  Part of the previous hypothesis 
about the role of Cj0425 as a peptidoglycan amidase inhibitor was based on the similarity 
between the active site of cysteine proteases and some types of peptidoglycan amidases, 
namely the presence of a reactive thiol group (Sanz-Gaitero et al., 2014).  As part of a future 
study on Cj0425 it may be worth testing for inhibitory activity against peptidoglycan specific 
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cysteine proteases rather than more generic ones like papain.  Unfortunately, I was unable to 
find any commercially available peptidoglycan specific cysteine protease enzymes so each one 
being tested would need to be purified individually and a suitable assay developed to look for 
inhibition. 
 
6.3.5 Cj0425 pulldown assays could not find any potential binding partners 
The Cj0425c pulldown assay shown in (Figure 88) did not reveal any immediately obvious 
binding partners for Cj0425.  As shown in (Figures 86-87) Cj0425 does not appear to inhibit 
cysteine protease enzymes in-vitro and as such it is difficult to predict what kind of proteins 
Cj0425 may bind to.  Bioinformatic analysis of 4699 publically available C. jejuni genomes by Dr 
Roy Chaudhuri could not find any likely binding partners for Cj0425, the analysis looked at 
correlations between the presence of cj0425 and other genes within the 11168 genome.  No 
likely candidate genes were strongly correlated (either positively or negatively) with the 
presence of cj0425 (data not shown).  Attempts to pulldown Cj0425 binding partners may have 
been more successfully using natively expressed protein rather than recombinant Cj0425.  
However, attempts to overexpress His tagged Cj0425 using the fdxA promoter (Figure 89) in 
wild type C. jejuni were unsuccessful.  As a side note, the same technique was used to 
overexpress the Cj0423 protein in Chapter 5, which also did not produce strong up-regulation.  
The lack of strong expression under the fdxA promoter highlights the need for a system of high 
protein expression in the C. jejuni background.  Work being continued by another student 
Aidan Taylor on the C. jejuni metK and fdxA promoters shows that the fdxA promoter is 
expressed to around 700-800 Miller units when induced with iron which is probably too low to 
overexpress enough protein for native pulldown assays.  
 
 The role of Cj0425 was thought to be as cysteine protease inhibitor based on the structure of 
the protein.  However, the lack of any inhibitory activity and the lack of any characterised 
binding partners mean the true role of Cj0425 remains elusive.  The Cj0425 protein may still 
act as a type of protease inhibitor, possibly acting on peptidoglycan specific cysteine proteases.  
The data shown in (Figure 12) in Chapter 3 shows that the cj0421c-cj0425 gene cluster varies 
between C. jejuni strains, the 3 structural genes within the C. jejuni 81116 operon include 2 
genes which are similar in domain architecture to cj0423 (c8j_0398 and c8j_0400).  The other 
gene in the 81116 operon (c8j_0399) is annotated as hypothetical periplasmic protein.  The 
mature protein sequence of C8j_0399 has a similar length to Cj0425 (97 to 118 residues 
respectively) and also contains 2 internal cysteine residues. Both cj0425 and c8j_0399 are 
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under the regulatory control of the Cj0422c repressor so it may be that C8j_0399 is also an un-
annotated cystatin.  This will need to be tested biochemically but if an un-related cystatin like 
protein is found in the same operon from 81116 then it strongly suggests separate 


























7 Chapter 7 general discussion and future work 
 
7.1 Unravelling the rid system 
The initial aim of this project was to examine the regulatory roles of Cj0421c and Cj0422c in 
relation to the resistance to innate defences (rid) operon.  The rid operon was thought to be 
involved in resistance to cationic antimicrobial peptides (CAMPs), partly because of the high 
sensitivity of the cj0422c mutant strain to the model CAMP polymyxin-B.  The microarray data 
shown in chapter 1 (Figure 7) appeared to imply that several genes throughout the NCTC 
11168 genome could be up or down-regulated by Cj0422c.  During the course of the data 
presented in chapter 3 it became apparent that the high level of CAMP sensitivity seen in the 
cj0422c mutant strain was not found in mutants of other genes within the same operon and 
that there is no apparent regulatory response within the operon to the presence of polymyxin-
B in wild type C. jejuni.  Initially it was thought that the high level of sensitivity seen in the 
cj0422c mutant was due to an un-intentional recombination event within the cj0423 promoter 
region (Figure 25), although this turned out to be unrelated to the polymyxin-B sensitive 
phenotype.  Further work showed that the the polymyxin-B sensitivity seen in the mutant 
strain was actually un-related to the cj0421c-cj0425 operon.  The complete genome sequences 
of two variants of the cj0422c mutant strain revealed that the likely cause of the polymyxin-B 
sensitivity seen in the cj0422c mutant was due to a single frame shift SNP within the cj0256 
ORF.  Cj0425 is an ethanolaminephosphotransferase protein responsible for attaching 
phosphoethanolamine to both lipid-A and the flagellar rod protein FlgG.  Another study has 
shown that deletion of cj0256 results in much higher sensitivity to polymyxin-B, which has 
been supported (albeit unintentionally) here (Cullen and Trent, 2010). 
 
The wild type strain of C. jejuni 11168 used in our laboratory was also genome sequenced 
which revealed multiple small variations from the original NCTC 11168 sequence (Parkhill et 
al., 2000).  The strain was re-named as C. jejuni 11168-DJK for the purposes of this study.  In 
total the laboratory strain genome contained 49 differences to the reference strain, of which 7 
were in intergenic regions, 21 resulted in in-frame codon changes, 12 resulted in a likely loss of 
gene product and 9 were other changes which are categorised in chapter 3 (Section 3.2.15).  
Many of the changes appeared to be adaptations to continued growth under laboratory 
conditions.  Many of the genes responsible for motility and chemotaxis contained frame shift 
SNPs.  Several genes responsible for the uptake of nutrients such as lactate also contained 
frame shift SNPs.  Since the laboratory strain of C. jejuni is routinely cultured in rich broth, the 
strain has no need for motility or the uptake of alternative metabolites.  The lack of Cj0076c (L-
lactate permease) is likely responsible for the inability of the lab strain to use lactate as a 
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primary carbon source, this was discovered when attempting to culture the strain in the 
MCLMAN minimal media which uses lactate as the primary carbon source, as discussed in the 
materials and methods.  The carbon source used for the media was subsequently altered to L-
serine. 
 
The genome sequence of the cj0422c mutant strains also showed a number of changes either 
nearby or within the genes which were differentially expressed in the cj0422c mutant 
microarray, such as cj0204, cj0653c and cj0864.  Initially it was thought that these differences 
may be due to the genes being differentially regulated in the mutant strain and that SNPs have 
accumulated to cope with the altered expression.  However, after further analysis of the 
expression of these genes by qRT-PCR, which is a considerably more accurate measure of 
individual gene expression, it seems apparent that the differences seen in the microarray data 
may be because of the SNPs, rather than causing them.  As discussed in (Section 4.2.8) this 
may be due to the inherent unreliability of microarray data concerning individual genes, where 
the probes are designed from a reference strain genome rather than the genome of the strain 
being tested.  
 
As as side project the genome sequence of a hypermotile variant of C. jejuni, known as NCTC 
11168-H was also genome sequenced.  This variant was originally described by (Karlyshev et 
al., 2002) who was looking at phase variable motility variants, to the best of our knowledge 
this variant has not been completely genome sequenced before.  The genome sequence of this 
strain revealed only 6 SNP variants between this strain and the reference strain (Parkhill et al., 
2000).  This implies that what is known as the hypermotile variant of C. jejuni may actually just 
be a closer relative to the original reference strain than other laboratory strains, which may 
have acquired SNPs or contain altered phase variable genes making them less motile. 
 
7.2 Bioinformatic analysis of the cj0421c-cj0425 operon 
As shown in Chapter 1 (Section 11), the proposed regulatory genes cj0421c and cj0422c are 
found in around 90% of C. jejuni strains.  The genes being regulated are however highly 
variable between strains.  Since the promoter region is conserved it appears that different C. 
jejuni strains contain a different set of genes to respond to the same hypothetical stimulus.  
Bioinformatic analysis shows that all the sub-strains contain at least one small inner membrane 
protein such as cj0423.  This is the only conserved feature between the sub strains and may act 




7.3 The cj0421c-cj0425 mutant strains show no obvious phenotype 
For chapter 4 a series of new mutant and complementation strains were produced in the 
11168-DJK background strain.  Initially the cj0421c and cj0422c mutant strains were assayed 
for changes in gene expression by qRT-PCR.  This showed that Cj0422c alone appears to be 
responsible for repression of the cj0423-5 operon and that deletion of cj0421c produces no 
detectable change in gene expression.  Following on from this the set of mutant strains were 
assayed for growth defects and for any changes in sensitivity to various antimicrobials, none 
were observed.  Because the cj0423-5 operon is repressed by Cj0422c under normal 
conditions, mutations within these genes may not show any observable phenotype.  The 
cj0422c mutant strain thus acts as a convenient overexpression strain and will be more likely 
to show a phenotypic difference compared to wild type C. jejuni.  The cj0422c mutant strain 
was assayed for differences in membrane order and integrity and showed no biologically 
significant difference to wild type.  Work performed in collaboration with Cosmin Chintoan-Uta 
in the laboratory of Professor Mark Stevens showed that the cj0423-4 double mutant strain 
showed no attenuation of chicken colonisation compared to wild type.  This is arguably the 
most relevant negative result from this chapter, as it suggests that the role of the cj0423-5 
operon is un-related to survival in chickens.  The fact that not all strain of C. jejuni contain 
these genes also backs up this hypothesis. 
 
7.4 Cj0425 and the type VI secretion system 
The crystal structure of Cj0425 was solved by Dr John Rafferty and was shown to be 
structurally similar to a family of cysteine protease inhibitors known as cystatins.  For reasons 
discussed in Chapter 4 (Section 4.2.14) it was thought that Cj0425 may act to inhibit 
periplasmically localised peptidoglycan hydrolase enzymes.  Because both bioinformatic 
analysis and pull-down assays could not locate a native binding partner for Cj0425 (though this 
does not conclusively disprove this), it was thought that Cj0425 may act to inhibit foreign 
peptidoglycan hydrolases or proteases.  One possible source for foreign peptidoglycan 
hydrolases being in the C. jejuni periplasm are from other bacteria via the type VI secretion 
system (T6SS).  In collaboration with Dr Sarah Coulthurst at the University of Dundee, various 
C. jejuni mutant strains were assayed for sensitivity to the Serratia marcescens T6SS.  While 
many laboratories have performed interbacterial T6SS killing assays, to the best of the authors 
knowledge this is the first time C. jejuni has been shown to be sensitive to the T6SS, and is also 
the first time an ε-proteobacterium has been shown to be sensitive to the T6SS.  The data 
shown in chapter 4 shows that C. jejuni is sensitive to S. marcescens and the killing appears to 
be dependent on the T6SS.  Unfortunately, the cj0422c mutant did not appear to be any more 
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resistant to the T6SS as would be expected if the cj0423-5 operon was designed to defend 
against the T6SS. 
 
7.5 Screening for potential inducers of the cj0423 promoter  
Because the cj0423 promoter is repressed by Cj0422c during normal growth, it seems logical 
that the operon should be up-regulated in response to a certain stimulus.  A lacZ reporter 
construct was generated to report on the regulation of the cj0423 promoter in response to 
various potential stimuli.  Despite testing nearly 1000 different compounds and conditions the 
reporter strain could not identify any particular condition that up-regulated the operon.  While 
this does not dis-prove that an external compound or condition may up-regulate the operon, it 
does suggest that whatever the induction signal is it may be internal rather than external.  I 
attempted to test the hypothesis that the signal may be the presence of the Cj0423 membrane 
protein itself, however due to difficulties in artificially up-regulating Cj0423 this hypothesis 
could not be tested thoroughly.   
 
7.6 Purification of Cj0421c, Cj0422c and Cj0425 
The work detailed in chapter 6 focuses on the expression and purification of Cj0421c, Cj0422c 
and Cj0425.  Cj0421c can be purified with relative ease and remains stable during storage.  
Cj0422c is harder to purify and readily precipitates out of solution, the protein can be readily 
crystalised but attempts to generate high resolution X-ray diffraction data have so far been 
unsuccessful.  Protein crosslinking assays between Cj0421c and Cj0422c show that the 
cytoplasmic domain of Cj0421c is probably monomeric and that Cj0422c forms a dimer in 
solution.  No evidence suggesting that Cj0421c and Cj0422c interact at the protein level could 
be found, though this may have been due to Cj0422c readily precipitating out of solution 
during the assays. 
 
Cj0425 can be readily purified, with the disulfide bond formed, from the periplasm of E. coli.  
Despite work by a previous student to the contrary Cj0425 does not appear to inhibit the 
activity of the cysteine protease enzymes papain or human cathepsin-B in-vitro. 
 
7.7 Future work 
To thoroughly examine the role of Cj0425 as a cystatin.  Since there is no evidence that Cj0425 
inhibits archetypal cysteine protease enzymes such as papain, it would be useful to determine 
if Cj0425 is able to inhibit periplasmically acting peptidoglycan hydrolase enzymes.  Since these 
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enzymes are not commercially available they would need to be purified and a suitable assay 
developed to look for inhibition. 
 
To examine the role of Cj0423 as a holin-like protein.  Holins typically contain two Met start 
sites within a single ORF, which Cj0423 also does.  In phage-derived holins these two produces 
form a holin-antiholin system which inhibits the formation of inner membrane pores until the 
phage is ready to lyse the cell.  This equilibrium can be upset in phage infected E. coli by energy 
inhibition toxins such as cyanide or dinitrophenol (Žiedaite et al., 2005).  This could in theory 
be tested in the cj0422c mutant where the cj0423 operon is strongly up-regulated and as such 
may be in a holin-antiholin equilibrium state.  Artificial up-regulation of cj0423 with a site 
directed alteration of the internal start codon may also allow this hypothesis to be tested. 
 
To continue with structural studies of the Cj0421c and Cj0422c proteins, potentially by 
attempting to produce native crystals of Cj0422c and to use other methods to generate X-ray 
diffraction data, such as iodine soaking to allow the phase of the diffraction to be solved.  
Cj0421c was unable to be crystalised in this study, so producing alternative protein constructs 
or by removing the His tag after purification may allow the protein to be crystalised.   
 
To examine the role of the cj0421c-cj0425 operon in phage defense.  With the role of Cj0425 
hypothesised to be as a foreign peptidoglycan hydrolase inhibitor, and Cj0423 thought to be a 
mimic of a phage derived holin, it may be that the gene cluster is involved in phage defence.  
The high level of variability seen in the operon between different C. jejuni sub strains implies 
that the role of the genes is related to a variable condition.  A recent publication on the 
transcriptomic response of C. jejuni to phage infection showed no change in the expression of 
the cj0423-5 operon compared to un-infected C. jejuni (Brathwaite et al., 2015).  However, this 
study was primarily looking at the response to phage in a carrier state and so not committed to 
lysis.  In order to thoroughly test the holin-cystatin hypothesis a Campylobacter specific phage 
with both holin genes and peptidoglycan hydrolase genes will need to be found before any in-
vivo work can be performed. 
 
To examine the role of the MORN protein Cj0424 as a membrane binding protein.  Previous 
data has shown that the presence of recombinant Cj0424 protects liposomes from lysis by 
polymyxin-B (unpublished data).  Neither the cj0422c or cj0424 mutant strains show any 
apparent difference in polymyxin-B sensitivity and the rigidity of the C. jejuni membrane is 
apparently not altered in either mutant.  Currently work on the Cj0424 protein is focused on 
NMR analysis of protein interactions with model membranes to assess which residues of the 
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protein are involved in lipid binding.  Preliminary data suggests that the MORN motifs are not 
actively involved in binding and are more likely involved in maintaining the ß-sheet structure.  






































8.1 Gel electrophoresis size markers 
The band size markers for agarose gel electrophoresis and SDS-PAGE from Bioline and Fisher 






8.2 Phenotype microarray plates 
The compounds from the individual wells from the phenotype microarray plates (Biolog) are 
listed below.  The plate wells correspond to the data shown in (Figures 66-69).  The list can also 
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